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Abstract
Infertile couples worldwide use assisted reproductive technologies (ARTs) to help conceive
their own biological child. Due to the rising use of ARTs, there is continual emergence of
new techniques implemented in human fertility clinics. When treatment is successful, there is
an increased risk even within singletons for perinatal complications including preterm birth,
intrauterine growth restriction, low and high birth weight and genomic imprinting disorders
Beckwith Wiedemann Syndrome, Angelman Syndrome, and Silver-Russel Syndrome.
Consequently, there is a need to investigate the effects of these treatments on the manipulated
oocyte and preimplantation embryo. To address this, I first analyzed the combined effects of
multiple ARTs on imprinted DNA methylation in human day 3 (6 to 8 cells) and blastocyststage embryos.

As imprinted DNA methylation is acquired during gametogenesis and

maintained throughout preimplantation development, I hypothesized that ARTs disrupt this
regulation in donated, good quality, human preimplantation embryos.

I observed that

seventy-six percent of day 3 embryos and fifty percent of blastocysts exhibited perturbed
imprinted methylation at the SNRPN, KCNQ1OT1 and/or H19 domains. This frequency was
similar to that previously observed in the mouse, and importantly demonstrated that extended
culture did not pose a greater risk for imprinting errors. Overall, human preimplantation
embryos generated with ARTs possessed a high frequency of imprinted methylation errors.
Next, I hypothesized that a single, indispensible ART treatment, ovarian stimulation, disrupts
mitochondria in mouse oocytes and preimplantation embryos. Ovarian stimulation led to a
decreased total and active mitochondrial pool in high hormone-treated oocytes, and an
increase in the percentage of oocytes displaying mislocalization of active mitochondria.
Although the total mitochondrial pool was unchanged in hormone-treated preimplantation
embryos compared to controls, the active mitochondrial pool was decreased in hormonetreated 1-cell, 2-cell, morula and blastocysts. Ultimately, the lower active mitochondrial pool
in treated embryos was associated with a decreased percentage of outer blastomeres
containing high amounts of active mitochondria in morula and blastocysts. In blastocysts,
this was associated with increased superoxide levels. Overall, my results provide novel
insight onto ARTs-induced disruption of imprinted DNA methylation and mitochondria in
human and mouse preimplantation embryos, respectively.
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Chapter 1

1

Introduction

1.1 Epigenetics
1.1.1

General Introduction

The term epigenotype was originally proposed by CH Waddington (1905-1975) to
represent the whole complex of developmental processes that form the connection between
genotype and phenotype (Waddington, 2012). Waddington also suggested that the name
‘epigenetics’ be used for the studies aimed at discovering the mechanisms behind the
epigenotype. In this context, epigenetics governs numerous developmental processes,
including cellular differentiation, where cells with identical genotypes exhibit distinct
patterns of gene expression and consequently, cellular function (Goldberg et al., 2007).
The modern definition of epigenetics is a heritable mechanism of transcriptional control
that does not involve a change to the DNA sequence (Rodenhiser and Mann, 2006).
Epigenetic changes that influence gene expression act by modifying overall chromatin
structure.

This is accomplished by the addition of covalent and/or non-covalent

modifications to the histone proteins (1.1.2) and DNA sequence (1.1.3) contained within the
nucleosome. Such modifications act to change the local microenvironment by modifying
charge or affecting binding of regulatory proteins. Additionally, long non-coding RNAs have
also been identified to play an epigenetic role in mediating gene expression (1.1.4).
Epigenetic changes to the chromatin that lead to condensation will render a gene as silent or
inactivated, whereas activating modifications generating open (decondensed) chromatin will
lead to gene activation or render a gene poised for expression (Goldberg et al., 2007;
Rodenhiser and Mann, 2006). Overall, it is only fitting that the study of these modifications
be referred to as epi- (translating to “above”) genetics.

1.1.2

Histone Modification

Chromatin is composed of DNA (147 base pairs) wrapped around a core octamer of
histone proteins to generate a nucleosome structure.

The histone protein octamer is

comprised of 2 molecules each of histone 2A (H2A), histone 2B (H2B), histone 3 (H3) and
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histone 4 (H4). Linker DNA connects nucleosomes together to form chromatin, which can
be further compacted by incorporation into polynucleosome fibers that are stabilized by
histone 1 (H1) binding (Quina et al., 2006).
Chromatin can be modified to form heterochromatin, which is highly condensed and
contains transcriptionally inactive genes, or euchromatin, which is decondensed and contains
actively transcribed genes (Quina et al., 2006; Rodenhiser and Mann, 2006). Chromatin
compaction and decompaction is controlled through post-translational modification to
histone tails. Specifically amino (N)-terminal tails protrude from the nucleosome and are
modified to affect inter-nucleosomal interactions in addition to recruiting chromatinremodeling enzymes that are involved in nucleosome repositioning (Bannister and
Kouzarides, 2011). Different classes of modifications identified on histone tails include but
are not limited to acetylation, phosphorylation, lysine and arginine methylation,
ubiquitylation, sumoylation and deimination (Kouzarides, 2007).

Among these

modifications, acetylation, phosphorylation and methylation are the most commonly studied.
Histone acetylation neutralizes positive charges, disrupting the stabilizing interactions
between DNA and histone proteins, which leads to open chromatin conformation (Bannister
and Kouzarides, 2011; Campos and Reinberg, 2009). This functions similarly to serine,
threonine and tyrosine phosphorylation, which adds negative charge to the histone structure
and leads to gene activation (Bannister and Kouzarides, 2011). In contrast, the covalent
addition of methyl groups to amino acids does not alter histone charge, and lysine residues
subjected to methylation can be mono-, di-, or tri-methylated while arginine residues can be
mono- or di-methylated (Bannister and Kouzarides, 2011). Histone methylation can be
activating or repressive depending on the residue onto which it is deposited on the histone
tail.
In general, active modifications to histone tails include histone acetylation (Bernstein et
al., 2005; Kim et al., 2005; Roh et al., 2005), H3K4 di- and tri-methylation (H3K4me2 and
H3K4me3) (Barski et al., 2007; Bernstein et al., 2002; Lauberth et al., 2013; Ruthenburg et
al., 2007), H3K36me3 (Bannister et al., 2005; Barski et al., 2007), H2BK120 ubiquitylation
(Thorne et al., 1987; Zhu et al., 2005) and H3S10 phosphorylation (Anest et al., 2003;
Sassone-Corsi, 1999). In contrast, transcriptional repression is generally accompanied by
lack of histone acetylation (Bannister and Kouzarides, 2011), H3K9me2 and H3K9me3
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(Bannister et al., 2001; Barski et al., 2007), H3K27me3 (Barski et al., 2007; Boyer et al.,
2006; Lee et al., 2006; Roh et al., 2006), H4K20me3 (Kalakonda et al., 2008; Kourmouli et
al., 2004), H2AK119 ubiquitylation (Wang et al., 2004a), deimination of H3 and H4 arginine
to citrulline (Cuthbert et al., 2004; Wang et al., 2004b), and sumoylation (Nathan et al., 2006;
Shiio and Eisenman, 2003). Overall, the combined effects of multiple active or repressive
histone modifications will partition the genome into areas of euchromatin and
heterochromatin, respectively (Figure 1-1).
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Figure 1-1: Activating and repressive histone modifications
Each nucleosome is composed of 147 bp of DNA (blue lines) wrapped around a protein
octamer containing 2 molecules of histone 2A (H2A), H2B, H3 and H4 (grey circles).
Linker DNA is shown as a blue line. Active chromatin modifications (A) to N-terminal
histone tails (wavy black lines) include H3K4 methylation (H3K4me2, H3K4me3),
H3K36me3 (red circles), H3 and H4 acetylation (H3Ac, green squares), H3S10
phosphorylation (orange triangles), ubiquitinated H2BK120 (purple octagons) and
unmethylated CpGs (small white dots). Repressive modifications (B) include H3K9me2/3,
H3K27me3, H4K20me3 (red circles), ubiquitinated H2AK119 (purple octagons) and
methylated CpGs (black dots). Each nucleosome in repressive chromatin is linked by histone
H1 (grey oval) and linker DNA (blue line).
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1.1.3

DNA Methylation

DNA methylation is the most widely studied epigenetic modification that controls gene
expression.
dinucleotides.

DNA methylation occurs at cytosine residues primarily within CpG
DNA methyltransferase (DNMT) enzymes regulate the acquisition and

maintenance of 5-methylcytosine (5mC). Specifically, the de novo DNMTs, DNMT3A and
DNMT3B (Okano et al., 1999), catalyze the establishment of 5mC at unmethylated cytosines
along with cofactor DNMT3L (Hata et al., 2002), whereas DNMT1 is the maintenance
methyltransferases that binds to hemi-methylated DNA during replication to maintain 5mC
on daughter strands (Figure 1-2). The cofactor UHRF1 (ubiquitin-like with PHD and ring
finger domain 1; NP95) recognizes hemi-methylated DNA at the replication fork and recruits
DNMT1 to these sites (Arita et al., 2008; Rottach et al., 2010; Sharif and Koseki, 2011;
Sharif et al., 2007). Mutations in DNMTs lead to early embryonic lethality (Li et al., 1992;
Okano et al., 1999). CpG methylation controls gene expression by altering association with
chromatin binding proteins and transcriptional regulatory factors.
In general, CpG dinucleotides are infrequent within the genome (roughly 28 million
CpGs exist within the human genome), and less than 10% occur in dense regions identified
as CpG islands (Smith and Meissner, 2013). CpG islands generally occur at transcriptional
start sites of housekeeping and developmental regulatory genes and are largely unmethylated.
However, CpG island methylation is essential for processes including chromosome
alignment, stabilization and integrity, silencing of repetitive elements, X-chromosome
inactivation and acquisition and maintenance of genomic imprinting (Smith and Meissner,
2013). It is important to note that the number of CpG islands per haploid genome and their
genomic positions (intergenic, intragenic, transcriptional start sites) are conserved between
mouse and human, indicating functional significance (Deaton and Bird, 2011; Illingworth et
al., 2010).
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Figure 1-2: DNA methylation
Unmethylated CpG dinucleotides (white circles) within active euchromatic regions can be de
novo methylated by DNMT3A/DNMT3B and cofactor DNMT3L to generate a repressive
chromatin structure composed of methylated CpGs (black circles). DNA methylation is
maintained during replication by DNMT1 and UHRF1.

The difference between cytosine

and methylated cytosine, circled in red, is the addition of a methyl (CH3) group to the 5th
carbon in the pyrimidine ring.
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While DNMTs establish DNA methylation at CpG dinucleotides, counteracting
mechanisms of DNA demethylation exist to remove methylation marks. DNA demethylation
can occur passively in a replication-dependent manner via loss of DNMT1 maintenance, or
through active DNA demethylation catalyzed by the ten eleven translocation (TET) family of
dioxygenases.

TET

proteins

specifically

catalyze

oxidation

of

5mC

to

5-

hydroxymethylcysosine (5hmC) and subsequently generate 5-formylcytosine (5fC) and 5carboxylcytosine (5caC) (Gu et al., 2011; Inoue and Zhang, 2011; Inoue et al., 2011). This is
then followed by replication-dependent loss to unmethylated cytosine (Inoue and Zhang,
2011), although it has also been shown that 5caC can be excised via the thymine-DNA
glycosylase (TDG)-mediated base excision repair (BER) pathway (He et al., 2011).

1.1.4

Non-coding RNA
Approximately 70-90% of the genome is transcribed into non-coding RNA (ncRNA)

molecules greater than 100 nucleotides in length (Lee, 2012). These ncRNAs have recently
been shown to play a role in epigenetic regulation.

RNA-mediated epigenetic control has

primarily been observed during X-inactivation (mediated by X-inactive specific transcript
(XIST) ncRNA), genomic imprinting (imprinted ncRNAs) and gene silencing by RNA
interference (RNAi) (Bernstein, 2005; Goldberg et al., 2007).

Evidence suggests that

ncRNAs function by providing a scaffold to recruit protein complexes that catalyze the
addition of DNA and histone modifications to a specific genomic location (Khalil et al.,
2009; Koziol and Rinn, 2010; Mercer and Mattick, 2013). This recruitment can occur in
trans, whereby chromatin proteins are guided to multiple sites spread across the genome
(Rinn et al., 2007), or in cis, such as at imprinted domains (Mohammad et al., 2009; Nagano
et al., 2008; Zhang et al., 2014) and the inactive X-chromosome (Pinter et al., 2012; Wutz,
2011), where chromatin-modifying enzymes are thought to be recruited to modify their
surrounding epigenetic neighborhood. In addition to protein recruitment, ncRNAs can
regulate expression by mediating intrachromosomal loop formation (Zhang et al., 2014).
Finally, studies at imprinted domains suggest that transcription of long ncRNAs (lncRNA)
though antisense promoters, rather than the lncRNA itself, mediates gene expression through
transcriptional interference mechanisms (Golding et al., 2011; Latos et al., 2012; Pauler et
al., 2007; Santoro and Pauler, 2013). Overall, the ability for ncRNAs to mediate gene
expression provides an additional layer of targeting specificity to epigenetic gene regulation.
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1.2 Genomic Imprinting
1.2.1

General Introduction
Genomic imprinting is a consequence of epigenetic gene regulation whereby

expression of a gene is restricted to one parental allele (Bartolomei and Ferguson-Smith,
2011).

Imprinting was originally discovered through experimental work aimed at

understanding failed mammalian parthenogenesis (Kaufman et al., 1977).

Elegant

pronuclear transplantation studies demonstrated that gynogenetic diploid embryos derived
from two maternal pronuclei can develop up to 10 days post coitus (dpc). However, these
embryos exhibit extremely poor development of extraembryonic lineages with relatively
normal embryonic development (Barton et al., 1984; McGrath and Solter, 1983; 1984; Surani
et al., 1984). In contrast, androgenetic embryos with two paternal genomes have welldeveloped extraembryonic tissues but exhibit poor embryonic development, dying shortly
after implantation (Barton et al., 1984; McGrath and Solter, 1983; 1984; Surani et al., 1984).
Both genetic conditions are lethal.

Consequently, it was established that maternal and

paternal contributions to embryo development are functionally non-equivalent, as both
parental genomes are required for complete embryogenesis. This developmental failure has
been attributed to the absence or overexpression of imprinted genes.
To identify and map the specific chromosomal regions that are subjected to parentalspecific regulation, reciprocal translocation experimentation was used to produce mice with
uniparental disomies (UPDs) (Cattanach, 1986; Cattanach and Kirk, 1985; Searle and
Beechey, 1978; 1990). For example, mice with maternal UPD for the central region of
chromosome 7 (7qB5) exhibit hypotonia, poor suckling response and postnatal lethality
between days 3-8, while paternal UPD for the same region produces postnatal growth
restriction, hyperactivity and brain pathologies (Gabriel et al., 1999; Leff et al., 1992; Tsai et
al., 1999). In humans, regions syntenic to those in mouse produce pathological disorders
known as imprinting syndromes. Maternal and paternal deletions and UPD for 15q11-13
result in Prader-Willi Syndrome and Angelman Syndrome, respectively, producing similar
pathologies to that seen for mouse 7qB5 (Knoll et al., 1989; Nicholls et al., 1989). These and
other UPDs further demonstrate the non-equivalence of parental contributions.
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1.2.2

Imprinted domains
The discovery of the first imprinted genes in 1990-1991 (Bartolomei et al., 1991;

DeChiara et al., 1990) paved the way for subsequent identification of numerous imprinted
genes in both mouse and human. Imprinted genes often reside in clusters that are regulated
by a germline CpG island differentially methylated region (gDMR) [reviewed in (Macdonald
and Mann, 2014)]. A subset of gDMRs have been identified as imprinting control regions
(ICRs), since experimental or congenital gDMR deletions cause loss of imprinted gene
expression (Spahn and Barlow, 2003). Differential chromatin modifications at the gDMR,
including CpG methylation, modulate allelic expression (Macdonald and Mann, 2014)
(Figure 1-3). In the mouse, there are 24 known imprinted gDMRs: 21 are maternal-in-origin,
where DNA methylation is established on the maternal alleles during oogenesis; while 3 are
paternal-in-origin, where DNA methylation is acquired on paternal alleles during
spermatogenesis (Macdonald and Mann, 2014). These differential methylation marks are
subsequently maintained throughout preimplantation development (discussed in detail in
section 1.3). Of the 24 mouse gDMRs, 17 exhibit differential methylation in human gametes
and/or tissues, 1 has no human orthologue and 6 have not been fully ascertained. Examples
of conservation include mouse chromosome 7 and human chromosome 11p15.5, which
harbor the H19 and KCNQ1OT1 (KCNQ1 overlapping transcript 1) imprinted domains
(Mancini-DiNardo et al., 2003; Pandey et al., 2008; Srivastava et al., 2000), and mouse
chromosome 7 and human chromosome 15q11-13 that contain the Small nuclear
ribonucleoprotein N (SNRPN) domain (Bourc'his et al., 2001; El-Maarri et al., 2001; Geuns
et al., 2003; Horsthemke, 1997; Shemer et al., 1997; Yang et al., 1998). These domains will
be discussed below. Importantly, abnormal CpG methylation levels at the ICRs of these
domains leads to genomic imprinting disorders.
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Figure 1-3: Genomic imprinting
Expression of most genes occurs biallelically (red box; maternal expression, blue box;
paternal expression). Imprinted genes can be maternally-expressed and paternally-silent
(grey box; silenced allele), or paternally-expressed and maternally-silent.

Generally,

methylated CpGs (filled black circles) mark the silent allele, whereas unmethylated CpGs
(unfilled white circles) occur on the expressed allele.
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1.2.2.1

H19 imprinted domain

The H19 imprinted domain was one of the first imprinted regions identified
(Bartolomei et al., 1991) and is currently one of the best characterized. It resides on distal
chromosome 7 in the mouse and chromosome 11p15.5 in human. In both mouse and human,
the H19 gDMR acquires methylation on the paternal allele during spermatogenesis while the
maternal allele is unmethylated in oocytes (Bartolomei et al., 1991; Borghol et al., 2006;
Ibala-Romdhane et al., 2011; Jinno et al., 1996). Genes in this domain include H19, Insulinlike growth factor 2 (Igf2), and Insulin II (Ins2). Insulin-like growth factor 2 (Igf2) is proteincoding gene that promotes fetal and placental growth (Constância et al., 2002; DeChiara et
al., 1990), H19 is a non-coding RNA that also modulates growth (Gabory et al., 2009; Keniry
et al., 2012) and tumor suppression (Yoshimizu et al., 2008), while Ins2 is involved in blood
glucose regulation (Deltour et al., 1995; Duvillié et al., 1998; Giddings et al., 1994). The
paternally-expressed Igf2 and Ins2 genes are located 90 kb upstream of the maternallyexpressed H19 gene (Bartolomei et al., 1991; DeChiara et al., 1991) and share common
enhancer sequences located downstream H19 (Tremblay et al., 1997). Imprinted expression
of Igf2, Ins2 and H19 is regulated by an enhancer-insulator mechanism (Figure 1-4).
The H19 ICR is located 2 to 4 kb upstream from the H19 transcriptional start site and
contains binding sites for the insulator protein CTCF [CCCTC-binding factor (zinc finger
protein)] (Hark et al., 2000; Li et al., 2008a).

CTCF controls higher-order chromatin

conformation by directing intrachromosomal loop formation through blocking, or insulating,
interactions between promoter and enhancer elements. Binding of CTCF is dependent on
allelic ICR methylation. CTCF binding to the unmethylated maternal H19 ICR blocks
(“insulates”) interactions between the enhancer regulatory element and Igf2 and Ins2,
consequently permitting interaction with the maternal H19 promoter (Hark et al., 2000;
Kurukuti et al., 2006; Li et al., 2008a). In contrast, H19 ICR methylation on the paternal
allele prevents CTCF binding, enabling intrachromosomal enhancer looping to the Igf2/Ins2
control elements (Hark et al., 2000; Li et al., 2008a). In addition to ICR-mediated regulation,
Igf2 and Ins2 expression is also controlled by two additional somatic paternally methylated
DMRs, DMR1 and DMR2. DMR1 is located proximal to Igf2 and functions as a silencer of
Igf2 expression in mesodermal tissues on the maternal allele, potentially through a tight loop
structure generated by H19 ICR and matrix attachment region 3 (MAR3) interactions
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(Constância et al., 2000; Kurukuti et al., 2006) (Figure 1-4). Matrix attachment regions are
DNA loci that localize to the nuclear matrix and are associated with repressed and active
chromatin (Macdonald et al., 2015). In contrast, DMR2 is located within the sixth Igf2 exon
where it functions as an methylated enhancer on the paternal allele to enable paternal Igf2
transcription (Murrell et al., 2001). The H19 ICR is required for monoallelic expression of
H19 and Igf2. A maternally inherited deletion of the ICR that prevents CTCF binding leads
to biallelic Igf2 expression while paternal deletion results in biallelic H19 expression (Engel
et al., 2006; Thorvaldsen et al., 1998; Tremblay et al., 1997). Furthermore, mutating CpG
dinucleotides within the ICR prevents paternal imprinted methylation and enables CTCF
binding that results in insulator activity and biallelic H19 expression (Engel et al., 2004).
Genetic and epigenetic errors at the H19 domain cause the imprinting disorder
Beckwith-Wiedemann Syndrome (BWS) (OMIM #130650). BWS is an overgrowth disorder
with clinical features that include macrosomia, macroglossia, abdominal wall defects,
hemihyperplasia, visceromegaly and predisposition to malignancies (Choufani et al., 2010;
2013; Weksberg et al., 2010). In the general population, BWS incidence is estimated to be 1
in 13, 700 (Weksberg et al., 2010). Microdeletions/microduplications, cytogenetic alterations
and point mutations at chromosome 11p15 account for ~15% of BWS cases (Choufani et al.,
2010; 2013). An imprinting defect at the H19 ICR can also lead to BWS. Five percent of
BWS cases are due to an abnormal gain of methylation (hypermethylation) of the maternal
H19 ICR (Choufani et al., 2010; Weksberg et al., 2010).
In addition to BWS, abnormal loss of methylation (hypomethylation) at the H19 ICR
leads to a growth restricted imprinting disorder, Silver Russell Syndrome (SRS) (OMIM
#180860). SRS is a severe intrauterine growth restriction disorder associated with poor
postnatal growth, craniofacial features that include pronounced forehead and triangular
shaped face, and other minor malformations (Begemann et al., 2011; Eggermann et al., 2006;
2010).

Hypomethylation of the paternal H19 ICR leads to SRS in >38% of patients

(Begemann et al., 2011; Eggermann et al., 2006; Hannula et al., 2001). Maternal UPD of
chromosome 11p15 has also been documented. In contrast, 10% of SRS cases demonstrate
uniparental disomy at another imprinted domain, Peg1 (paternally expressed gene 1), located
on human chromosome 7q32 (mouse chromosome 6) (Begemann et al., 2011).
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Figure 1-4: Structure and regulation of the H19 domain
On the maternal allele (A, B), H19 ICR is unmethylated, allowing for CTCF binding and
intrachromosomal loop formation. The ICR, DMR1 and MAR regions interact in a tight loop
formation, excluding Igf2/Ins2 and bringing the enhancer elements to the H19 promoter. In
contrast on the paternally methylated allele (C, D), CTCF is unable to bind, generating a loop
formation that brings the enhancer elements to the Igf2/Ins2 region, and preventing H19
expression. Somatic DMRs, DMR1 and DMR2, function in maternal Igf2 silencing and
paternal Igf2 expression, respectively.
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1.2.2.2

Kcnq1ot1 imprinted domain

The Kcnq1ot1/KCNQ1OT1 imprinted domain is also located on the distal portion of
mouse chromosome 7 and human chromosome 11p15.5. This domain includes the paternally
expressed Kcnq1ot1 lncRNA, 9 maternally expressed protein-coding genes, and 6 biallelic
genes that escape imprinted regulation (Figure 1-5). Of the 9 maternally expressed genes, 5
exhibit placental-specific imprinted expression (oxysterol binding protein-like 5, Osbpl5;
tumor-suppressing subchromosomal transferable fragment 4, Tssc4; CD81 antigen, Cd81;
achaete-scute complex homolog 2, Ascl2; and tyrosine-hydroxylase, Th) while the remaining
4 are imprinted in both placental and embryonic lineages (pleckstrin homology-like domain,
family A, member 2, Phlda2; solute carrier family 22, member 18, Slc22a18; cyclindependent kinase inhibitor 1C, Cdkn1c; and potassium voltage-gated channel, subfamily Q,
member 1, Kcnq1) (Golding et al., 2011; Lewis et al., 2004; Mohammad et al., 2012; Umlauf
et al., 2004).
The Kcnq1ot1 domain contains an ICR, within which the Kcnq1ot1 promoter is
embedded. In the mouse and human, this ICR is methylated during oogenesis, unmethylated
in sperm, and maintains maternal methylation during embryogenesis (Beatty et al., 2006;
Khoueiry et al., 2008; 2012). On the maternal allele, methylation at the Kcnq1ot1 ICR
prevents Kcnq1ot1 transcription, thereby allowing expression of the 9 maternally transcribed
genes. On the paternal allele, the Kcnq1ot1 ICR is unmethylated and Kcnq1ot1 is expressed,
producing a 471 kb transcript that is involved in paternal repression of surrounding genes
(Golding et al., 2011). The complete mechanisms responsible for imprinting at the Kcnq1ot1
cluster are not fully elucidated. However, it has been demonstrated that both the Kcnq1ot1
ICR and Kcnq1ot1 long ncRNA (lncRNA)-mediated repression are important. Loss of
maternal methylation at the Kcnq1ot1 ICR results in biallelic Kcnq1ot1 expression and
silencing of the normally expressed maternal alleles of the imprinted genes (Fitzpatrick et al.,
2002; Lewis et al., 2004; Smilinich et al., 1999). In contrast, deletion of the maternal
Kcnq1ot1 ICR recapitulates the wildtype situation where a maternally methylated Kcnq1ot1
ICR or a deleted Kcnq1ot1 ICR (and Kcnq1ot1 promoter) prevent production of the
Kcnq1ot1 lncRNA, thereby permitting expression of maternally transcribed genes
(Fitzpatrick et al., 2002). Paternal inheritance of a deleted Kcnq1ot1 ICR also results in loss
of Kcnq1ot1 expression, consequently re-activating the normally silent paternal alleles of
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imprinted genes in the domain (Fitzpatrick et al., 2002; 2007; Mancini-DiNardo et al., 2003;
Shin et al., 2008). These data suggest that the Kcnq1ot1 ICR mediates imprinting at this
domain by regulating expression of the Kcnq1ot1 lncRNA, although the exact role of the
Kcnq1ot1 lncRNA in mediating the regulation of imprinting at this domain is still under
debate.

Some studies suggest the Kcnq1ot1 lncRNA acts by coating the domain and

preventing transcription by recruiting repressive complexes to the promoter regions of silent
paternal alleles of imprinted genes within the domain (Mager et al., 2003; Pandey et al.,
2008; Terranova et al., 2008; Umlauf et al., 2004; Wagschal et al., 2008). Furthermore,
activation of paternally silent imprinted genes occurs when Kcnq1ot1 stability is decreased,
paternal Kcnq1ot1 is truncated and repressive epigenetic marks are lost (Fitzpatrick et al.,
2002; Lewis et al., 2004; Mancini-DiNardo et al., 2006; Pandey et al., 2008; Shin et al.,
2008; Thakur et al., 2003; 2004). Finally, a study conducted in our lab suggests that the act
of transcription rather than the transcript itself is involved in domain regulation in embryoderived stem cells (Golding et al., 2011).
Genetic and epigenetic errors at the KCNQ1OT1 domain also cause the imprinting
disorder Beckwith-Wiedemann Syndrome (BWS) (OMIM #130650). Here, 50% of BWS
cases result from hypomethylation of the maternal KCNQ1OT1 ICR (Choufani et al., 2010;
2013; Horike et al., 2000). An additional 5-10% of BWS patients have mutations within
CDKN1C, a maternally expressed gene in the KCNQ1OT1 cluster. Finally, 20% of cases
consist of paternal uniparental disomy (UPD) involving chromosome 11p15, involving both
the KCNQ1OT1 and H19 domains (Choufani et al., 2010; 2013).
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Figure 1-5: Structure and regulation of the Kcnq1ot1 domain
Imprinting at the Kcnq1ot1 domain is controlled by differential methylation at the maternal
(upper strand) and paternal (bottom strand) ICRs. Maternal methylation of the ICR represses
Kcnq1ot1 transcription, permitting maternal expression of surrounding genes. On the paternal
allele, the ICR is unmethylated, the Kcnq1ot1 lncRNA is expressed and surrounding genes
are repressed.
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1.2.2.3

Snrpn imprinted domain

The small nuclear ribonucleoprotein N (Snrpn/SNRPN) imprinted domain is located
on the central region of mouse chromosome 7 and human chromosome 15q11-q13. The
Snrpn/SNRPN ICR within the promoter and exon 1 is methylated during oogenesis,
unmethylated

in

sperm,

and

maintains

maternal-specific

methylation

throughout

preimplantation (El-Maarri et al., 2003; Geuns et al., 2003; Shemer et al., 1997). This
imprinted cluster contains numerous genes expressed exclusively from the paternal
chromosome, including Snurf-Snrpn (Snrpn upstream reading frame-Snrpn), Frat3
(frequently rearranged in advanced T-cell lymphomas 3), Mkrn3 (makorin ring finger protein
3), Magel2 (melanoma antigen-like 2), Ndn (Necdin), Ipw (imprinted in Prader-Willi
Syndrome), over 70 snoRNA genes and a Snrpn lncRNA transcript (Snrpnlt) (Figure 1-6).
This lncRNA, which is over 470 kb in human and 1,000 kb in mouse, includes Snrpn and
extends through Ipw, the snoRNAs and Ube3a (ubiquitin protein ligase E3A), also known as
the Ube3a antisense transcript, Ube3a-as (Horsthemke and Wagstaff, 2008; Landers et al.,
2005; Runte et al., 2001) (Figure 1-6). Maternal-specific expression of the Ube3a/UBE3A
gene is restricted to the brain in both human and mouse, maternal expression of ATP10C
(ATPase, class V, type 10C) is imprinted in human brain and fibroblasts (Herzing et al.,
2001; Meguro et al., 2001), although there are conflicting reports as to whether Atp10c is
imprinted in the mouse (Kashiwagi et al., 2003; Kayashima et al., 2003).
The Snrpn ICR is located in the Snrpn promoter and extends into exon 1. Regulation
of the Snrpn imprinted domain is not fully understood; however, both the Snrpn ICR and
Snrpnlt are likely required. A PWS family with paternal SNRPN ICR deletions exhibited
loss of MKRN3, MAGEL2, NDN and SNRPN expression (Bielinska et al., 2000). This effect
was recapitulated in a mouse model harboring a similar deletion (Bielinska et al., 2000) as
well as in mice inheriting a paternal 42 kb deletion covering Snrpn exons 1-6 and 23 kb
upstream (Yang et al., 1998). In contrast, a smaller 0.9 kb microdeletion including the
majority of the mouse Snrpn promoter and exon 1 did not affect Mkrn3, Ndn, Magel2 and
Ube3a expression, while a small deletion (4.8 kb) produced mosaic effects. With respect to
the Snrpnlt lncRNA, it is thought that imprinted expression of Ube3a/UBE3A is the result of
transcriptional interference of the Snrpnlt, but this still remains to be validated (Chamberlain
and Brannan, 2001; Chamberlain et al., 2014; Rougeulle et al., 1998; Runte et al., 2001).
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Figure 1-6: Structure and regulation of the Snrpn domain
The Snrpn domain consists of a bipartite ICR (AS-IC and PWS-IC). On the paternal allele,
the unmethylated PWS-IC region of the ICR permits Snrpnlt expression and enables paternal
transcription of surrounding genes Frat3, Mkrn3, Magel2, Ndn, Snrpn, Ipw, and snoRNA
genes, and represses Ube3a and Atp10c. In contrast, on the maternal allele, Snrpn ICR
methylation at PWS-IC prevents Snrpnlt transcription and enables Ube3a and Atp10c
expression in a brain-specific manner.
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On the paternal allele, the Snrpn ICR is unmethylated, the Snrpn lncRNA is
transcribed, directing expression of other paternally expressed genes, while interfering with
transcription of Ube3a and Atp10c (Horsthemke and Wagstaff, 2008). In contrast, on the
maternal allele, the Snrpn ICR is methylated, the Snrpn lncRNA is not transcribed and Ube3a
and Atp10c are expressed in a brain-specific manner (El-Maarri et al., 2001; Horsthemke and
Wagstaff, 2008).

For this domain, ICR regulation is more complicated since the

Snrpn/SNRPN ICR has a bipartite structure, containing two specific regions termed the
Angelman Syndrome imprinting centre (AS-IC) and Prader-Willi Syndrome IC (PWS-IC)
(Horsthemke, 1997).

The PWS-IC is a 4.3 kb sequence located around the SNRPN

promoter/exon1 (Ohta et al., 1999), while the AS-IC is 880 bp and is located approximately
35 kb upstream of the SNRPN transcriptional start site (Buiting et al., 1999). On the maternal
allele, exons within the unmethylated AS-IC are transcribed, which leads to methylation at
the PWS-IC (Horsthemke and Wagstaff, 2008; Kantor et al., 2004; Shemer et al., 2000). This
in turn silences the Snrpnlt lncRNA and permits expression of Ube3a and Atp10c
(Horsthemke and Wagstaff, 2008). On the paternal allele, AS-IC is methylated, blocking
transcription of exons within the AS-IC (Horsthemke and Wagstaff, 2008; Kantor et al.,
2004; Shemer et al., 2000). Thus, PWS-IC is unmethylated, enabling Frat3, Mkrn3, Magel2,
Ndn, Snrpn, Snrpnlt, Ipw, snoRNAs and transcription, and silencing Ube3a and Atp10c (ElMaarri et al., 2001).
Genetic and epigenetic errors at the SNRPN domain cause the imprinting disorders
Angelman Syndrome (AS) (OMIM #105830) and Prader-Willi Syndrome (PWS) (OMIM
#176279). Angelman Syndrome is a neurological syndrome characterized by severe
intellectual and motor retardation, limited speech, ataxia, hypotonia and unusual facies such
as open-mouthed expression (Van Buggenhout and Fryns, 2009). Its incidence is
approximately 1 in 15, 000 newborns (Horsthemke, 1997; Van Buggenhout and Fryns,
2009). Maternal deletions of the 15q11.2-q13 region (including AS-IC microdeletions, 6075%), paternal UPD (2-5%) and mutations in the UBE3A gene (10%) cause AS (Van
Buggenhout and Fryns, 2009).

Less than 5% of cases result from loss of maternal

methylation at the SNRPN ICR (Horsthemke, 1997; Van Buggenhout and Fryns, 2009). In
contrast to AS, Prader-Willi Syndrome is characterized by intellectual disability, decreased
fetal activity, obesity, small hands and feet, muscular hypotonia, short stature and
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hypogonadotropic hypogonadism. The incidence of PWS is about 1 in 20, 000 and results
from a lack of paternal-specific gene expression from the domain due to paternal 15q11.2q13 deletions (including PWS-IC microdeletions, 65-75%), maternal UPD (20-30%) and
gain of methylation at the paternal SNRPN ICR (1-3%) (Cassidy et al., 2012).

1.2.3

Evolution of genomic imprinting and the placenta
The importance of imprinted genes in fetal and placental growth and development

was originally identified by nuclear transplantation experiments as well as uniparental
disomies of specific chromosomal regions containing imprinted genes (Cattanach, 1986;
Cattanach and Kirk, 1985; Searle and Beechey, 1990) (see 1.2.1).

Failed embryo

development in androgenetic and gynogenetic embryos, in part due to defects in the
trophoblast, indicated that imprinted genes likely play a role in placental development and
function.

Furthermore, there is an evolutionary link between imprinted genes and the

placenta, as existence of imprinting seemingly evolved at the same time Therian mammals
(marsupial and placental mammals) separated from egg-laying monotremes (Ager et al.,
2007; Killian et al., 2000; Renfree and Pask, 2011; Smits et al., 2008; Suzuki et al., 2011;
Weidman et al., 2004). Consequently numerous theories have arisen regarding the emergence
genomic of imprinting. The parental conflict theory states that imprinting arose to balance
the opposing interests between maternal and paternal genomes with respect to maternal-fetal
nutrient transfer (Moore and Haig, 1991).

In contrast, another theory suggests that

imprinting evolved to protect the female from trophoblast invasion, or ectopic trophoblast
(Hall, 1990; Varmuza and Mann, 1994).

The latter theory relates to the fact that the

trophoblast must invade the uterine epithelium for successful pregnancy. This theory states
that genomic imprinting protects females from excessive trophoblast invasion in the ovary
when oocytes spontaneously activate by suppressing maternal genes involved in placental
development (Hall, 1990; Varmuza and Mann, 1994). Irrespective of their differences, the
above theories suggest that a subset of genes must be appropriately regulated by imprinting
to balance proper embryonic and placental development, and maternal survival.
The specific functions of a numerous imprinted genes in the placenta have been
determined (Figure 1-7) (Tunster et al., 2013). For example, both the H19 and Kcnq1ot1
imprinted domains play an important role in placental function and resulting growth (Tunster
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et al., 2013). With respect to the H19 domain, loss of paternal Igf2 expression results in
reduced placental weight and growth restriction while elevated Igf2/loss of expression of H19
results in fetal overgrowth (Angiolini et al., 2011; Lefebvre, 2012; Sandovici et al., 2012).
The role of the H19 domain in placental function and growth is conserved in the human and
also causes growth deficiencies or overgrowth abnormalities in human babies (BouwlandBoth et al., 2013; Demetriou et al., 2014; Gonzalez-Rodriguez et al., 2016; Kappil et al.,
2015; McMinn et al., 2006) including Beckwith-Wiedemann Syndrome (Aoki et al., 2011)
and Silver Russell Syndrome (Yamazawa et al., 2008). Furthermore, numerous genes within
the Kcnq1ot1 cluster have been implicated in placental function. Specifically, 5 out of the 9
maternally expressed genes in this domain exhibit placental-specific imprinted expression
(Osbpl5, Tssc4, Cd81, Ascl2 and Th) while the remaining 4 genes are imprinted in both the
placenta and embryo (Phlda2, Slc22a18, Cdkn1c, Kcnq1) (Golding et al., 2011; Lewis et al.,
2004; Mohammad et al., 2012; Umlauf et al., 2004). The roles of Ascl2, Cdkn1c and Phlda2
in placental function have been analyzed (Fitzpatrick et al., 2002; Mancini-DiNardo et al.,
2006). Briefly, decreased Ascl2 impairs placental and in turn embryonic growth (Tunster et
al., 2010), loss of Cdkn1c results in placental and fetal overgrowth (Takahashi et al., 2000)
while Phlda2 overexpression impairs fetal growth during late gestation (Tunster et al., 2010).
Similar to the H19 domain, the role of the Kcnq1ot1 region in controlling placental growth
and function has been identified in the human (Kanber et al., 2009; López-Abad et al., 2016;
Mandò et al., 2014; McMinn et al., 2006), including its role in Beckwith-Wiedemann
Syndrome (Bourque et al., 2011).
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Figure 1-7: Imprinted genes with demonstrated placental function in the mouse
Mouse imprinted genes with known placental functions are shown beside identified gametic
DMRs.

Imprinted genes with an asterisk indicate suspected placental function.

Blue

rectangles, paternal allele; red rectangles, maternal allele; black triangles, centromere; white
circles, unmethylated CpGs; black circles, methylated CpGs. Chromosome number is
indicated below each chromosome set.
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1.3 DNA methylation reprogramming in mouse and human
As mentioned above, imprinted gDMRs acquire allele-specific methylation during
gametogenesis, which is then maintained throughout preimplantation development.

In

general, global and imprinted DNA methylation marks are dynamically regulated during
early mammalian development (Bartolomei and Ferguson-Smith, 2011). There are three
major waves of DNA methylation reprogramming that occur during gamete and
preimplantation development (Figure 1-8). First, global and imprinted DNA methylation
marks from previous generations are erased in primordial germ cells (PGCs). Subsequently,
maternal and paternal-specific DNA methylation and imprints are acquired differentially
during oocyte and sperm development.

Finally, imprints are maintained during

preimplantation development when the remainder of the genome undergoes an erasure stage
to establish totipotency of the early embryo. This section describes the three phases of DNA
methylation reprogramming in mouse, and concludes with a description of the conservation
of these phases in the human [reviewed in (White et al., 2016)].

1.3.1

DNA methylation erasure during mouse primordial germ cell
development
The first phase of epigenetic programming is DNA methylation erasure. Here,

previous parental DNA methylation marks are removed in sexually uncommitted primordial
germ cells (PGCs). In the mouse, global DNA methylation loss occurs in two distinct waves.
In stage I, DNA methylation erasure is initiated at embryonic day 8.0 (E8.0) (Hajkova et al.,
2002a; Saitou et al., 2012; Seki et al., 2005). Global 5mC levels progressively decline in a
passive, replication-dependent manner to E9.0, reducing global methylation levels to ~30%
(Guibert et al., 2012; Seisenberger et al., 2012; Seki et al., 2005). Although the maintenance
methyltransferase Dnmt1 remains highly expressed at these stages, its recruitment cofactor
Uhrf1/Np95 is not, likely accounting for methylation loss (Kurimoto et al., 2008). Stage II
methylation erasure produces a further decline in 5mC levels between E10.5-13.5. Here,
erasure occurs via active demethylation, resulting from ten-eleven translocation 1 and 2
(TET1, TET2) oxidation of 5mC to the intermediate 5-hydroxymethylcytosine (5hmC)
(Hajkova et al., 2008; 2010; Piccolo et al., 2013; Yamaguchi et al., 2013) (Figure 1-9). The
base excision repair pathway may also have a role in active demethylation, involving
activation-induced cytidine deaminase and thymine-DNA glycosylase (TDG) (Cortellino et
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al., 2011; Hajkova et al., 2010; Morgan et al., 2004; Popp et al., 2010). At E13.5, 5mC
declines to its lowest levels (Guibert et al., 2012; Popp et al., 2010; Saitou et al., 2012;
Seisenberger et al., 2012; Yamaguchi et al., 2013), representing the epigenetic ground state
of the germline genome (Hajkova, 2011).
In comparison to the whole genome, DNA methylation erasure at imprinted gDMRs
is delayed. Onset of erasure begins after E9.5 and is complete at or after E13.5 (Guibert et al.,
2012; Hackett et al., 2013; Hajkova et al., 2002a; Kagiwada et al., 2013; Kobayashi et al.,
2013). More specifically, of the 18 maternal gDMRs and 3 paternal gDMRs analyzed, only 7
still retain some level of methylation (~20% methylation or less) at E13.5, while
demethylation is completed at the remaining 14 gDMRs (Kobayashi et al., 2013). Current
studies investigating imprinted gDMR methylation loss in PGCs indicate roles for both
passive and active demethylation. Passive replication-dependent demethylation, beginning at
E9.5 (Kagiwada et al., 2013), is supported by repression of Uhrf1 (Kurimoto et al., 2008). By
comparison, active demethylation occurs through TET1 conversion of 5mC to 5hmC
commencing at E10.5 (Hackett et al., 2013; Piccolo et al., 2013; Vincent et al., 2013) (Figure
1-9). There is little evidence for demethylation through the base excision repair pathway at
imprinted gDMRs (Hackett et al., 2013; Kagiwada et al., 2013; Popp et al., 2010).
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Figure 1-8: DNA methylation dynamics during gametogenesis and preimplantation
development
Global DNA methylation (orange line) and imprinted DNA methylation (purple line) is first
erased in primordial germ cells. Then, sex-specific DNA methylation is acquired both
globally and at imprinted gDMRs during gametogenesis. Specifically global (dark blue) and
imprinted (light blue) methylation is established early during spermatogenesis, with
methylation mostly completed at birth. In contrast, DNA methylation acquisition globally
(red) and at imprinted domains (pink) is delayed in oogenesis, occurring after birth and
beginning in growing oocytes up to MII ovulated oocytes.

Despite global DNA

demethylation of the paternal (blue) and maternal (red) genomes after fertilization during
preimplantation development, imprinted DNA methylation is maintained at imprinted genes
(light blue, pink). Assisted reproductive technologies occur during imprint acquisition and
imprint maintenance phases, with examples shown in grey italicized text. E, embryonic day;
P, postnatal day; MI, meiosis I; MII, meiosis II; Prospg, prospermatogonia; Spg,
spermatogonia; Scy, spermatocyte; RS, round spermatid; ES, elongating spermatid; IVF, in
vitro fertilization; ICSI, intracytoplasmic sperm injection.
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1.3.2

DNA methylation acquisition during mouse gametogenesis
Following erasure, the next phase of DNA methylation programming is DNA

methylation acquisition.

In males, global DNA methylation acquisition commences in

E14.5-E16.5 mitotically-arrested fetal prospermatogonia, reaching 50% methylation levels
by E16.5, and continues to rise through to the spermatogonia stage (Kobayashi et al., 2013),
where the highest global methylation levels are present during spermatogenesis (Kobayashi
et al., 2013; Niles et al., 2011; Seisenberger et al., 2012; Vlachogiannis et al., 2015). In
mature sperm, ~80% of cytosines are methylated (Kobayashi et al., 2012). This pattern was
recently confirmed in a genome-wide DNA methylation study, where overall 5mC levels
increased from 30% in E16.5 prospermatogonia to 76%, ~77% and 79% in postnatal day 0.5
(P0.5) prospermatogonia, P7.5 spermatogonia and adult spermatozoa, respectively (Kubo et
al., 2015). In mature sperm, ~78-90% of cytosines are methylated (Kobayashi et al., 2012;
Kubo et al., 2015; Smith et al., 2012; Wang et al., 2014). Mechanistically, DNA methylation
acquisition occurs through the de novo DNA methyltransferases, DNMT3A and DNMT3B,
and accessory protein DNMT3L (Kato et al., 2007) (Figure 1-9).
In contrast to male germ cells, E16.5 diplotene stage female germ cells (Ewen and
Koopman, 2010) remain globally hypomethylated (Kobayashi et al., 2012). Instead,
acquisition of global de novo methylation is delayed until oocytes enter the growth phase
(Smallwood et al., 2011). By the time oocytes are at the germinal-vesicle and mature MII
stages, acquisition of DNA methylation is complete (Kobayashi et al., 2012; Shirane et al.,
2013; Smallwood et al., 2011; Smith et al., 2012; Tomizawa et al., 2011). Globally, ~40-55%
of cytosines are methylated in oocytes (Kobayashi et al., 2012; Smallwood et al., 2011;
Smith et al., 2012; Wang et al., 2014). Mechanistically, DNMT3A and DNMT3L are
indispensable for DNA methylation acquisition in female germ cells (Kobayashi et al., 2012;
Smallwood et al., 2011) (Figure 1-9).
Recently, CpG island DNA methylation acquisition in oocytes has also been linked to
transcription (Veselovska et al., 2015).

Transcription initiating from alternative

transcriptional start sites throughout oogenesis is highly correlated with hypermethylated
CpG domains in fully grown GV oocytes (Veselovska et al., 2015). This occurs in part
during transcription elongation where disposition of histone 3 lysine 36 trimethylation
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(H3K36me3) enhances DNMT3A activity (Dhayalan et al., 2010; Veselovska et al., 2015;
Zhang et al., 2010).
For imprinted DNA methylation, acquisition occurs with similar timing to that of the
whole genome. In the male germline, imprinted methylation acquisition at H19, Gtl2 and
Rasgrf1 has begun by E14.5, increasing progressively through to E18.5 in fetal
prospermatogonia until being completed in P0 mitotically arrested spermatogonia (Davis et
al., 2000; Kaneda et al., 2004; Kato et al., 2007; Kobayashi et al., 2013; Lee et al., 2010;
Lucifero et al., 2002; Ueda et al., 2000). The two parental alleles undergo differential
methylation acquisition, with de novo methylation initiating earlier (E14.5) on the previous
paternally-methylated H19, Gtl2 and Rasgrf1 alleles than on the previous maternallyunmethylated alleles (E16.5) (Davis et al., 2000; 1999; Kato et al., 2007; Ueda et al., 2000).
This differential acquisition indicates that some previous parental identity is retained in the
absence of DNA methylation.

H19 and Gtl2 imprinted methylation acquisition during

spermatogenesis is dependent on DNMT3A and DNMT3L, while Rasgrf1 additionally
requires DNMT3B (Bourc'his and Bestor, 2004; Hirasawa et al., 2008; Kaneda et al., 2004;
Kato et al., 2007; Vlachogiannis et al., 2015; Webster et al., 2005) (Figure 1-9).
In E16.5 female germ cells, imprinted gDMRs have low methylation levels
(Kobayashi et al., 2013). DNA methylation acquisition at the Snrpn, Igf2r, Peg1, Peg3,
Kcnq1ot1, Zac1, Meg1 and Impact gDMRs is delayed compared to male imprint acquisition,
which occurs prenatally. Instead, DNA methylation is acquired during oocyte growth in a
size-dependent manner from the primary to antral follicle stage, and is completed by the
ovulated metaphase II (MII) stage (Denomme et al., 2012; Hiura et al., 2006; Lucifero, 2004;
Lucifero et al., 2002; Obata and Kono, 2002). In oocytes, as in sperm, allelic identity also
influences DNA methylation acquisition. Specifically, de novo methylation is initiated earlier
(P10) on the previous maternally-methylated Snrpn, Zac1 and Peg1 alleles than on the
previous paternally-unmethylated alleles (P15) (Davis et al., 2000; Hiura et al., 2006; Kato et
al., 2007; Lee et al., 2010; Lucifero, 2004). This again indicates that epigenetic memory of
parental

identity

is

DNA

methylation-independent.

Expression

of

de

novo

methyltransferases, Dnmt3A, Dnmt3B and Dnmt3L, occurs during 10-25 days post partum
(dpp), increasing co-ordinately with oocyte diameter (Lucifero et al., 2007) and DNA
methylation acquisition (Lucifero, 2004). However, imprinted DNA methylation
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establishment is dependent on DNMT3A and DNMT3L (Bourc'his et al., 2001; Hata et al.,
2002; Kaneda et al., 2010; Lucifero, 2004; Lucifero et al., 2002; Obata and Kono, 2002) but
not DNMT3B (Kaneda et al., 2010) (Figure 1-9). Similar to global DNA methylation
acquisition, imprinted DNA methylation acquisition at gDMRs within the oocyte is
dependent on transcription through gDMRs, as shown for Snrpn (Smith et al., 2011), Gnas
(Chotalia et al., 2009), and Zac1/Plagl1 (Veselovska et al., 2015).

1.3.3

DNA methylation dynamics during mouse preimplantation
development
Preimplantation development represents the third epigenetic reprogramming phase

where DNA methylation loss occurs globally through the zygote to blastocyst stages, albeit
not to the epigenomic ground state level seen in PGCs. Following fertilization, there is
active loss of DNA methylation globally in zygotes (Okamoto et al., 2016; Smith et al.,
2012) and 2-cell embryos (Wang et al., 2014). As the latter study did not analyze zygotes
(Wang et al., 2014), active DNA methylation loss was hypothesized to occur at the 1-cell
stage, consistent with loss of global 5mC staining in the paternal pronucleus 4-6 hours
following in vitro fertilization (Santos et al., 2002; 2013). Based on 5hmC staining and
DNA methylation analyses of Tet3-deficient zygotes, active demethylation of the paternal
pronucleus occurs via TET3-mediated 5mC conversion to 5hmC (Gu et al., 2011; Guo et al.,
2014a; Inoue and Zhang, 2011; Inoue et al., 2011; Iqbal et al., 2011; Wossidlo et al., 2011)
(Figure 1-9). Consistent with this, Tet3 mRNA is more abundant than Tet1 and Tet2
transcripts in oocytes and zygotes (Okae et al., 2014; Wossidlo et al., 2011), and TET3
protein along with 5hmC levels are restricted to/overabundant in the paternal compared to
maternal pronucleus (Gu et al., 2011; Inoue and Zhang, 2011; Inoue et al., 2011; Shen et al.,
2014; Wang et al., 2014). Having said this, TET3 hydroxylation and the spike in 5hmC
levels may be restricted to S-phase (pronuclear stage 3, PN3) (Santos et al., 2013), which
occurs subsequent to initiation of DNA demethylation (Amouroux et al., 2016; Okamoto et
al., 2016), indicating a role for additional mechanisms in this initial demethylation event. In
fact, abrogated 5hmC formation via small molecule TET inhibitors or oocyte Tet3 deletion
had no effect on paternal 5mC loss in early PN3 zygotes (Amouroux et al., 2016). Thus,
additional mechanisms are likely involved in pre-replicative active DNA demethylation of
the paternal pronucleus (Amouroux et al., 2016). In post-replicative PN3 to PN4 zygotes,
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genome-wide CpG sites exhibited methylation loss both actively (TET3-dependent) and/or
passively (replication-dependent) (Guo et al., 2014a). The latter includes repetitive elements,
where DNA demethylation in the paternal pronucleus possessed hemimethylated CpG
dinucleotides due to replication-dependent dilution, with minor replication-independent
active demethylation (Amouroux et al., 2016; Arand et al., 2015). Interestingly, production of
5hmC by TET3 is linked to DNMT1 and DNMT3A in late P4 zygotes, suggesting that de
novo methylated cytosines may be targets of hydroxylation (Amouroux et al., 2016). Overall,
such evidence supports both active and passive pathways in paternal pronuclear
demethylation.
In comparison to the paternal pronucleus, the maternal pronucleus is protected from
5mC demethylation. Protection from DNA demethylation is accomplished via maternal
effect proteins, which are synthesized by the oocyte and required in the preimplantation
embryo. In zygotes, the maternal effect protein developmental pluripotency associated factor
3 (DPPA3/Stella/PGC7) binds to maternal chromatin containing histone 3 lysine 9
dimethylation (H3K9me2), thereby inhibiting TET3 activity (Nakamura et al., 2007; 2012;
Nakatani et al., 2015) (Figure 1-9). DPPA3 binding to chromatin may be dependent on the
H3K9me2 methyltransferase protein euchromatic histone lysine methyltransferase 2
(EHMT2/G9a) as well as on its heterodimeric partner, EHMT1/GLP, since their deletion in
embryonic stem cells results in reduced DNA methylation at promoter regions (Nakamura et
al., 2012; Zhang et al., 2016). Despite this protection, active demethylation may lead to
partial DNA methylation loss on the maternal genome, since low 5hmC levels are present in
maternal pronuclei of zygotes (Salvaing et al., 2012; Wossidlo et al., 2011). In support of
this, haploid parthenogenetic embryos (only maternal genome) display pre-S-phase 5mC
depletion 6 hours post-activation (Amouroux et al., 2016; Okamoto et al., 2016); and Tet3deficient zygotes show impaired DNA demethylation on both paternal and maternal
pronuclei (Guo et al., 2014a).
After the first cleavage division, demethylation of the majority of the maternal
genome is initiated in a passive, replication-coupled manner. Thus, DNA methylation loss of
~50% at each cell cycle leads to the lowest levels by the early blastocyst stage (Mayer et al.,
2000; Oswald et al., 2000; Santos et al., 2002). The absence of highly concentrated oocytespecific DNMT1o in nuclei, except for at the 8-cell stage, and the presence of small amounts
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of the somatic DNMT (DNMT1s) in nuclei during preimplantation development, are the
contributing factors to passive DNA demethylation (Cirio et al., 2008a; 2008b; Hirasawa et
al., 2008). However, DNA methylation loss may not occur solely through replication
dilution. A recent genome-wide, allele-specific study has documented 5mC, 5hmC, and
subsequent oxidized derivatives 5fC and 5caC in 2-cell to 4-cell embryos, identifying a role
for active demethylation of the paternal and maternal genome at these stages (Wang et al.,
2014). Thus, passive replicative dilution of maternal DNA methylation may be delayed until
the 4-cell stage. However, the loss of paternal genomic 5hmC is controversial as evidence
has been presented for active BER pathways (Guo et al., 2014a; He et al., 2011; Santos et al.,
2013) as well as passive replication-dependent dilution (Arand et al., 2015; Guo et al., 2014a;
Inoue and Zhang, 2011; Inoue et al., 2011; Shen et al., 2014). For the latter, there is a
progressive decline in asymmetric 5hmC, 5fC and 5caC staining on the presumptive paternal
metaphase chromatids from the 2-cell to 8-cell stage, pointing to passive replicationdependent dilution of these oxidized derivatives (Inoue and Zhang, 2011; Inoue et al., 2011;
Shen et al., 2014). Future studies are needed to uncover the mechanisms and dynamics of
demethylation during preimplantation development.
Genome-wide data have reported higher than expected DNA methylation levels in the
blastocyst if subjected to passive demethylation (Kobayashi et al., 2012). This is attributed to
maintenance methylation at oocyte gDMRs, imprinted gDMRs and repetitive elements,
which retain DNA methylation though preimplantation development. For imprinted gDMRs,
several proteins have been identified that maintain/protect imprinted methylation during
preimplantation development. In zygotes, maternally (Peg1, Peg3 and Peg10) and paternally
[H19 and Rasgrf1 (Ras protein-specific guanine nucleotide-releasing factor 1)] imprinted
gDMRs are protected from TET3 demethylation of 5mC to 5hmC by maternally-derived
DPPA3 binding to H3K9me2 (Nakamura et al., 2007; 2012) (Figure 1-9). After the 1-cell
stage, maternal and embryonic zinc finger protein 57 (ZFP57) likely protects imprinted
gDMRs from passive demethylation by binding to CpG methylation (Li et al., 2008b;
Quenneville et al., 2011; Zuo et al., 2012) and recruiting repressive complex machinery, that
includes tripartite motif 28 protein (TRIM28), the H3K9me3 histone methyltransferase SET
domain bifurcated 1 (SETDB1), and DNMT1s/1o (Alexander et al., 2015; Bilodeau et al.,
2009; Cirio et al., 2008a; 2008b; Howell et al., 2001; Kurihara et al., 2008; Li et al., 2008b;
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Lorthongpanich et al., 2013; Messerschmidt et al., 2012; Quenneville et al., 2011; Ratnam et
al., 2002; Schultz et al., 2002; Zuo et al., 2012) (Figure 1-9). As studies involving ZFP57
have been performed in later stage embryos (E11.5) and ES cells, future studies are required
to validate this mechanism in preimplantation embryos. Overall, current evidence indicates
that imprinted gDMRs are protected from both active and passive forms of demethylation
during preimplantation development by maternal effect DNA methylation protector proteins.
Further investigations are also required to elucidate the mechanisms and dynamics of
methylation maintenance at non-imprinted oocyte gDMRs and repetitive elements.
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Figure 1-9: Maternal effect products
Upon erasure of methylation marks from the previous generation by TET1/TET2 (light
purple circle), imprints are established differentially by DNMT3A/DNMT3L/DNMT3B
(light green circle) in spermatocytes and DNMT3A (green circle)/DNMT3L (maroon circle)
in oocytes. During this period of imprint establishment during oogenesis, mitochondria
numbers rapidly increase from a small progenitor pool in PGCs (maroon dotted line). After
fertilization DPPA3 (dark purple circle) protects the maternal genome and paternally
methylated ICRs from TET3 (bright green circle)-catalyzed active demethylation of the
paternal genome. DNMT1 (DNMT1o/s, grey circle) maintains imprinted methylation during
the S-phase of cleavage divisions while ZFP57 (dark blue circle) and additional complex
members regulate methylation maintenance beginning at the 8-cell stage. Mitochondrial
DNA is not replicated during preimplantation development, suggesting that total
mitochondrial numbers remain relatively constant though preimplantation. Consequently,
mitochondrial numbers per blastomere would be halved after each cell division.
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1.3.4

Conservation of DNA methylation dynamics between mouse
and human
While a greater body of data exists on DNA methylation dynamics during gamete and

preimplantation development for the mouse compared to the human, available data in the
human highlight striking similarities between these species.

1.3.4.1

Conservation of DNA methylation erasure in human PGCs

Prior to comparing DNA methylation erasure in mouse and human, it is important to
correlate developmental time points. PGC development takes place between E6.25-E13.5 in
the mouse, with PGC development occurring during weeks 2-9 of gestation in humans (De
Felici, 2013; Ewen and Koopman, 2010; Leitch et al., 2013; Tang et al., 2015). More
specifically, PGC migration and colonization of the developing genital ridge occurs between
E8-E10.5 in mouse, which corresponds to ~3-5 weeks gestation in humans (Park et al., 2009;
Tang et al., 2015). Mouse PGCs at E11.5-12.5 were most similar to week 7-9 human PGCs
(Tang et al., 2015). At E13.5 in mouse and after week 9 in human, germ cell sexual
differentiation has produced oogonia and prospermatogonia in female and male gonads,
respectively (Ewen and Koopman, 2010; Kocer et al., 2009; Tang et al., 2015). To study
earlier stages of PGC development, human PGC-like cells have been generated from
embryonic stem cells and are representative of E6.5-E7.5 premigratory mouse PGCs (Tang et
al., 2015).
Overall, studies on PGC methylation erasure dynamics in human have yielded
comparable results to mouse.

Stage I of methylation erasure in mouse occurring prior to

E10.5 (Guibert et al., 2012; Hajkova et al., 2002b; Saitou et al., 2012; Seisenberger et al.,
2012; Seki et al., 2005) likely initiates prior to week 5.5 gestation in human (Tang et al.,
2015). Similar stage II methylation erasure events have been reported globally in human 519 week PGCs (Driscoll and Migeon, 1990; Gkountela et al., 2015; Guo et al., 2015; Tang et
al., 2015; Wermann et al., 2010), corresponding to stage II of methylation erasure in mouse
E10.5-13.5 PGCs (Hajkova et al., 2008; 2010; Piccolo et al., 2013; Yamaguchi et al., 2013).
Globally for both mouse and human, this erasure produces the greatest loss of DNA
methylation throughout development (Gkountela et al., 2015; Guo et al., 2015; Hajkova,
2011; Tang et al., 2015). Mechanistically, active demethylation may contribute to erasure of
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stage I and/or II global methylation in human since TET1 protein, 5hmC, and BER pathway
members are present (Gkountela et al., 2015; 2013; Guo et al., 2015; Tang et al., 2015). This
indicates a potential conserved role to mouse for TET1, 5hmC (Hajkova et al., 2008; 2010;
Piccolo et al., 2013; Yamaguchi et al., 2013) and BER (Cortellino et al., 2011; Hajkova et al.,
2010; Morgan et al., 2004; Popp et al., 2010) in PGC methylation erasure. For DNA
methylation erasure dynamics at imprinted domains in humans, one group showed similar
delayed DNA methylation erasure (Gkountela et al., 2013; 2015) as in mouse (Kobayashi et
al., 2013), while other studies reported DNA methylation erasure initiating coincident with
global erasure (Guo et al., 2015; Tang et al., 2015). In both cases, imprinted methylation
erasure was more protracted than global erasure. Like mouse (Hackett et al., 2013; Piccolo et
al., 2013; Vincent et al., 2013), imprinted gDMR methylation loss in PGCs may occur by
active DNA demethylation, since oxidation of 5mC to 5hmC was evident at H19 and GNAS
ICRs (Tang et al., 2015), and at the PEG3 DMR (Gkountela et al., 2013). The role of passive
demethylation has not been investigated.

1.3.4.2

Conservation of DNA methylation acquisition in human
gametes

Regarding methylation acquisition in gametes, available data point to spatial,
temporal and mechanistic conservation of global and imprinted methylation acquisition in
sperm and oocytes between mouse and human (Guo et al., 2014b; Kobayashi et al., 2012;
Okae et al., 2014; Smallwood et al., 2011; Smith et al., 2012; 2014; Wang et al., 2014). Both
species establish global DNA methylation profiles prenatally during spermatogenesis
(Kobayashi et al., 2013; Wermann et al., 2010) and postnatally during oocyte growth
(Kobayashi et al., 2012; Shirane et al., 2013; Smallwood et al., 2011; Smith et al., 2012;
Tomizawa et al., 2011; Wermann et al., 2010). Similarly, imprinted DNA methylation
acquisition is already fully acquired in human adult spermatogonia, spermatocytes, round and
elongating spermatids and mature ejaculated spermatozoa (Boissonnas et al., 2010; Kerjean
et al., 2000; Kobayashi et al., 2007; Marques et al., 2008; 2011; Sato et al., 2011), and
therefore likely occurs prior to birth as in mouse (Davis et al., 2000; Kaneda et al., 2004;
Kato et al., 2007; Kobayashi et al., 2013; Lee et al., 2010; Lucifero et al., 2002; Ueda et al.,
2000). Maternal imprint acquisition in human occurs in an oocyte size-dependent manner
(Arima and Wake, 2006; Sato et al., 2007), similar to the mouse (Arima and Wake, 2006;
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Denomme et al., 2012; Lucifero, 2004; Sato et al., 2007). With respect to mechanistic
conservation, mouse and human gametes possess DNMT3A and DNMT3B transcripts at
similar levels in comparative oocyte analysis (Okae et al., 2014) and corresponding
DNMT3A and DNMT3B protein products have been detected in human (Petrussa et al.,
2014). However, unlike the mouse (Kato et al., 2007; La Salle et al., 2007; Niles et al., 2013),
DNMT3L transcripts/protein have not been detected in human spermatogenic cells or oocytes
(Huntriss et al., 2004; Okae et al., 2014; Petrussa et al., 2014), suggesting divergence in its
role in global and imprinted methylation acquisition. Further investigations should also be
aimed at the specific roles of DNMT3A, DNMT3B and DNMT3L in human sperm and preGV methylation acquisition in oocytes.

1.3.4.3

Conservation of DNA methylation programming during
preimplantation development

In the preimplantation embryo, DNA methylation dynamics are more complex than
expected. Globally in zygotes, active DNA demethylation of the paternal genome by the TET
family likely occurs in both species, with potential for roles at maternal genomes (Beaujean
et al., 2004; Fulka et al., 2008; 2004; Gu et al., 2011; Guo et al., 2014b; Inoue and Zhang,
2011; Inoue et al., 2011; Iqbal et al., 2011; Pendina et al., 2011; Wossidlo et al., 2011). Both
mouse and human oocytes express elevated Tet3/TET3 compared to Tet1/TET1 and
Tet2/TET2, in addition to expressing the protective Dppa3/DPPA3 factor (Kobayashi et al.,
2012; Okae et al., 2014; Wossidlo et al., 2011; Yan et al., 2013). A confirmed role for these
proteins in human zygotes remains to be elucidated. However, since the human maternal
pronucleus harbors greater 5mC and lower 5hmC than the paternal pronucleus, it is likely
that at least a portion of the maternal genome must be protected from active demethylation
(Fulka et al., 2004; 2008; Pendina et al., 2011). During cleavage divisions, DNA methylation
and hydroxymethylation marks display an asymmetric chromatid localization, which are
passively diluted though replication in both species (Efimova et al., 2015; Inoue and Zhang,
2011; Inoue et al., 2011; Shen et al., 2014; Wang et al., 2014). However, a role for active
demethylation also exists for both mouse (Smith et al., 2012) and human (Efimova et al.,
2015), possibly in a stage-specific and sequence-specific manner. Mechanistically in mouse,
passive loss of DNA methylation during preimplantation development was attributed to
DNMT1o exclusion from nuclei (except at the 8-cell stage) and low nuclear DNMT1s levels
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at all preimplantation stages (Cirio et al., 2008a; 2008b; Hirasawa et al., 2008; Howell et al.,
2001; Kurihara et al., 2008; Ratnam et al., 2002). In humans, DNMT1o nuclear localization
occurs throughout preimplantation, while nuclear localization of DNMT1s is restricted to
nuclei of 6-cell to morula stage embryos (Petrussa et al., 2014). Not withstanding this
difference, it appears that DNMT1o and DNMT1s are present at sufficient levels to maintain
imprinted methylation during mouse and human preimplantation development.

Further

research is required to delineate the functions of these DNMT1 isoforms.
With regards to imprinted DNA methylation, genome-wide methylation studies of
human gametes and preimplantation embryos indicate preservation of maintenance of DNA
methylation at imprinted gDMRs (Guo et al., 2014b; Kobayashi et al., 2012; Okae et al.,
2014). As in mouse (Nakamura et al., 2007; 2012), high abundance of DPPA3 in human
oocytes (Goto et al., 2002; Kobayashi et al., 2012; Yan et al., 2013) suggests a conserved role
for this protein in protecting imprinted gDMRs from active DNA methylation loss in zygotes.
During cleavage division, the presence of DNMT1o/DNMT1o and DNMT1s/DNMT1s and
nuclear localization of DNMT1o/DNMT1s during human preimplantation development
(Huntriss et al., 2004; Petrussa et al., 2014) suggests conservation to mouse (Cirio et al.,
2008a; 2008b) in maintaining DNA methylation at imprinted gDMRs. With regard to the
DNMT1 interacting partner ZFP57, limited data exists for its role in human embryos.
However, to assess its function, mouse embryonic stem cells were transfected with human
ZFP57. The mouse and human ZFP57 proteins are interchangeable in maintaining imprinted
DNA methylation as well as binding to TRIM28 (Takikawa et al., 2013). In line with this, in
human embryonic stem cells, TRIM28 is recruited to the majority of human imprinted DMRs
by KRAB-containing zinc finger proteins (KRAB-ZFPs)(Jacobs et al., 2014; Turelli et al.,
2014) (Table 1). Since ZFP57 and TRIM28 are maternal effect proteins in mouse, their
expression has also been examined in human oocytes. Although TRIM28 mRNA abundance
was similar between human and mouse oocytes (Okae et al., 2014), human oocytes were
reported to lack ZFP57 transcripts (Okae et al., 2014; Yan et al., 2013), with embryonic
ZFP57 expression commencing at the morula stage (Yan et al., 2013). This requires further
validation since ZFP57 protein levels were not assessed. Overall, current evidence indicates
that imprinted gDMRs are maintained during human preimplantation development, with
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potential conservation of DNA methylation protector proteins that bar active and passive
demethylation.
In conclusion, regulation of DNA methylation dynamics during gamete and
preimplantation development is complex. While a greater body of data exists for the mouse
compared to the human, available data highlight striking similarities between these species.
Regardless of differences that may exist, in both species it is evident that proper regulation of
imprinted DNA methylation dynamics is necessary for successful preimplantation embryo
development. Consequently, any disruption of imprinted DNA methylation dynamics during
this period could lead to aberrant or failed development or genomic imprinting disorders.

1.4 Mitochondria
Mitochondrial dysfunction has confirmed roles in mitochondrial disease, failed
reproductive success and age-related infertility. Many studies have confirmed the vital role
mitochondria play as important determinants of developmental competence throughout
oocyte and preimplantation embryo growth. As mitochondria are dynamically regulated and
critically required during this early period of development, defects in mitochondrial
distribution, quantity, and/or activity have negative developmental consequences in multiple
species, including mouse and human (Ge et al., 2012; Thouas et al., 2004; Van Blerkom et
al., 1995; 2000; Van Blerkom, 2004; 2008; 2009; 2011; Wakefield et al., 2011).

1.4.1

Mitochondrial dynamics during oogenesis and preimplantation
development
At fertilization in the fully grown mature oocyte, the mitochondrial complement has

been derived from approximately 10-20 mitochondria in PGCs that increases rapidly via
mitochondrial biogenesis and mitochondrial DNA replication during mouse and human
oocyte growth up to the MII stage (Cummins, 2002; Jansen, 2000; St John et al., 2010; Van
Blerkom, 2011). In the human, mitochondrial numbers reach about 100,000 to 400,000 in the
mature MII oocyte (Cummins, 2002; Jansen, 2000; Jansen and de Boer, 1998; Jansen and
Burton, 2004), similar to the 92,500 ± 7000 identified in the mouse egg (Pikó and
Matsumoto, 1976).

This oocyte mitochondrial pool represents the sole source of

mitochondria present during oogenesis, preimplantation development and throughout life.
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After fertilization in both human and mouse, mitochondrial DNA molecules are not
replicated until the blastocyst stage of preimplantation development (Larsson et al., 1998;
Pikó and Chase, 1973; Pikó and Taylor, 1987; Thundathil et al., 2005). Thus, mitochondrial
numbers are anticipated to remain relatively constant within the preimplantation embryo.
This would mean that mitochondrial numbers decrease by half per blastomere with each
successive cleavage division (Motta et al., 2000; Sathananthan and Trounson, 2000; St John
et al., 2010; Thundathil et al., 2005; Van Blerkom, 2011; Zamboni, 1971) (Figure 1-9). After
implantation, the molecular machinery for mitochondrial DNA replication becomes active,
with mitochondrial DNA copy number and mitochondrial biogenesis increasing first
primarily in trophectodermal cells then subsequently in the epiblast (Assou et al., 2006;
Larsson et al., 1998; St John et al., 2010; Thundathil et al., 2005).
Although mitochondria are in a state of replicative senescence during preimplantation
development, the organelles undergo dynamic changes in morphology. In oocytes and early
embryos, mitochondria are small, spherical and structurally underdeveloped but still
functional and active in generating ATP (Motta et al., 2000; Pikó and Chase, 1973). As
preimplantation development continues, mitochondria elongate, increase cristae numbers,
and by the expanded blastocyst stage they begin to resemble forms present in differentiated
somatic cells, again predominantly in trophectoderm (Motta et al., 2000; Pikó and Chase,
1973; Van Blerkom et al., 1973). These structural changes occur in parallel to increased
respiration to meet the energy demands for blastocyst formation and the development of the
fluid filled cavity by trophectoderm cells (Houghton, 2006). Most of the energy produced in
blastocyst trophectoderm is hypothesized to drive and support activity of the ATP-dependent
Na+/K+-ATPase (sodium-potassium adenosine triphosphatase) (Houghton, 2006; Van
Blerkom, 2008), which is known to be vital for blastocyst formation/cavitation (Madan et al.,
2007; Watson et al., 2004).
In addition to dynamic morphological changes, mitochondria also actively translocate
to specific regions of the cytoplasm during oogenesis and preimplantation development.
Perinuclear translocation of active mitochondria occurs during meiosis, with nuclear
localization coinciding with bursts of ATP production specifically during nuclear maturation
(germinal vesicle break down (GVBD), metaphase I (MI) spindle migration, MI to MII
transition, and polar body (PB) extrusion) (Van Blerkom, 1991; Yu et al., 2010). At the
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ovulated MII stage, both perinuclear mitochondrial localization (Kan et al., 2011; Nagai et
al., 2006) and a homogenous distribution throughout the cytoplasm (Tokura et al., 1993; Van
Blerkom, 2004; Yu et al., 2010) has been documented. In addition to this distribution of
active mitochondria during oogenesis, a persistent subcortical high potential mitochondrial
ring in the oocyte exists and is required for sperm penetration, fertilization and meiotic
maturation (Van Blerkom and Davis, 2007).

The localization of mitochondria during

preimplantation development is less characterized. However, perinuclear localization at the
2-cell stage (Van Blerkom et al., 2000; Van Blerkom, 2009), symmetrical distribution of
mitochondria between pronuclei/blastomeres from the pronuclear 1-cell to 8-cell stage (Van
Blerkom et al., 2000), and higher mitochondrial activity in trophectoderm cells (TE) versus
inner cell mass (ICM) cells in blastocysts (Houghton, 2006) have all been reported.

1.4.2

The role of mitochondria in developmental competence
Recently, many studies performed in mouse and human have concentrated on

analyzing mitochondrial parameters with respect to reproductive success of the oocyte and
preimplantation embryo.

With regards to oocyte competence, nuclear and meiotic

maturation (and consequently fertilization) are dependent on ATP generation (Dumollard et
al., 2004; St John et al., 2010; Yu et al., 2010). Those oocytes with sufficient ATP and
mitochondria numbers generate higher-quality blastocyst embryos (Takeuchi et al., 2005)
and exhibit an increased potential for continued embryogenesis, implantation (Van Blerkom
et al., 1995), and postimplantation development (Wai et al., 2010). Perinuclear accumulation
of active mitochondria is also necessary for oocyte competence (Van Blerkom, 1991; Van
Blerkom and Runner, 1984; Yu et al., 2010).
As during oogenesis, mitochondrial function and the ability to generate sufficient
ATP is required for successful cleavage throughout preimplantation development (Liu et al.,
2000; May-Panloup et al., 2005; Thouas et al., 2004). Upon successful fertilization, failure
to accumulate mitochondria to the perinuclear region in zygotes is associated with decreased
blastocyst developmental rates (Zhao et al., 2009). Furthermore, decreased ATP content
occurs in mouse embryos undergoing a 2-cell block in development (Wang et al., 2009).
With regard to mitochondrial distribution, 1-cell zygote to 8-cell stage preimplantation
embryos exhibiting an asymmetrical segregation of mitochondria surrounding pronuclei and
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between blastomeres undergo increased developmental arrest, with lysis of blastomeres
inheriting lower amounts of mitochondria (Van Blerkom et al., 2000). Finally, mitochondrial
inhibition during preimplantation development leads to impaired ATP production,
incrementally reduced blastocyst development, decreased blastocyst ICM and TE cell
numbers, and reduced fetal and placental growth, thus highlighting the importance of
mitochondria both during preimplantation and postimplantation development (Wakefield et
al., 2011).
In conclusion, appropriate regulation of mitochondrial dynamics is critical for
successful development of human and mouse oocytes and preimplantation embryos.
Consequently, perturbations in mitochondrial dynamics during this critical period have the
potential to negatively impact developmental outcomes.

1.5 Assisted Reproductive Technologies (ARTs)
1.5.1

Infertility and ART
Infertility is generally defined as the inability to conceive naturally after 1 year of

unprotected sex. Recent figures alarmingly estimate that approximately 48.6 million couples
worldwide are unable to conceive after 5 years of unprotected sex (Mascarenhas et al., 2012).
In Canada and the United States, infertility affects 16% and 10-15% of couples, respectively,
tripling Canadian rates since 1984 (5.4%) (Bushnik et al., 2012; Chandra et al., 2013).
Medically assisted reproductive technologies (ARTs) represent infertility treatment methods
that give infertile/subfertile couples the best chance to conceive. These techniques include
ovarian stimulation, in vitro oocyte maturation, in vitro fertilization (IVF), intracytoplasmic
sperm injection (ICSI), in vitro embryo culture, blastocyst hatching, preimplantation genetic
diagnosis (PGD), embryo transfer, oocyte and embryo cryopreservation, and recently
mitochondrial replacement therapy and AUGMENT (discussed in section 1.5.3).
Due to the rising prevalence of infertility, since the birth of Louise Brown, the first
human infant conceived through ARTs in July of 1978 (Steptoe and Edwards, 1978), the use
of ARTs has drastically increased. Now, the proportion of infants born following ARTs is
approximately 1.6% of all births in the United States (Sunderam et al., 2015), reaching as
high as 4.5% of births in developed countries (Ferraretti et al., 2013). In Canada, 32 of 33
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clinics reported completion of approximately 16, 062 ART cycles in 2013, with an overall
live birth rate of 25% (Human Assisted Reproduction 2014). However, when treatment is
successful (< 40%), it carries an increased risk of perinatal complications even within
singleton pregnancies, including; (1) preterm birth; (2) intrauterine growth restriction; (3)
low birth weight (Helmerhorst et al., 2004; Jackson et al., 2004; McGovern et al., 2004;
Okun and Sierra, 2014; Reddy et al., 2007; Savage et al., 2011; Schieve et al., 2002;
Sunderam et al., 2014; Wisborg et al., 2010); (4) large for gestational age (Hansen and
Bower, 2014; Ishihara et al., 2014; Korosec et al., 2014; 2016; Li et al., 2014; Pinborg et al.,
2014; Sazonova et al., 2012; Wennerholm et al., 2013); and (5) higher incidences of the
genomic imprinting disorders, (a) Beckwith-Wiedemann Syndrome (DeBaun et al., 2003;
Doornbos et al., 2007; Gicquel et al., 2003; Maher et al., 2003a; Sutcliffe et al., 2006;
Vermeiden and Bernardus, 2013), (b) Angelman Syndrome (Cox et al., 2002; Doornbos et
al., 2007; Ludwig et al., 2005; Maher et al., 2003a; Ørstavik et al., 2003), and (c) SilverRussell Syndrome (SRS) (Bliek et al., 2006; Chiba et al., 2013; Chopra et al., 2010; Cocchi
et al., 2013; Hiura et al., 2012; Kagami et al., 2007; Lammers et al., 2012; Vermeiden and
Bernardus, 2013).

1.5.2

ART and imprinting disorders
The overall risk for an imprinting disorder such as BWS, AS or SRS after ART is

approximately 1 in 5,000 children (Okun and Sierra, 2014). This is compared to the low risk
in the general population for BWS (1 in 13,700), AS (1 in 15,000) and SRS (unknown
prevalence). Specifically, the risk of BWS is 3-16 times greater in ART-conceived children
compared to the general population (DeBaun et al., 2003; Gicquel et al., 2003; Gosden et al.,
2003; Halliday et al., 2004; Hiura et al., 2012; Lim et al., 2009; Lucifero et al., 2004; Maher
et al., 2003a; 2003b; Rossignol et al., 2006; Sutcliffe et al., 2006; van Montfoort et al., 2012;
Vermeiden and Bernardus, 2013). Within BWS patients conceived by ART, imprinted
methylation errors occur at a greater frequency, with over 90% of ART cases showing
KCNQ1OT1 hypomethylation compared to 50% in the general population (DeBaun et al.,
2003; Gicquel et al., 2003; Gosden et al., 2003; Halliday et al., 2004; Hiura et al., 2012; Lim
et al., 2009; Maher et al., 2003a; 2003b; Rossignol et al., 2006; Sutcliffe et al., 2006), and
conversely, 17% of ART cases showing H19 hypermethylation compared to 5% in general
(DeBaun et al., 2003; Lennerz et al., 2010; Rossignol et al., 2006). Likewise for AS, 46% of
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patients conceived by ARTs possessed imprinting defects at the SNRPN ICR (Cox et al.,
2002; Ludwig et al., 2005; Ørstavik et al., 2003) compared to 5% in general (Horsthemke
and Wagstaff, 2008; Van Buggenhout and Fryns, 2009) while for SRS, 11 out of 12 (92%)
ART patients harboured H19 hypomethylation (Bliek et al., 2009; Chopra et al., 2010;
Cocchi et al., 2013; Hiura et al., 2012; Kagami et al., 2007; Lammers et al., 2012; Vermeiden
and Bernardus, 2013) compared to 40% in the general population (Chiba et al., 2013).
Overall, studies suggest that ARTs increase imprinting disorders, likely through alterations in
epigenetic regulation of imprinted gene expression. Specifically, one explanation for this
risk is that gamete and embryo manipulations disrupt acquisition and/or maintenance of
genomic imprints during gametogenesis and preimplantation development. It is therefore
essential to determine where imprinted methylation errors are occurring and which aspect(s)
of ARTs lead to these adverse epigenetic effects.

1.5.2.1

Mouse model system

Much of what we know regarding imprinting disorders and ARTs has been
discovered using the mouse model system. This system has specifically been instrumental in
the investigation of the effects of individual ARTs on genomic imprint acquisition during
gametogenesis and maintenance throughout preimplantation development. Additionally, the
mouse model allows for controlled studies without issues of confounding infertility that are
unavoidable when studying human assisted conception. Major findings from mouse studies
indicate that imprinted methylation acquisition is not perturbed by superovulation (Denomme
et al., 2011) or in vitro oocyte maturation in oocytes (Anckaert et al., 2009; 2010; Geuns et
al., 2003; 2007), but instead imprint maintenance in preimplantation embryos is disrupted by
superovulation (Hajj et al., 2011; Market-Velker et al., 2010b), in vitro fertilization (IVF)
(Fauque et al., 2010), in vitro embryo culture (Li et al., 2005; Mann et al., 2004; MarketVelker et al., 2010a; 2012) and oocyte vitrification (Cheng et al., 2014). Within these
studies, imprinted methylation errors in preimplantation embryos occurred at a relatively
high frequency, with errors present in 10-90% of embryos analyzed. Studies in our lab have
specifically analyzed the effect of ovarian stimulation, or superovulation, on imprinted
methylation at both low (6.25 IU) and high (10 IU) hormone doses. Superovulation using
high and low hormone-doses did not perturb imprinted methylation acquisition in individual
oocytes at Snrpn, Peg3, Kcnq1ot1 or H19 (Denomme et al., 2011). In contrast, individual
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blastocyst-stage embryos derived from superovulated females exhibited a dose-dependent
loss of methylation at imprinted domains, specifically Snrpn, Peg3, Kcnq1ot1 and H19
(Market-Velker et al., 2010b). Consequently, we demonstrated that superovulation alone
perturbs imprinted methylation in blastocyst embryos at a high frequency. This finding is
additionally supported by two studies in human that discovered patients receiving ovarian
stimulation alone as an ART gave birth to BWS and AS children (Chang et al., 2005; Ludwig
et al., 2005).

1.5.2.2

Discrepancy between human and mouse

Disparity has arisen concerning the frequency of imprinting errors produced by ARTs
in humans compared to mice. When comparing the overall risk for an imprinting disorder,
10-90% of treated preimplantation mouse embryos show abnormal imprint maintenance
(Fauque et al., 2010; Hajj et al., 2011; Market-Velker et al., 2010b; 2012), while only 1 in
5, 000 ART children are at risk for BWS, AS or SRS (Okun and Sierra, 2014). Overtly, it
would therefore appear that the mouse is more sensitive than the human with respect to the
incidence of ART-induced imprinting errors. This has lead to questioning whether the effects
of ARTs on imprint regulation in the mouse recapitulate those processes involved in humans.
However, one key difference in studies between these species is the time of analysis. The
majority of mouse studies have focused on preimplantation or mid-gestation development,
while human studies are primarily retrospective studies of ART children with imprinting
disorders. Although few studies on human preimplantation embryos exist (Chen et al., 2010;
Geuns et al., 2003; 2007; Ibala-Romdhane et al., 2011; Khoueiry et al., 2012; Shi et al.,
2014), most embryos that have been analyzed were poor quality embryos unsuitable for
transfer. Therefore it becomes essential to identify the risk for imprinting errors in high
quality human preimplantation embryos.

1.5.3

Mitochondria in Assisted Reproductive Technologies
The importance of mitochondria during gametogenesis and preimplantation has

recently been acknowledged in human Assisted Reproductive Technologies (ARTs;
discussed in detail section 1.5).

Fertility clinics around the world are now actively

addressing the role mitochondria play during preimplantation development by utilizing novel
techniques to overcome perturbed mitochondrial function. For example, dietary coenzyme
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Q10, or CoQ10, an essential component of the electron transport chain, is used in human
clinics to increase mitochondrial activity with the intention of improving oocyte quality
(Ben-Meir et al., 2015; Bentov et al., 2010; 2014; Chappel, 2013; Meldrum et al., 2016).
Additionally, more invasive procedures are also being implemented.

Specifically,

mitochondrial replacement therapy (MRT) is currently being used in the United Kingdom
(UK) to circumvent the inheritance of mitochondrial DNA mutations and mitochondrial
disease to offspring of affected mothers (Reinhardt et al., 2013).

In this technology,

pronuclear DNA of the intended parents is injected into an enucleated donor oocyte
containing “mutation-free” mitochondria. This technique was originally performed in mice
(Sato et al., 2005), and before implementation in human was also used to produce macaque
babies (Tachibana et al., 2009).

Currently, juvenile macaque offspring born through

mitochondrial replacement therapy are seemingly healthy with normal metabolic profiles
(Tachibana et al., 2013). However as of now, concern from the United States Food and Drug
Agency (FDA) has prevented the use of this technology until more data are available to
support its safety (Couzin-Frankel, 2015). Consistent with this, results in the mouse suggest
that MRT could potentially alter respiration, growth, and exercise and learning ability in
adults (Nagao et al., 1998; Roubertoux et al., 2003). This could be due to disrupted crosstalk between genes encoded in the nucleus and the mitochondria, as coordinated interactions
between mitochondria and nuclear alleles are favored, and these are disrupted by MRT (Muir
et al., 2016; Reinhardt et al., 2013; Woodson and Chory, 2008). Nonetheless, although
controversial, MRT is currently being used in the UK to avoid inherited mitochondrial
disease.
Another mitochondrial treatment has recently been made available to assist
conception in women of advanced reproductive age or in couples with repetitive failed in
vitro fertilization (IVF) cycles.
fertility

treatment,

termed

The US-based company OvaScience developed a new

Autologous

Germline

Mitochondrial

Energy

Transfer

(AUGMENT), and it is based on improving oocyte quality through supplying the egg with a
supposedly germline-derived source of mitochondria from the ovarian cortex (Woods and
Tilly, 2015). Again, the FDA has prohibited its current use in the US. However, it is offered
at the Toronto Centre for Advanced Reproductive Technology (TCART) clinic in Canada, as
well in London UK, Istanbul, Japan, Panama, Spain, Turkey and Dubai (Motluk, 2015). This
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technique is different from the MRT technique that is used for disease prevention, since
AUGMENT does not require donor mitochondria but depends on the existence of
controversial (Zhang et al., 2012), patient-matched cells that are extracted from the ovary
(Bukovsky et al., 2004; Johnson et al., 2004; Pacchiarotti et al., 2010; Virant-Klun et al.,
2013; White et al., 2012; Zou et al., 2009). These putative cells are in the ovarian cortex and
studies in mouse have shown that when reintroduced into adult ovaries they can produce
mature oocytes and viable preimplantation embryos, including blastocysts (White et al.,
2012). Additionally, a separate group that transfected these ovarian cells with a GFP virus
reported production of live offspring that inherited the GFP transgene, birthed from
transplanted infertile females (Zou et al., 2009). Importantly, the role of these cells in normal
folliculogenesis is unknown (Begum et al., 2008).

The AUGMENT technique isolates

mitochondria from a patient’s own cells extracted from the ovary and injects them into the
oocyte at the time of intracytoplasmic sperm injection (ICSI) (Tilly and Sinclair, 2013;
Woods and Tilly, 2015). Although controversial, the world’s first AUGMENT baby was
born in Toronto over 1 year ago, on April 13th, 2015.

1.5.3.1

Effects of ARTs on mitochondria

Many studies have focused on mitochondrial dynamics during gametogenesis and the
preimplantation period. However, much of what we know is based on samples obtained by
assisted reproductive technologies (ARTs).

ART treatments coincide with critical time

points where mitochondria are drastically increased during oogenesis, translocated to provide
stage-specific spatial ATP requirements, and sustained in a non-replicative state during
preimplantation development while still functioning as the primary ATP source. Few studies
in mouse and human have addressed the effect of ARTs on mitochondrial dynamics and
function, with the majority of these focusing on oocyte freezing. Albeit, a few studies have
analyzed the effect of ovarian stimulation on mitochondria in mouse (Combelles and
Albertini, 2003; Ge et al., 2012; Shu et al., 2015) and macaque (Gibson et al., 2005). These
studies have shown that ovarian stimulation decreases mitochondrial DNA copy number,
ATP levels and mitochondrial membrane potential in resulting mouse oocytes (Combelles
and Albertini, 2003; Ge et al., 2012; Shu et al., 2015) and increases mitochondrial DNA
deletions in macaque oocytes (Gibson et al., 2005).
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1.6 Rationale
With the use of ARTs rising worldwide (Dyer et al., 2016), there is a continual
emergence of new techniques being implemented in human IVF, including mitochondrial
replacement therapy (Reinhardt et al., 2013; Wolf et al., 2015) and AUGMENT (Woods and
Tilly, 2015). Furthermore, due to the announcement of ART funding in Ontario, which was
implemented December 2015 (Motluk, 2016), and the absence of strict regulation of ARTs in
Canada (Assisted Human Reproduction Act), it is becoming increasingly important for
researchers to investigate the effects of these treatments on the manipulated oocyte and
preimplantation embryo.

This is especially important as ART techniques coincide with

critical time points where imprinted DNA methylation marks are being maintained and
mitochondria are very dynamic (Figure 1-9). As discrepancy in the field exists between risk
for imprinting disorders in preimplantation mouse embryos and human infants born through
ARTs, it is essential to identify the risk for imprinting abnormalities in early human embryos.
Furthermore, with the advent of novel treatments targeting mitochondria, the effects of
widely used ARTs on mitochondria, such as the indispensible procedure of ovarian
stimulation, must be determined.

1.7 Hypothesis
My overall hypothesis is that imprinted DNA methylation maintenance and
mitochondrial dynamics are disrupted by ARTs during preimplantation development.
Specifically, I hypothesize that imprinted methylation errors occur at similar frequencies in
donated, good quality, human preimplantation embryos compared to those identified in
mouse. Furthermore, I hypothesize that ovarian stimulation disrupts maternally derived
mitochondria in oocytes and preimplantation embryos derived from hormone-treated
females.

1.8 Objectives
1. To determine the effect of ARTs on imprinted DNA methylation in human
preimplantation embryos. Specifically, this objective will address whether donated
human ART-produced preimplantation embryos harbour aberrant imprinted
methylation at similar incidences to that observed in the mouse.
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a. Determine baseline imprinted DNA methylation levels at SNRPN, KCNQ1OT1
and H19 in untreated human buccal cell samples.
b. Determine whether imprinted methylation errors occur in human day 3 (~6-8
cells) and blastocyst-stage embryos, and whether short or extended culture
produces a greater frequency of imprinted methylation errors.
c. Determine whether aberrant imprinted methylation in human day 3 and blastocyst
embryos correlates with parental biometrics or clinical treatment.
2. My second objective further extends analyses on the effects of ART treatments on
resulting embryos by analyzing the effects of ovarian simulation on mitochondria in
the oocyte and throughout preimplantation development.
a. Determine whether superovulation disrupts the pool of total mitochondria, active
mitochondria,

and

mitochondrial

distribution

in

oocytes

and

during

preimplantation development
b. Determine whether resulting blastocyst embryos exhibit perturbed mitochondrial
function.
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Chapter 2
The work in this chapter originates from the following peer-reviewed article:
White, C.R., Denomme, M.M., Tekpetey, F.R., Feyles, V., Power, S.G.A., and Mann,
M.R.W. (2015). High Frequency of Imprinted Methylation Errors in Human Preimplantation
Embryos. Sci Rep 5, 17311.

2

High frequency of imprinted methylation errors in human
preimplantation embryos
Assisted reproductive technologies (ARTs) represent the best chance for infertile

couples to conceive, although increased risks for morbidities exist, including imprinting
disorders. This increased risk could arise from ARTs disrupting genomic imprints during
gametogenesis or preimplantation. The few studies examining ART effects on genomic
imprinting primarily assessed poor quality human embryos. Here, we examined day 3 and
blastocyst stage, good to high quality, donated human embryos for imprinted SNRPN,
KCNQ1OT1 and H19 methylation. Seventy-six percent of day 3 embryos and 50% of
blastocysts exhibited perturbed imprinted methylation, demonstrating that extended culture
did not pose greater risk for imprinting errors than short culture. Comparison of embryos
with normal and abnormal methylation didn’t reveal any confounding factors. Notably, two
embryos from male factor infertility patients using donor sperm harboured aberrant
methylation, suggesting errors in these embryos cannot be explained by infertility alone.
Overall, these results indicate that ART human preimplantation embryos possess a high
frequency of imprinted methylation errors.

2.1 Introduction
Alarming figures indicate that an estimated 48.5 million couples worldwide are unable
to conceive after 5 years of unprotected sex (Mascarenhas et al., 2012). For these couples,
medically assisted reproductive technologies (ARTs) represent the best chance to conceive.
However, when treatment is successful (< 40%), there is an increased risk of perinatal
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complications even within singletons, including preterm birth, intrauterine growth restriction,
low birth weight (Mascarenhas et al., 2012; Okun and Sierra, 2014; Savage et al., 2011) and
the genomic imprinting disorders; (1) Beckwith-Wiedemann Syndrome (BWS) (DeBaun et
al., 2003; Doornbos et al., 2007; Gicquel et al., 2003; Maher et al., 2003a; Sutcliffe et al.,
2006), (2) Angelman Syndrome (AS) (Cox et al., 2002; Doornbos et al., 2007; Ludwig et al.,
2005; Maher et al., 2003a; Ørstavik et al., 2003), and (3) Silver-Russell Syndrome (SRS)
(Bliek et al., 2006; Chiba et al., 2013; Chopra et al., 2010; Cocchi et al., 2013; Hiura et al.,
2012; Kagami et al., 2007; Lammers et al., 2012).
Genomic imprinting is an epigenetic phenomenon that restricts expression to one
parental allele while the other allele is in an inactivated state. Imprinted genes are regulated
by a master control switch known as a gametic differentially methylated region (gDMR) or
imprinting control region (ICR). Importantly, abnormal cytosine methylation levels at the
ICR can lead to imprinting disorders such as BWS, AS and SRS.
Risk association studies have found increased risks of imprinting disorders in ART
children. The risk of BWS is 3-16 times greater in children in the ART population compared
to those in the general population (DeBaun et al., 2003; Gicquel et al., 2003; Halliday et al.,
2004; Hiura et al., 2012; Lim et al., 2009; Maher et al., 2003b; Maher, 2005; Rossignol et al.,
2006; Sutcliffe et al., 2006; van Montfoort et al., 2012). Epigenetic errors at KCNQ1OT1,
namely maternal hypomethylation, are observed in more than 90% of ART BWS cases
compared to 50% in the general population (DeBaun et al., 2003; Gicquel et al., 2003;
Halliday et al., 2004; Hiura et al., 2012; Horike et al., 2000; Lim et al., 2009; Maher et al.,
2003b; Maher, 2005; Rossignol et al., 2006; Sutcliffe et al., 2006; Weksberg et al., 2010),
while H19 maternal hypermethylation occurs in 17% of ART BWS cases compared to 5% in
the general population (DeBaun et al., 2003; Lennerz et al., 2010; Rossignol et al., 2006;
Weksberg et al., 2010). Of the small number of patients analyzed, 46% of AS patients
conceived by ARTs possessed imprinting defects at the SNRPN ICR compared to 5% in the
general population (Cox et al., 2002; Ludwig et al., 2005; Van Buggenhout and Fryns, 2009;
Ørstavik et al., 2003), while 92% of SRS patients conceived by ARTs harboured H19
hypomethylation compared to 40% in the general population (Bliek et al., 2006; Chiba et al.,
2013; Chopra et al., 2010; Cocchi et al., 2013; Hiura et al., 2012; Kagami et al., 2007;
Lammers et al., 2012),. The overall risk for an imprinting disorder such as BWS, AS or SRS
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in ART children is estimated to be around 1 in 5,000 (Okun and Sierra, 2014). Thus,
disparity has arisen concerning the frequency of imprinting errors produced by ARTs in
humans compared to mice, as mouse studies have identified between 10% to 90% of treated
preimplantation embryos showing abnormal imprint maintenance (Fauque et al., 2007; Hajj
et al., 2011; Mann et al., 2004; Market-Velker et al., 2012; 2010). However, one key
difference in studies between these species is the time of analysis. The majority of mouse
studies have focused on preimplantation or mid-gestation development, while human studies
are primarily retrospective studies of ART children with imprinting disorders. Consequently,
we sought to determine whether donated human ART-produced preimplantation embryos
harbour aberrant imprinted methylation at similar incidences to that observed in the mouse
(Fauque et al., 2007; Hajj et al., 2011; Mann et al., 2004; Market-Velker et al., 2010; 2012).
Additionally, we analyzed whether short or extended culture produces a greater frequency of
imprinted methylation errors, and whether aberrant imprinted methylation correlates with
parental biometrics or clinical treatment. We analyzed methylation levels at SNRPN,
KCNQ1OT1 and H19 ICRs in individual good to high quality day 3 cleavage and blastocyst
stage ART-produced human embryos.

2.2 Materials and Methods
2.2.1

Donated human embryos
Twenty-three patients who had completed their fertility treatment at The Fertility

Clinic at London Health Sciences Centre donated for research 24 day 3 cleavage and 29
blastocyst-stage human embryos that were no longer needed for their treatment. Buccal cells
(B1-B4) were obtained from 4 healthy, non-patient adults (<30 years old). Research ethics
approval was obtained through the Western University’s Health Science Research Ethics
Board (102659) and the methods were carried out in accordance with the approved
guidelines. Informed consent was obtained from patients donating embryos and non-patient
adults providing buccal cell samples. All embryos were cultured in the glucose/phosphatefree preimplantation stage 1 (P1) culture medium (Irvine Scientific, California) to day 3,
then in Blastocyst Medium (BM) in a sequential media protocol (Irvine Scientific,
California) to the blastocyst stage. Embryos were slow frozen between the years 2000-2007
and thawed between October 2013-August 2014. Slow freezing was performed according to
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the Testart's (propanediol) freezing method (Testart et al., 1986) using Sydney IVF
Cryopreservation Kits.
Day 3 human embryos were graded by blastomere number, and morphological
fragmentation levels by either the former A through F grading system or the currently used
G1 through G6 system: A, even, regular, no fragments; B, uneven, irregular, no fragments;
slight C (slC), slight fragmentation; C, minor (<25%) fragmentation; D, major (between 2550%) fragmentation; E, extensive (>50%) fragmentation; F, degenerate; or by fragmentation
levels: G1, <5% fragmentation; G2, 5-10% fragmentation; G3, 11-25% fragmentation; G4,
26-50% fragmentation; G5, >50% fragmentation; and G6, degenerate (Hardy et al., 2003;
Rijnders and Jansen, 1998; Sjöblom et al., 2006).

Following thawing, the majority of

embryos were G1-G3 grade and had an average of 4 cells (data not shown).
Blastocyst grading was according to blastocyst cavity size/hatching, inner cell mass
characteristics and trophoblast cell number giving a numeric-alpha-alpha score based on the
Gardner and Schoolcraft scoring system (Gardner and Schoolcraft, 1999). Cavity size or
hatching score was graded as 1, early blastocyst with cavity less than half the embryo
volume; 2, blastocyst with cavity greater than half the embryo volume; 3, full blastocyst,
cavity full; 4, expanded blastocyst, cavity expanded beyond earlier embryo size with thinning
zona; 5, hatching blastocyst; 6, hatched blastocyst. Inner cell mass (ICM) grading was A,
tightly packed ICM, many cells; B, loosely grouped ICM, several cells; and C, very few
cells, and trophectoderm was graded as A, many cells with cohesive epithelium; B, few cells
with loose epithelium; and C, very few large cells. All embryos were immediately processed
for methylation analysis following thawing.

2.2.2

Isolation of Control Cells
Buccal cells were collected using the end of a sterile 20 μL pipet tip and diluted into

approximately 1000, 100, 50 and 5-10 cells in 20 μL of 1 X PBS (Phosphate-Buffered
Saline). Buccal cells were then embedded into a 2:1 3% LMP agarose and lysis solution, and
then subjected to imprinted DNA methylation analysis. One confluent well of a 6-well dish
(~1x106 cells) of HES2 human ESCs (WiCell Research Institute Inc.) was washed once with
1X PBS (Sigma) and incubated in TrypLE Express (GIBCO) in Dulbecco’s PBS (DPBS).
Trypsin was inactivated by addition of DMEM and 10% Fetal Bovine Serum (FBS) medium.
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Detached hESCs were collected, pelleted gently, washed with 1X PBS and re-suspended in
1000 μL of 1X DPBS. Approximately 1 μL of cells (~1000 cells) was embedded into a 2:1
3% LMP agarose and lysis solution, then subjected to bisulfite mutagenesis.

2.2.3

Imprinted DNA Methylation Analysis
Immediately following thawing individual embryos were embedded under mineral oil

(Sigma) into 10 μL of a 2:1 mixture of 3% LMP agarose (Sigma) and lysis solution [100 mM
Tris–HCl, pH 7.5 (Bioshop), 500 mM LiCl (Sigma), 10 mM EDTA, pH 8.0 (Sigma), 1%
LiDS (Bioshop), and 5 mM DTT (Sigma), 1 μl 2mg/ml proteinase K (Sigma), and1 μl 10%
Igepal (Sigma)]. DNA methylation analysis was performed using the bisulfite mutagenesis
and clonal sequencing method as previously described (Denomme et al., 2011). Samples
were placed on ice for 10 minutes to generate an agarose/lysis bead and subsequently
incubated overnight in SDS lysis buffer for 20 hours in a 50°C water bath. Lysis buffer was
removed and replaced with 300 μL of mineral oil and embryos were either frozen at -20°C
for a maximum of 3 days or immediately processed for bisulfite mutagenesis. Briefly, for
bisulfite treatment, samples were incubated at 90°C to inactivate proteinase K (Sigma) for
2.5 minutes and transferred to ice for 10 minutes. DNA denaturation was performed in 1 mL
of 0.1 M NaOH at 37°C for 15 minutes. Samples were covered with 300 μL of mineral oil
and 500 μL of 2.5 M bisulfite solution for a 3.5-hour bisulfite conversion at 50°C. After
conversion, desulfonation was performed in 1 mL of 0.3 M NaOH at 37°C for 15 minutes.
Negative controls (beads containing no embryo or buccal cell sample) were processed with
each bisulfite reaction.

For first round PCR amplification, agarose bead with bisulfite

converted DNA (10 μL) was added directly to 15 μL of Hot Start Ready-To-Go (RTG) (GE
Healthcare) PCR bead that contained 0.5 μL of each 10 μM gene-specific external primer,
1 μL of 240 ng/mL transfer RNA and water with a 25 μL mineral oil overlay. Multiplexing
of H19 and KCNQ1OT1 was performed during the first round of PCR. SNRPN amplification
was performed individually. Five microliters of first round PCR product was added to 20 μL
of RTG beads mixed with 19 μL 0.5 μL of each 10 μM internal primer and water for nested
PCR. Separate second round PCR reactions were performed for H19 and KCNQ1OT1.
The KCNQ1OT1 PCR bisulfite primers were described previously (Ibala-Romdhane
et al., 2011; Khoueiry et al., 2012).

The KCNQ1OT1 region analyzed contained a G
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(94.7%)/A (6.3%) SNP (rs56134303). For the H19 region (GenBank Af087017, 6161-6409),
external primers used were as described previously (Khoueiry et al., 2012). Due to SNPs
residing in the previously described inner primers (Khoueiry et al., 2012), newly designed
forward inner primer 5’-TTGGTTGTAGTTGTGGAAT-3’ and H19 reverse inner primer 5’AACCATAACACTAAAACCCT-3’ were used for nested PCR, amplifying a 249 base pair
sequence encompassing 20 CpGs and rs2071094 A (33.6%)/C (66.4%) and rs2107425 G
(55.5%)/A (44.5%) common SNPs. For SNRPN, nested primers (UCSC, chr15:25, 200, 00925, 200, 379) were designed to amplify a 360 base pair region encompassing 24 CpGs and a
G (84.8%)/A (15.2%) SNP (rs220029) within the ICR as follows, SNRPN outer forward, 5’TAGTGTTGTGGGGTTTTAGGG-3’;

SNRPN

outer

reverse,

5’-

TACCCACCTCCACCCATATC-3’;

SNRPN

inner

forward,

5’-

AGGGAGGGAGTTGGGATTT-3’;

SNRPN

inner

reverse,

5’-

CACAACAACAAACCTCTAAACATTC-3’.

All PCR reactions were performed as

previously described (Al-Khtib et al., 2011), 94°C for 10 minutes followed by 55 cycles of
94°C for 15 seconds, 56°C for 20 seconds and 72°C for 20 seconds, with a final 72°C for 10
minute extension.
PCR products were ligated into the pGEM-T EASY vector system (Promega),
transformed into Z-competent DH5α Escherichia coli cells (Zymo Research) and following
blue/white selection and colony PCR, samples were sent for sequencing at Bio Basic Inc.
(Markham, ON, Canada) (Market-Velker et al., 2010). For both day 3 and blastocyst-stage
embryos, 30-65 clones were sequenced per embryo per gene. Methylation patterns were
determined using online software (BISMA). Identical clones (identical location and number
of unconverted CpG-associated cytosines and identical location and number of unconverted
non-CpG-associated cytosines) were included only once and represented one individual DNA
strand. Only clones with ≥85% conversion rates were included. Total DNA methylation for
each gene, or for each allele of a gene, if parental identity was assigned, was calculated as a
percentage of the total number of methylated CpG/the total number of CpG dinucleotides.

2.2.4

Statistical Analysis

Student’s t-test was used to examine significance between embryos with normal methylation
and those with abnormal methylation for maternal age, hormone dose, and stimulation
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response (E2 levels). Statistical analyses for patient diagnosis, hormone induction method,
fertilization method, and embryo grade was determined using the nonparametric
Kolmogorov-Smirnov (KS) test to analyze differences between groups. A p-value of <0.05
was considered to be significantly different.

2.3 Results
2.3.1

Imprinted methylation in control samples
As with previous studies, non-ART-treated, human preimplantation embryos cannot

be obtained for experimental purposes. I therefore determined the imprinted methylation
levels in readily obtainable cells from adults as a control. Imprinted DNA methylation at the
SNRPN, KCNQ1OT1 and H19 ICR was first assessed in untreated human buccal cell (Bu)
samples from 4 young, non-patient adults. Bisulfite clonal sequencing was used to analyze
20-24 CpGs per gene. For all controls, a total of 30-65 clones were sequenced to obtain
representative DNA strands.

Sequences with identical CpG methylation profiles and

unconverted cytosines were considered to be identical and were included once to eliminate
clonal bias. Each region of analysis included a single nucleotide polymorphism (s) (SNP) that
when present in heterozygous samples could distinguish between parental alleles (Table 2-1).
Since we did not have access to patient samples, we consider the methylated strands as the
presumptive paternal H19, maternal SNRPN and maternal KCNQ1OT1 alleles, and the
unmethylated strands as the maternal H19, paternal SNRPN and paternal KCNQ1OT1 alleles,
as was done in previous studies (Ibala-Romdhane et al., 2011; Khoueiry et al., 2012).
For the SNRPN ICR, a 360 bp-region was analyzed comprising 24 CpGs and a G/A
SNP (rs220029) that occurs at a general population frequency of 84.8% and 15.2%,
respectively (Figure 2-1A). All control samples were homozygous at this SNP (Table 2-1),
and thus no allelic assignment could be made. Total SNRPN methylation levels in buccal cell
controls (~1000 cells) were Bu1-1000 46%, Bu2-1000 45%, Bu3-1000 43% and Bu4-1000
40% (Figure 2-1B). Since buccal samples exhibited a mean SNRPN methylation level less
than anticipated (43%), we analyzed SNRPN methylation in human embryonic stem cells
(hESCs), an undifferentiated cell type that more closely matched preimplantation embryos.
In hESCs, SNRPN methylation levels were 41% (Figure 2-1B), consistent with those in
buccal cells. To assess cell numbers similar to blastocyst and day 3 embryos, methylation
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levels were analyzed in ~50 or ~100 cells (Figure 2-1C) and 5-10 cells (denoted hereafter as
10 cells) (Figure 2-1D) for Bu1 and Bu3 samples. Total SNRPN methylation levels were
Bu1-100 39%, Bu1-50 41% (Figure 2-1C), Bu1-10 44% and 41% (Figure 2-1D), and Bu3100 49%, Bu3-50 44% (Figure 2-1C), Bu3-10 38% and 42% (Figure 2-1D). Thus within
sample, methylation level mean and standard deviation were 42.2±2.8 for Bu1 and 43.2±4.0
for Bu3.
For the KCNQ1OT1 ICR, a 265 bp-region was analyzed encompassing 22 CpGs
(Khoueiry et al., 2012) and a G (94.7%)/A (6.3%) SNP (rs56134303), that eliminated the
first CpG (Figure 2-2A). All controls were homozygous at the KCNQ1OT1 SNP (Table 2-1).
Total KCNQ1OT1 methylation levels in control samples were Bu1-1000 63%, Bu2-1000
57%, Bu3-1000 58% and Bu4-1000 65%

(Figure 2-2B). Since the mean KCNQ1OT1

methylation level was greater than anticipated (60%), KCNQ1OT1 methylation was assessed
in hESCs. KCNQ1OT1 methylation levels were hESC-1000 65% (Figure 2-2B), consistent
with those in buccal cells.

At cell numbers similar to blastocyst and day 3 embryos,

KCNQ1OT1 methylation levels were Bu1-100 57%, Bu1-50 65%, (Figure 2-2C), Bu1-10
64% and 64% (Figure 2-2D), and Bu3-100 54%, Bu3-50 57% (Figure 2-2C), Bu3-10 54%
and 57% (Figure 2-2D). Thus within sample, methylation level mean and standard deviation
were 62.6±3.2 for Bu1 and 56.0±1.8 for Bu3.
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Figure 2-1: SNRPN imprinted methylation in buccal cell and human embryonic stem
cell (hESC) control samples.
(A) Map of the SNRPN region analyzed. Accession numbers are located below genes, primer
locations are marked with arrows, and SNPs are indicated by arrowheads. Methylation
analyses in (B) four buccal cell (Bu1-4) and human embryonic stem cell (hESC) control
samples with ~1000 cells, (C) in buccal cell samples with ~50 or ~100 cells, as indicated,
representing blastocysts, and (D) with buccal cell samples ~10 cells, representing day 3
cleavage embryos. Each group of circles represents an individual human sample. Each line is
an individual DNA strand. Methylated CpGs are filled black circles and unmethylated CpGs
are open circles. Percent methylation is indicated above each set of DNA strands for a gene
or parental allele and was calculated as the number of methylated CpGs divided by the total
number of CpG dinucleotides.
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Figure 2-2: KCNQ1OT1 imprinted methylation in buccal cell and hESC control samples
(A) Map of the KCNQ1OT1 region analyzed. Methylation analyses in (B) buccal cell (Bu)
and human embryonic stem cell (hESC) control samples with ~1000 cells, (C) in buccal cell
samples with ~50 or ~100 cells (as indicated), representing blastocysts, and (D) with buccal
cell samples ~10 cells, representing day 3 cleavage embryos. See Figure legend 2-1 for
details.
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Samples assessed for KCNQ1OT1 methylation levels were also analyzed for DNA
methylation at the H19 ICR. We initially began our analysis for a 234 bp-region within the
H19 imprinting control region that included 18 CpGs (Khoueiry et al., 2012) and a common
A (33.6%)/C (66.4%) SNP (rs2071094) (Figure 2-3A). However, we observed biased allelic
recovery and subsequently found two additional SNPs present in the forward and reverse
inner nested primers. Thus, we designed new internal primers for a larger 249 bp-region
within the H19 ICR containing 20 CpGs, the rs2071094 (A, 33.6%; C, 66.4%) SNP and
rs2107425 (G, 55.5%; A, 44.5%) SNPs (Figure 2-3A). For buccal cell samples, Bu3 was
heterozygous at both H19 SNPs, Bu4 was heterozygous at one SNP, while Bu1 and Bu2
were homozygous for both H19 SNPs (Table 2-1). Samples Bu1-1000 and Bu2-1000 had
total H19 methylation levels of 57% and 61%, respectively. Sample Bu3-1000 had 96%
methylation on the presumptive paternal H19 allele and 11% methylation on the presumptive
maternal H19 allele (56% total methylation), while Bu4-1000 had 94% and 11% methylation
on the presumptive paternal and maternal H19 alleles, respectively (52% total methylation)
(Figure 2-3B). Thus, total methylation levels fell with a mean (56%) expected for paternally
methylated and maternally unmethylated alleles. For smaller cell numbers, total H19
methylation levels were Bu1-100 55%, Bu1-50 60% (Figure 2-3C), Bu1-10 63% and 53%
(Figure 2-3D), and Bu3-100 59%, Bu3-50 50% (Figure 2-3C), Bu3-10 52% and 54% (Figure
2-3D), with 94-98% and 3-12% methylation on the presumptive paternal and maternal H19
alleles, respectively. Thus within samples, methylation level mean and standard deviation
were 57.6±4.0 for Bu1 and 54.2±3.5 (Pat 95.6±1.5; Mat 8.8±3.6) for Bu3.
Given the SNRPN, KCNQ1OT1 and H19 methylation levels in all control samples,
conservatively, we considered a methylation range of 4 times the standard deviations
above/below the mean as a normal methylation level. For SNRPN, the mean methylation
level was 42.2%±3.0, generating a 30%-54% normal methylation range. For KCNQ1OT1, the
mean methylation level was 60.0%±4.4, giving a normal methylation range of 42%-78%.
The mean methylation level for H19 was 56.0%±4.1, generating a 40%-72% normal
methylation range. For embryos with heterozygous SNPs, conservatively ≥70% methylation
on the presumptive maternal SNRPN, maternal KCNQ1OT1 and paternal H19 alleles and
≤20% methylation on the presumptive paternal SNRPN, paternal KCNQ1OT1 and maternal
H19 alleles were considered as normal methylation levels.
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Figure 2-3: H19 imprinted methylation in buccal cell control samples
(A) Map of the H19 region analyzed. Methylation analyses in (B) buccal cell (Bu) and
human embryonic stem cell (hESC) control samples with ~1000 cells, (C) in buccal cell
samples with ~50 or ~100 cells (as indicated), representing blastocysts, and (D) with buccal
cell samples ~10 cells, representing day 3 cleavage embryos. Grey circles are not included in
methylation analyses as they represent a C/T SNP that cannot be distinguished following
bisulfite conversion. Alleles are separated into presumptive maternal (Mat) and paternal (Pat)
strands in samples with heterozygous SNPs. See Figure legend 2-1 for details.
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2.3.2

Aberrant imprinted methylation in day 3 embryos
During fertility treatment, embryos were cultured to day 3, after which embryos were

either transferred to the mother, or cryopreserved and stored for future cycles, or cultured to
the blastocyst stage then cryopreserved and stored for future cycles. For identification
purposes, embryos were given an alphanumeric ID that included patient number (1-23),
freeze stage [day 3 cleavage (C) or blastocyst (B)], and embryo number (1-6), for example
“9C2” represents patient 9, day 3 cleavage embryo 2. Individual, cryopreserved day 3
cleavage embryos were analyzed for maintenance of imprinted methylation. For all day 3 and
blastocyst-stage embryos, a total of 30-65 clones were sequenced to obtain representative
DNA strands and to sequence all possible unique DNA strands following thawing and
bisulfite treatment. Data were obtained for 9 of 12 day 3 embryos for SNRPN; 7 of 12 day 3
embryos for KCNQ1OT1; and 7 of 12 day 3 embryos for H19.
SNRPN is normally methylated on the silent maternal allele, while the paternal allele
is unmethylated. All day 3 embryos were homozygous at the rs220029 SNP (Table 2-1) and
thus were examined for total methylation levels. Of the 9 day 3 cleavage embryos analyzed,
normal methylation levels were observed for 4 embryos (Figure 2-4A). By comparison, 5
embryos had abnormal SNRPN methylation levels, with 4 embryos exhibiting aberrant
hypermethylation (1C1, 62%; 1C5, 67%; 1C6, 59%; 18C1, 62%) while 1 embryo (21C1)
displaying aberrant hypomethylation of 18%. Overall, 56% of day 3 cleavage embryos had
abnormal SNRPN imprinted methylation.
KCNQ1OT1 is also normally methylated on the silent maternal allele, while the
paternally inherited allele is unmethylated. All 7 day 3 embryos were homozygous at the
rs56134303 SNP (Table 2-1), and thus, total methylation levels were analyzed. One embryo
had methylation levels within the normal range (Figure 2-4B). Of the remaining 6 embryos,
1 embryo had abnormal hypermethylation (9C1, 80%) while 5 embryos exhibited aberrant
KCNQ1OT1 hypomethylation (12C1, 19%; 7C1, 33%; 7C2, 35%; 6C1, 22%; 4C1, 19%). In
total, 86% of day 3 cleavage embryos had aberrant KCNQ1OT1 imprinted methylation.
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Figure 2-4: Methylation of the (A) SNRPN, (B) KCNQ1OT1 and (C) H19 ICRs in day 3
human cleavage-stage embryos
Each group of DNA strands is an individual day 3 embryo with embryo ID (top left), and
percent methylation and presumptive maternal/paternal allele designation (top right)
indicated. Normal (N) and abnormal (A) embryos are designated next to percent methylation
values (top right). The pre-freeze and post-thaw cell numbers, respectively, are indicated in
brackets beside each embryo name. Grey circles are not included in methylation analyses as
they represent a C/T SNP that cannot be distinguished following bisulfite conversion. See
Figure legend 2-1 for details.
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H19 is normally methylated on the paternal allele, while the maternally inherited
allele is unmethylated. Three day 3 cleavage embryos (4C1, 7C1, 7C2) were heterozygous at
both rs2071094 and rs2107425, 1 embryo (6C2) was heterozygous at rs2071094 and 2
embryos (6C1, 9C1) were heterozygous at rs2107425 (Table 2-1), allowing for allelic
assignment. Only one embryo (3C1) was homozygous at the rs2071094 and rs2107425 SNPs
and was examined for total methylation levels. Out of 7 day 3 embryos, 2 had a normal
methylation pattern with methylation ≥70% on the presumptive paternal allele and ≤20%
hypomethylation on the presumptive maternal allele (Figure 2-4C). Of the remaining 5
embryos, 3 showed loss of methylation on the presumptive paternal H19 allele (6C1, 35%;
6C2, 61%) and 2 displayed a gain of methylation on the presumptive maternal allele (7C1,
85%; 7C2, 71%). Finally, for the homozygous embryo (3C1), there was a loss of total H19
methylation (38%). Overall, 71% of day 3 cleavage embryos were abnormally hypo- and/or
hypermethylated at H19. Furthermore, of the 6 embryos successfully assessed for both
KCNQ1OT1 and H19 methylation, 3 embryos (50%) displayed aberrant methylation levels at
both genes (7C1; 7C2; 6C1).

2.3.3

Abnormal imprinted methylation in blastocyst stage embryos
Individual, cryopreserved blastocysts were also analyzed for maintenance of

imprinted methylation. Data were obtained for 12 of 15 blastocysts for SNRPN; 13 of 14
blastocysts for KCNQ1OT1; and 14 of 14 blastocysts for H19. For SNRPN, 3 blastocyst-stage
embryos (22B1, 9B2, 17B1) were heterozygous at rs220029, while the remaining 9 embryos
were homozygous at the rs220029 SNP (Table 2-1). Four embryos had total methylation
levels within the normal range (30%-54%) (Figure 2-5). Of the 8 remaining embryos, 3
homozygous embryos showed a gain of total SNRPN methylation (10B3, 63%; 14B3, 57%;
and 14B4, 62%), and 2 homozygous blastocysts exhibited SNRPN hypomethylation (16B2,
28%; and 23B1, 15%), while 1 heterozygous blastocyst (9B2) exhibited a gain of paternal
SNRPN methylation (24% Pat) and 2 heterozygous blastocysts possessed both a loss of
maternal SNRPN methylation and a gain of paternal SNRPN methylation (17B1, 65% Mat,
26% Pat; and 22B1, 48% Mat, 26% Pat) (Figure 2-5). In total, 67% of blastocyst embryos
exhibited abnormal SNRPN imprinted methylation.
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For KCNQ1OT1, all embryos were homozygous at the rs56134303 SNP (Table 2-1),
allowing total methylation levels to be determined. Normal KCNQ1OT1 methylation levels
(42%-78%) were observed in 9 blastocysts (Figure 2-6). For the remaining 4 blastocysts, a
loss of KCNQ1OT1 methylation was observed (14B2, 16%; 11B1, 19%; 19B1, 37%; and
2B2, 39%). Overall, 4 of 13 (31%) blastocysts had abnormal KCNQ1OT1 methylation
levels.
The same 14 embryos analyzed for KCNQ1OT1 imprinted methylation were assessed
for H19 imprinted methylation. Three blastocysts (4B1, 8B1, 14B2) were heterozygous at
rs2071094 and rs2107425, 3 blastocysts (9B1, 19B1, 2B1) were heterozygous at rs2071094,
and 2 blastocysts (2B2 and 13B1) were heterozygous for rs2107425 (Table 2-1). The
remaining 6 blastocysts (14B1, 11B1, 15B1, 21B1, 4B2 and 20B1) were homozygous for
both H19 SNPs (Table 2-1). All blastocysts, except 2, fell within the normal H19 methylation
range (40%-72%) (Figure 2-7). One blastocyst displayed a loss of total H19 methylation
(20B1, 29%) and one displayed abnormal gain of maternal H19 methylation (14B2, 87% Pat,
36% Mat).

Overall, 14% of blastocysts had an abnormal H19 methylation profile.

Blastocyst 20B1, with aberrant H19 methylation, had normal KCNQ1OT1 methylation, while
blastocyst 14B2 had abnormal methylation at both H19 and KCNQ1OT1. In total for all three
genes, 76% day 3 embryos and 50% blastocysts exhibited abnormal imprinted methylation
(Figure 2-8).
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Figure 2-5: Methylation of the SNRPN ICR in human blastocyst-stage embryos
Each group of DNA strands is an individual blastocyst with embryo ID (top left), and percent
methylation and presumptive maternal/paternal allele designation (top right) indicated.
Normal (N) and abnormal (A) embryos are designated next to percent methylation values
(top right). See Figure legend 2-1 for details.
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Figure 2-6: Methylation of the KCNQ1OT1 ICR in human blastocyst-stage embryos
Each group of DNA strands is an individual blastocyst with embryo ID (top left), and percent
methylation and presumptive maternal/paternal allele designation (top right) indicated.
Normal (N) and abnormal (A) embryos are designated next to percent methylation values
(top right). See Figure legend 2-1 for details.
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Figure 2-7: Methylation of the H19 ICR in human blastocyst-stage embryos
Each group of DNA strands is an individual blastocyst with embryo ID (top left), and percent
methylation and presumptive maternal/paternal allele designation (top right) indicated.
Normal (N) and abnormal (A) embryos are designated next to percent methylation values
(top right). Grey circles are not included in methylation analyses as they represent a C/T
SNP that cannot be distinguished following bisulfite conversion. See Figure legend 2-1 for
details.
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Figure 2-8: Graphical representation for (A) SNRPN, (B) KCNQ1OT1 and (C) H19
methylation levels in control buccal and ESC samples, and day 3 cleavage and
blastocyst-stage embryos
Black diamonds, control sample methylation levels with grey shaded area indicating normal
methylation range. Green diamonds, total methylation levels in day 3 embryos and blastocyst
embryos. Red diamonds indicate presumptive SNRPN, KCNQ1OT1 and H19 maternal alleles
and blue diamonds indicate presumptive SNRPN, KCNQ1OT1 and H19 paternal alleles, with
grey dashed lines representing ≥70% methylation and ≤20% methylation allelic cutoffs.
Asterisk (*) represents a data point for which more than one embryo exists.
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2.3.4

Intra-patient comparison of imprinted methylation in embryos at
different preimplantation stages
The design of this study allowed multiple embryos from the same patient to be

compared for their imprinted methylation status. Out of 22 patients for whom data were
obtained, 10 patients had more than one embryo analyzed (Table 2-2). For two patients, 6
and 7, all in vitro-produced embryos experienced perturbations in imprinted methylation
(KCNQ1OT1/H19 or H19). The remaining 8 patients had a portion of embryos with normal
and a portion of embryos with abnormal methylation levels. For patient 1, 3/6 day 3 embryos
had aberrant SNRPN imprinted methylation. For patients 2, 10, 14 and 16, 1/2 (abnormal
KCNQ1OT1), 1/3 (abnormal SNRPN), 3/5 (aberrant KCNQ1OT1/aberrant H19; aberrant
SNRPN) and 1/2 (abnormal SNRPN) blastocysts had aberrant methylation levels,
respectively. Finally, three patients had both day 3 cleavage and blastocyst-stage embryos.
For patient 21 and 4, the day 3 embryos had aberrant methylation (abnormal SNRPN;
abnormal KCNQ1OT1), while the blastocysts displayed normal methylation levels. Finally,
for patient 9, 1 day 3 embryo and 1 blastocyst possessed normal methylation levels, while 1
day 3 embryo and 1 blastocyst had perturbed methylation (abnormal KCNQ1OT1; abnormal
SNRPN). Overall, all 10 patients had at least one embryo with aberrant imprinted
methylation. Since there were embryos with and without imprinted methylation errors from
the same patient, and there were genes with and without aberrant imprinted methylation in
the same embryo, methylation errors were likely stochastic in nature. Furthermore, the
presence of methylation errors in both day 3 cleavage and blastocyst-stage embryos indicates
that methylation errors arise as early as the 6-8 cell stage, and that extended culture does not
pose a greater risk for imprinting errors than short culture.

2.3.5

Correlation between parental biometrics, clinical treatment and
aberrant imprinted methylation
Medical records were examined for parental biometrics, clinical treatment and

pregnancy outcomes. Clinical pregnancy rates for fresh embryo transfers as determined by
gestational sac by ultrasound were 65% for the same cycle in which the surplus embryos
were cryopreserved and donated. Live birth rate was 61% and live births/embryo transfer was
36% (Table 2-3). Of all live births, 45% (9/20) of newborns (2 singletons, 3 sets of twins,
and 1 of the triplets) were outside clinically normal birth weight, with 1 high birth weight
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(>4000 g), 5 low birth weight (<2500), 1 very low birth weight (<1500 g) and 2 extremely
low birth weight (<1000 g). Gestational age was not obtained. To discern any confounding
factors related to parental biometrics or clinical treatment, embryos with methylation levels
in the normal range were compared to embryos with aberrant methylation for maternal age,
patient diagnosis, induction method, hormone dose, stimulation response (E2 levels),
fertilization method (IVF/ICSI), and embryo grade (Table 2-4). Note that for all embryos,
the same conditions and reagents were used for in vitro culture and slow-freezing
cryopreservation, and thus no comparison could be made. For this analysis, the premise was
that each embryo could have a different response to influences/exposures, although we
acknowledge that embryos from the same mother may have similar exposures to maternal
factor treatment. To make a comparison at the patient level for maternal age, hormone dose
and estrogen response, separate analyses was also done for patients with only one embryo
(12/22), since the remaining 10 patients with more than one embryo had a least one embryo
with abnormal methylation. Data from both stages were combined for analyses, except for
embryo grade.
Maternal age range for patients in this study was 23-42 years. Mean maternal age for
embryos with normal methylation levels was 34 years while that for embryos with aberrant
methylation was 33 years (Figure 2-9A), which was not statistically different (p=0.21).
Excluding patients with more than one embryo, maternal age for embryos with normal
methylation levels was 33 years while that for embryos with abnormal methylation was 30
years (results not shown) (p=0.38). Multiple etiologies contributing to infertility were
diagnosed in patients. The four most common patient diagnoses were bilateral tubal
obstruction/occlusion (BTO, 29.4% normal, 26.9% abnormal), male factor (MF, 17.6%
normal, 15.4% abnormal), blocked tubes with endometriosis (BTO+ENDO, 11.8% normal,
15.4% abnormal) and polycystic ovarian syndrome (PCOS, 11.8% normal, 11.5% abnormal)
(Figure 2-9B). Thus, patient diagnoses were not statistically different between embryos with
normal and abnormal methylation levels (p>0.99).

For induction method, Nafarelin

(Synarel®) and Follitropin-alpha (Gonal-F®) was the most common hormone combination
for patients with both normal (70.6%) and abnormal (69.2%) embryo groups, followed by
Urofollitropin (Bravelle®) and Ganirelix Acetate (Orgalutran®) (11.8% normal and 7.7%
abnormal) (Figure 2-9C). Thus, no significant difference was observed for hormone
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induction method (p=0.80). Mean hormone dose and estrogen response (E2) was calculated
at 2894.1 IU and 15084.4 pM/L for the normal group and at 2361.5 IU and 12484.7 pM/L for
the abnormal group (Figure 2-9D,E), which was not significantly different (p=0.18 and 0.20,
respectively). Excluding patients with more than one embryo, dose and estrogen response
(E2) was 4150 IU and 15394.3 pM/L for the normal group and 2233.3 IU and 11546.6 pM/L
(results not shown), which was not significantly different (p=0.06 and p=0.43, respectively).
For fertilization method, percentage of embryos in the normal group was 62.5% IVF and
47.5% ICSI, and in the abnormal group was 57.7% IVF and 42.3% ICSI (Figure 2-9F),
which did not differ statistically (p=0.33). For day 3 embryo grade, embryos with normal
methylation levels exhibited a grade of slight C/G2 (slC/G2) (3 embryos) and C/G3 (1
embryo) while those with abnormal methylation levels had a grade of A/B/G1 (4 embryos),
slC/G2 (8 embryos) and C (1 embryo) (Figure 2-9G). Importantly, embryos transferred to
patients (Table 2-3, 28A/B/G1, 15 slC/G2 and 12 C/G3) had similar grading information to
those that were frozen. For blastocysts, 10 of the 13 embryos with normal methylation levels
had grading information; 3 were AA, 1 AB, 1 BA, 2 BB, 1 BC, 1CA and 1 CB (Figure 29H). For embryos with abnormal methylation levels, 6 of the 13 had grading information: 5
were AA and 1 BA. These grades were not statistically different (p=0.25). A comparison of
these grading criteria separately showed that for stage (all 26 embryos included), embryos
with normal methylation (5 stage 2, 2 stage 3, 6 stage 4) were not significantly different
(p>0.99) from embryos with abnormal methylation (1 stage 1, 7 stage 2, 3 stage 3, 2 stage 4).
For ICM grade, embryos with normal methylation (4 A, 4 B, and 2 C) were not statistically
different (p=0.40) than embryos with abnormal methylation levels (5 A, 1 B). For TE grade,
embryos with normal methylation (5 A, 4 B, 1 C) were not statistically different (p=0.60)
from embryos with abnormal methylation levels (6 A). Overall, no specific parameter was
identified to have an association with abnormal imprinted methylation. Importantly, we
found that embryos of the highest quality with day 3 A/B/G1 and blastocyst AA grading can
have abnormal methylation.
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Figure 2-9: Patient characteristics and embryo outcome for embryos with normal and
abnormal imprinted methylation
Day 3 cleavage and blastocyst-stage embryos exhibiting normal imprinted methylation
(purple bars; n=17) were compared to those with abnormal methylation (orange bars; n=26)
for (A) maternal age (t-test), (B) patient diagnosis (KS test), (C) induction method (KS test),
(D) hormone dose (t-test), (E) estrogen levels (t-test), and (F) fertilization method (KS test).
Means are indicated by black line for maternal age, hormone dose and estrogen levels. (G)
Grading of day 3 embryos with normal (n=4) and abnormal methylation (n=13) (no statistical
analysis). (H) Blastocysts with normal [n=13 (stage), n=10 (grade)] and abnormal
methylation [n=13 (stage), n=6 (grade)] were compared for embryo stage and grade (KS
test). No significant difference was observed for any parameter between embryos with
normal and abnormal methylation. BTO, bilateral tubal obstruction/occlusion; MF, male
factor; ENDO, endometriosis; PCOS, polycystic ovarian syndrome; AMA, advanced
maternal age; IDIO, idiopathic; ANOV, anovulatory; TD, tubal disease; (donor), donor
sperm; FPES Fresh/frozen percutaneous epididymal/testicular sperm aspiration sample; Syn,
Synarel® (Nafarelin); G-F, Gonal-F® (Follitropin-alpha); Brav, Bravelle® (Urofollitropin);
Org, Orgalutran® (Ganirelix Acetate); Lup, Lupron® (Leuprolide Acetate); Rep, Repronex®
(Menotropins); Men, Menopur® (Menotropins); Pur, Puregon® (Follitropin-beta); Fert,
Fertinorm® (Urofollitrophin); IVF, in vitro fertilization; ICSI intracytoplasmic sperm
injection. See methods for embryo grades.
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2.4 Discussion
Although mouse models have been instrumental in analyzing the effects of ARTs on
genomic imprinting in oocytes and early embryos, it is important to assess the effects of these
technologies in donated human counterparts. This is especially important, as imprinting
errors were perceived to be more common in mouse preimplantation embryos than in ARTconceived children. In this study, we observed that 76% day 3 embryos exhibited perturbed
imprinted methylation, with 56%, 86% and 71% day 3 embryos possessing aberrant SNRPN,
KCNQ1OT1 and H19 imprinted methylation, respectively. Furthermore, 50% blastocyststage embryos exhibited abnormal methylation levels with 67%, 31% and 14% blastocysts
having aberrant SNRPN, KCNQ1OT1 and H19 imprinted methylation, respectively. Both
losses and gains of imprinted methylation were observed, and in some cases, both within the
same embryo (ex. 17C1, 22B1). Additionally, 50% of day 3 and one blastocyst embryo
exhibited both KCNQ1OT1 and H19 imprinted methylation perturbations (6C1, 7C1, 7C2,
14B2). This is similar to the multi-locus loss of imprinting we previously observed in the
mouse (Market-Velker et al., 2010) and that others have reported in BWS and SRS children
(Azzi et al., 2009; Bliek et al., 2009; Chang et al., 2005; DeBaun et al., 2003; Hiura et al.,
2012; Lennerz et al., 2010; Lim et al., 2009; Rossignol et al., 2006; Turner et al., 2010).
Very few studies have examined the effects of ARTs on genomic imprinting in
donated human preimplantation embryos (Chen et al., 2010; Geuns et al., 2003; 2007; IbalaRomdhane et al., 2011; Khoueiry et al., 2012; Shi et al., 2014). Moreover, these studies were
primarily performed on poor quality embryos that were unsuitable for transfer. Nevertheless,
their results were similar to what is reported here. For SNRPN, 8/9 day 3 embryos (89%)
possessed a loss or gain of methylation (Geuns et al., 2003). For KCNQ1OT1, 7/67 day 3
embryos (10%) (Shi et al., 2014) and 9/16 poor quality blastocysts (56%) harboured aberrant
methylation (Khoueiry et al., 2012). Finally for H19, 3 studies reported aberrant imprinted
methylation in 6/32 day 3 embryos (17%) (Chen et al., 2010), 9/21 poor quality morulablastocysts (43%) (Ibala-Romdhane et al., 2011), and 5/60 blastocysts (8%) (Shi et al., 2014),
while the remaining study did not observe any alterations in H19 imprinted methylation in 8
low quality blastocysts (0%) (Khoueiry et al., 2012). In addition to these genes, previous
studies identified 11/65 day 3 embryos (17%) with abnormal PEG1 imprinted methylation
(Shi et al., 2014) and 18/24 day 3 embryos (75%) with aberrant GTL2 imprinted methylation
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(Geuns et al., 2007). All together, our study along with previous publications demonstrate
that the frequency of imprinting errors in human donated preimplantation embryos (6-89%)
occurs at a similar frequency to that produced in mouse preimplantation embryos (10-90%)
(Fauque et al., 2007; Hajj et al., 2011; Market-Velker et al., 2010; 2012).
Of the above studies, two examined imprinted methylation in good quality, in vitro
produced embryos. For KCNQ1OT1, 2/5 high quality (40%) blastocysts harboured aberrant
methylation (Khoueiry et al., 2012), which was similar to what we report here (4/13; 31%).
For H19, 0/5 high quality (0%) morula-blastocysts (Ibala-Romdhane et al., 2011) and 0/5
high quality blastocysts (0%) possessed aberrant methylation (Khoueiry et al., 2012). This
contrasted with our study where we observed 2/14 blastocysts (14%) with aberrant H19
methylation. This discrepancy may relate to the number of embryos analyzed in these
studies.
The design of our study allowed comparison of short culture to day 3 cleavage stages
and extended culture to the blastocyst stage. Our data together with previous studies found
imprinted methylation errors at both stages; SNRPN day 3 (56%, 89%) versus blastocysts
(67%); KCNQ1OT1 day 3 (86%, 10%) versus blastocysts (31%, 40%, 56%); and H19 day 3
(71%, 17%) versus blastocysts (14%, 8%, 0%) (Chen et al., 2010; Ibala-Romdhane et al.,
2011; Khoueiry et al., 2012; Shi et al., 2014). Thus, the presence of methylation errors in
embryos undergoing both short (55% embryos) and extended (31% embryos) culture
indicates that methylation errors arise as early as the 6-8 cell stage. Furthermore, extending
culture from day 3 to the blastocyst stage does not appear to pose any greater risk for
imprinting errors. Consequently, our study offers additional support for extended culture to
the blastocyst stage to select the most developmentally competent embryos.
Although the frequency of imprinting errors was similar between mice and human
preimplantation embryos, disparity still exists between frequencies of imprinting errors in
human preimplantation embryos compared to frequencies of imprinting errors reported in
ART children. One explanation for this discrepancy may be that imprinting errors in the early
embryo lead to reduced levels of implantation or pregnancy failure. Alternatively,
blastomeres with aberrant imprinted methylation may be preferentially relegated to the
extraembryonic lineages. Previous studies in the mouse provide support for the latter
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explanation, since we and others have observed a selective loss of imprinting in the placenta
compared to the embryo in midgestation mouse embryos following preimplantation
development in culture (de Waal et al., 2014; Mann et al., 2004; Rivera et al., 2008).
Infertility rates have increased around the world (Chandra et al., 2013; Mascarenhas
et al., 2012). Advanced maternal age (>35 years) is directly related to this rise, consequently
leading to the question of whether delayed childbearing in ART women may contribute to
increased imprinting errors in ART children. Additionally, current evidence indicates that the
supra-physiological hormonal milieu of ovarian stimulation may produce adverse outcomes
in ART pregnancies. For example, similar incidences of low birth weight and preterm low
birth weight were present in ART children produced from donor oocytes from fertile women
compared to oocytes from subfertile mothers (Kalra and Barnhart, 2011). This birth weight
variation in in vitro-conceived children may be explained by alterations in DNA methylation
levels at growth-related genes, as detected in newborn cord blood and placenta (Turan et al.,
2012). With respect to imprinting disorders, ovarian stimulation has also been linked to BWS
and AS in ART-conceived children (Chang et al., 2005; Ludwig et al., 2005; Sutcliffe et al.,
2006), and for some of these children, the only procedure used was ovarian stimulation
(Chang et al., 2005; Ludwig et al., 2005). Our comparison of maternal age, induction
method, hormone dosage levels and stimulation response in embryos with and without
aberrant methylation revealed no significant difference between these groups. These results
were not all that surprising, since embryos with and without methylation errors may have had
similar exposures to maternal factor treatment and/or parental biometrics; and all embryos
were generated using supra-physiological hormone dosages and the same conditions for in
vitro culture and slow-freezing cryopreservation. Similarly, no significant difference in
fertilization method (IVF/ICSI) or blastocyst grade was observed between embryos with
normal or abnormal imprinted methylation. However, it should be noted that even the highest
quality day 3 cleavage (A/B/G1) and blastocyst-stage (AA) embryos harbour abnormal
methylation levels. This finding has significant bearing on future studies employing high
quality embryos as their control group. One further observation of note was that two embryos
(19B1, 20B1), produced via donor sperm for male factor infertility, possessed abnormal
imprinted methylation. This suggests that imprinting errors in these embryos cannot be
explained by inherent infertility, but instead may point to ART-induced errors. Further
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studies are required to investigate imprinted methylation errors in in vitro-produced embryos
using donor oocytes and sperm
There were several limitations of this study. Similar to other studies on ART human
embryos, our investigation lacks naturally conceived controls, which is ethically
unavoidable. Additionally, due to limited availability of donated embryos, this study and
others employed small numbers in analyses. However, the statistical analyses used in this
type of study remains valid within the embryo population analyzed, and may allow
cumulative analysis of larger sample sizes in the future. Finally, although our study
controlled for operating procedure in the clinic, donated embryos analyzed here were
obtained from a single fertility clinic.
Going forward, future research should focus on determining differences between
human embryos with and without imprinting errors with respect to embryo properties, the
timing and origin of these errors, as well as the molecular factors responsible for inducing
imprinted methylation errors in ART embryos. Animal models will be instrumental in these
studies prior to investigation in human embryos.

111

Table 2-1: Buccal cell sample, hESCs and embryo genotype
SNRPN

KCNQ1OT1

H19

H19

rs220029

rs56134303

rs2071094

rs2107425

(Mat/Pat)*

(Mat/Pat)*

(Mat/Pat)*

(Mat/Pat)*

Bu1

G/G

G/G

A/A

G/G

Bu2

G/G

G/G

T/T

A/A

Bu3

G/G

G/G

T/A

A/G

Bu4

G/G

G/G

A/T

G/G

hESCs

G/G

G/G

Study ID
Controls

Day 3
1C1

G/G

1C2

G/G

1C3

G/G

1C4

G/G

1C5

G/G

1C6

G/G

9C2

G/G

18C1

G/G

21C1

G/G

3C1

G/G

A/A

G/G

3C2

IC

IC

IC

4C1

G/G

T/A

A/G

6C1

G/G

T/T

A/G

6C2

IC

T/A

G/G

7C1

G/G

T/A

A/G

7C2

G/G

T/A

A/G

9C1

G/G

A/A

A/G

12C1

G/G

IC

G/G

T/A

Blastocyst
9B2

A/G

10B1

G/G

10B2

G/G

10B3

G/G

14B3

G/G

14B4

G/G

14B5

G/G

16B1

G/G

16B2

G/G

17B1

A/G

22B1

G/A

23B1

G/G

2B1

G/G
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2B2

G/G

T/T

G/A

4B1

G/G

T/A

A/G

4B2

G/G

A/A

G/G

8B1

G/G

T/A

A/G

9B1

G/G

A/T

G/G

11B1

G/G

A/A

G/G

13B1

G/G

T/T

A/G

14B1

G/G

A/A

G/G

14B2

G/G

T/A

A/G

15B1

G/G

A/A

G/G

19B1

G/G

A/T

G/G

20B1

G/G

A/A

G/G

21B1

IC

A/A

G/G

* presumptive maternal and paternal alleles
Bu, buccal cell samples; hESCs, human embryonic stem cells; Mat, maternal; Pat, paternal;
C, day 3 cleavage stage embryo; B, blastocyst stage embryo; ND, not determined; IC,
inconclusive.
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Table 2-2: Comparison of imprinted methylation status of patients with single and
multiple embryos
Emb
C1

3
K
65
H
38

12

18

K
19

S
62

Patients with a single embryo
8
11
13
15
17

19

20

K
62

K
37

K
51

H
89P
14M

H
29

K
19

K
70

K
74

B1

Emb

C1

C2

C3
C4
C5
C6

B1

B2

B3
B4
B5

6

7

K
22

K
33

H
35P
5M

H
95P
85M
K
35
H
94P
71M

H
61P
11M

S
65M
26P

H
H
H
H
88P
45
89P 4M
61
9M
Patients with multiple embryos
1
2
10
14
15

S
62

21

S
18

22

23

S
48M
26P

S
15

4
K
19
H 86P
14M

S
42

9
K
80
H
70P
5M
S
52

S 46
S 42
S 67
S 59
K
57
H
90P
10M
K
39
H
88P
9M

S
33

S
36
S 63

K
76
H
53
K
16
H
87P
36M
S 57
S 62
S 33

S
42

H
66

S
28

K
48
H
89P
9M
K
45
H
41

Emb, embryo; S, SNRPN; K, KCNQ1OT1; H, H19; Numbers, % methylation; P, paternal; M,
maternal; purple, normal methylation levels; orange, abnormal methylation levels.

K
48
H
88P
9M
S
77M
24P
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Table 2-3: Pregnancy outcome for each patient
Patient

# ET

Embryo grade

Pregnancy

Live birth

BW (g)

Category

1

2

8B,10slC

No

-

2

3

8B,8B,7B

No

-

3

2

9slC,8A

Yes

Y (twins)

925, 820

EL,EL

4

2

8B, 9B

No

-

5

3

8A,8A,8slC

Yes

Y (twins)

2240, 2466

L,L

6

3

10slC,8A,8A

Yes

Y

1185

VL

7

2

9slC,10slC

Yes

Y

3856

N

8
9

2

10C,8B

No

-

3

8B,8slC,8A

Yes

Y (twins)

2722, 2665

N,N

10

2

8slC,9C

Yes

Y

3600

N

11

2

8slC,6slC

Yes

Y

3260

N

12

3

8A,7C,A*

Yes

Y

2920

13

3

7C,4B,5C

No

-

14

3

8A,8B,8B

Yes

Y (triplets)

15

2

7C,10C

No

-

16

2

6slC,6C

Yes

N

17

2

7B,7slC

Yes

18

2

8B,10B

19

2

20
21

2268, 2551, 2551

L, N, N

Y

2948

N

Yes

Y

4678

H

8slC,10C

No

-

3

8B,8slC,8A

Yes

Y

3912

N

3

8C,8C,8C

Yes

Y (twins)

2325, 2041

L,L

22

2

7A,9A

Yes

Y

3515

N

23

2

10slC,8A

No

-

ET, embryos transferred; BW, birth weight; N, normal BW; L, low BW; VL, very low BW;
EL, extremely low BW. Asterisk indicates embryo was compacting. Gestational age was not
obtained.
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Table 2-4: Patient biometrics and clinical treatment

Emb, embryo; Mat, maternal; C, day 3 cleavage stage embryo; B, blastocysts; E2, serum
estrogen on day of hCG trigger; ICSI, intracytoplasmic sperm injection; IVF, in vitro
fertilization;

MF,

male

factor;

ENDO,

endometriosis;

BTO,

bilateral

tubal

obstruction/occlusion; IDIO, idiopathic; PCOS, polycystic ovarian syndrome; AMA,
advanced maternal age; ANOV, anovulatory; TD, tubal disease; DONOR, donor sperm;
FPES, Fresh/frozen percutaneous epididymal/testicular sperm aspiration sample; --, no grade
available.
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Chapter 3

3

Superovulation disrupts mitochondria in mouse oocytes
and preimplantation embryos

3.1 Introduction
Mitochondria are vital for oocyte and preimplantation embryo developmental
competence. This has been perpetually demonstrated over the years in multiple different
species, including mouse and human [reviewed in (Chappel, 2013; Schatten et al., 2014; Van
Blerkom, 2011)]. Consequently, in the assisted reproductive technology (ART) field, fertility
clinics around the world have been exploring experimental techniques that target
mitochondria to improve IVF success. For example, three-parent mitochondrial replacement
therapy (MRT) was approved for human clinical investigation in the United Kingdom on
February 3rd, 2015. This technique has emerged to bypass inheritance of mitochondrial
disease from affected mothers to offspring by injecting the pronuclei of intended parents into
an enucleated donor oocyte (Reinhardt et al., 2013).

Furthermore, AUGMENT (for

autologous germline mitochondrial energy transfer), a novel and controversial technique, is
currently being offered in one city in North America, first originating at the Toronto Centre
for Advanced Reproductive Technology (TCART) clinic, in addition to being offered in
London,

Japan,

Panama,

Spain,

Turkey

and

Dubai

(Motluk,

2015)

(http://www.augmenttreatment.com/#find-a-clinic). This technique injects patient-matched
mitochondria obtained from a population of cells existing within the woman’s ovarian cortex
into the oocyte at the time of intracytoplasmic sperm injection (ICSI) (Motluk, 2015; Tilly
and Sinclair, 2013; Woods and Tilly, 2015). The idea behind AUGMENT is to supplement
the mitochondrial pool in oocytes from women of advanced reproductive age or in couples
with multiple failed rounds of infertility treatments (Motluk, 2015; Woods and Tilly, 2015).
The world’s first AUGMENT baby was born in Toronto in April of 2015. However, despite
this success, there are still many unanswered questions regarding the risks these treatments
pose to the resulting offspring. Furthermore, little research has been conducted to determine
what effects common ART treatments, such as ovarian stimulation, have on the oocyte and
preimplantation embryo during in vitro development.
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The mature human MII oocyte contains about 100,000 to 400,000 mitochondria
(Cummins, 2002; Jansen, 2000; Jansen and de Boer, 1998; Jansen and Burton, 2004), which
is similar to the number originally identified in mouse eggs (92,500 ± 7000) (Pikó and
Matsumoto, 1976). In somatic cells the number of mitochondria vary depending on ATP
requirements but are orders of magnitude lower than the MII oocyte, ranging from 265 ± 40
in mouse fibroblasts to 308 ± 47 in human lung fibroblasts (Robin and Wong, 1988). The
mitochondrial complement in the MII oocyte is derived from approximately 10-20
mitochondria in primordial germ cells (PGCs), which increases during oocyte growth
through mitochondrial DNA replication and biogenesis (Cummins, 2002; Jansen, 2000; St
John et al., 2010; Van Blerkom, 2011). The resultant mitochondrial population in MII
oocytes represents the only source of mitochondria in resulting offspring.
Given the large size of the mature oocyte, adequate mitochondria numbers and proper
mitochondrial distribution are necessary to fulfill spatial ATP requirements. In the mouse,
bursts of ATP production coincide with perinuclear mitochondrial translocation throughout
meiotic maturation, specifically during germinal vesicle breakdown (GVBD), metaphase I
(MI) spindle migration, MI to MII transition, and polar body (PB) extrusion (Van Blerkom,
1991; Yu et al., 2010). At the MII ovulated stage, some reports suggest mitochondria
organize to the perinuclear region (Calarco, 1995; Kan et al., 2011; Nagai et al., 2006), while
others indicate mitochondria are homogeneously distributed throughout the cytoplasm
(Tokura et al., 1993; Van Blerkom, 2004; Yu et al., 2010). In addition, a subcortical ring of
high potential mitochondria is necessary for sperm penetration and consequently fertilization
and meiotic maturation (Van Blerkom and Davis, 2007).
Upon oocyte meiotic maturation, mitochondrial DNA replication ceases and does not
resume until post-implantation (Larsson et al., 1998; Pikó and Chase, 1973; Pikó and Taylor,
1987; Thundathil et al., 2005). This absence of mitochondrial DNA replication during
cleavage stages of embryogenesis has been confirmed in mice (Ebert et al., 1988; Larsson et
al., 1998; Pikó and Chase, 1973; Pikó and Taylor, 1987), rats (Meziane et al., 1989), pigs
(Kameyama et al., 2007), and frogs (Shourbagy et al., 2006). Although mitochondrial
numbers are anticipated to remain relatively constant within the preimplantation embryo,
paradoxically after fertilization, this means that the mitochondrial complement per
blastomere halves with each cell division in concert with an increased demand for ATP (Van
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Blerkom, 2009; 2011). Spatial distribution of mitochondria is also important throughout
preimplantation development. In mouse and human, mitochondria predominantly exhibit
perinuclear localization in 1-cell (Tokura et al., 1993; Van Blerkom, 2000; Van Blerkom et
al., 2000; Van Blerkom, 2009; Zhao et al., 2009) and 2-cell (Tokura et al., 1993; Van
Blerkom et al., 2000; Van Blerkom, 2009; Wilding et al., 2001) embryos. During cell
cleavage, symmetrical segregation of mitochondria surrounding the pronuclei in 1-cell
embryos and between blastomeres of 2-cell to 8-cell embryos is associated with enhanced
developmental competence (Van Blerkom et al., 2000). By comparison, asymmetric
distribution of mitochondria in early cleavage embryos can result in arrested division and
lysis (Van Blerkom et al., 2000).

Beyond the 8-cell stage, mitochondria segregate

differentially between outer and inner blastomeres (Van Blerkom et al., 2000) to ultimately
establish a higher mitochondrial content in trophectoderm (TE) cells compared to inner mass
cells (Assou et al., 2006; Houghton, 2006; St John et al., 2010; Thundathil et al., 2005). This
asymmetric distribution is likely required during cavitation to power the sodium-potassium
adenosine triphosphatase (Na+/K+-ATPase) pump, which is present on the basolateral surface
of TE cells, to enable blastocoel cavity formation (Houghton, 2006; Van Blerkom, 2008).
Although numerous studies have analyzed mitochondrial dynamics during
gametogenesis and preimplantation development, this knowledge is based on oocytes and
embryos obtained through assisted reproductive technologies (ARTs).

However, ART

treatments coincide with critical time points where mitochondria are highly replicative and
drastically increase in numbers during oogenesis, distributed to provide stage-specific spatial
ATP requirements, and sustained in a non-replicative state during preimplantation
development. Few studies in mouse and human have described negative effects of ARTs on
mitochondrial dynamics and function, with most focusing on oocyte freezing (Demant et al.,
2012; Jones et al., 2004; Lei et al., 2014; Manipalviratn et al., 2011; Martino et al., 2013;
Wilding et al., 2001; Zander-Fox et al., 2013; Zhao et al., 2009). These studies also have the
confounding effects of superovulation/ovarian stimulation. Finally, there is an emerging
interest in the role mitochondria play in epigenetic gene regulation (Martinez-Pastor et al.,
2013; Rathmell and Newgard, 2009; Wallace, 2010; Wallace and Fan, 2010; Wellen et al.,
2009). More specifically, mitochondria provide the cell with its source of ATP, which
powers chromatin-remodeling complexes and is needed for conversion of methionine to S-
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adenosylmethionine (SAM), the cells sole methyl donor required for histone and DNA
methylation (Martinez-Pastor et al., 2013; Wallace, 2010). Additionally acetyl-coA required
for histone acetylation is mainly derived from citrate, a byproduct derived solely from the
mitochondria through the tricarboxylic acid (TCA) cycle (Wallace, 2010; Wallace and Fan,
2010; Wellen et al., 2009).

Therefore, disruptions in mitochondrial numbers, dynamics

and/or function could lead to perturbations in epigenetic gene regulation.
Here, I investigated, for the first time, the effect of ovarian stimulation on
mitochondrial levels, distribution, and function in mouse oocytes and preimplantation
embryos under control and stimulated conditions. As a detailed analysis of mitochondrial
properties throughout all stages of preimplantation development has not been obtained, I
analyzed mitochondrial dynamics in oocytes, and 1-cell, 2-cell, 4-cell, 8-cell, morula- and
blastocyst-stage embryos. To assess if mitochondrial perturbation coincides with disrupted
DNA methylation, I investigated levels of CHDH, an inner mitochondrial membrane enzyme
required in the betaine pathway of methylation production, in control embryos and embryos
obtained after hormone stimulation. Overall, the results of this novel study improves our
knowledge of mitochondrial dynamics in control oocytes and preimplantation embryos, in
addition to providing insight on the effect of hormone treatment on mitochondrial dynamics.

3.2 Materials and Methods
3.2.1

Ethics Statements, source of animals
Experiments were performed in compliance with the guidelines set by the Canadian

Council for Animal Care and the policies and procedures approved by the University of
Western Ontario Council on Animal Care.

3.2.2

Oocyte and embryo collection
Metaphase II (MII) oocytes were collected from C57BL6/CAST7p6 [B6(CAST7p6)]

x C57BL/6 (Charles River) F1 females at 6-8 weeks of age. These females have a Mus
musculus castaneous (CAST) chromosome 7 and partial regions of chromosome 6 on a
C57BL/6 (B6) background. To obtain spontaneously ovulated oocytes, untreated females
were examined for estrus and at noon the following day, the oviduct/ampulla was dissected
and flushed in warmed M2 media (Sigma) to retrieve cumulus-oocyte-complexes.

For
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superovulated oocytes, females were injected intraperitoneally (ip) with 6.25 IU or 10 IU
equine chorionic gonadotropin (eCG) (Intervet Canada), followed 44-48 hours later by
6.25 IU or 10 IU human chorionic gonadotropin (hCG) (Intervet Canada), respectively.
Hormone concentrations of 6.25 IU and 10 IU were considered low and high hormone
dosages, respectively. At noon the following day, superovulated cumulus-oocyte-complexes
were flushed into warmed M2 media. Spontaneous and superovulated oocytes were washed
in 2-3 drops of M2 media containing 0.3 mg/mL hyaluronidase (Sigma) under mineral oil
(Sigma) to denude surrounding cumulus cells. Pronuclear to blastocyst-stage embryos were
derived from control and hormone-treated B6(CAST7p6) females crossed to B6 males.
Embryos were retrieved from oviducts/uteri at 0.5 days postcoitum (dpc) (1-cell), 1.5 dpc (2cell), 2 dpc (4-cell) and 2.5 dpc (8-cell), 3 dpc (morula) and 3.5 dpc (blastocyst).

3.2.3

Total mitochondrial quantification
To analyze total mitochondrial pools, at least 40 spontaneously ovulated, hormone-

treated oocytes and ~20 1-cell, 2-cell, morula and blastocyst-stage embryos from control and
hormone-treated females were stained with 0.250 µM Mitotracker® Green FM (Molecular
Probes, Invitrogen) in M2 media under mineral oil for 30 minutes at 37°C and 5% CO2 in air.
Following this, DNA was stained in M2 drops containing Hoechst 33342 (1:200 dilution) for
15 minutes at 37°C and 5% CO2 in air. For imaging, individual oocytes and embryos were
immediately transferred to 4 µL M2 drops under mineral oil in glass bottom dishes (MatTek
Corporation). The Olympus FluoViewTM FV1000 coupled to the IX81 Motorized Inverted
System Microscope (IX2 series) confocal scanning microscope was used to obtain live cell
images compiled of Z stacks of 4 µm slices. During image acquisition the microscope was
kept warm at 37oC. To maintain consistent fluorescence intensity values between samples
imaged on different days, acquisition parameters were identical for all oocytes (filter, 490
HV; Gain, 1; Offset, 2%), and embryos (filter, 445 HV; Gain, 2; Offset 2%). Determination
of total Mitotracker green signal intensity was done using Volocity 6.3 Image Analysis
Software (Perkin Elmer). For quantification, each oocyte or embryo was outlined to create a
region of interest (ROI). The ROI for MII oocytes included all cytoplasm contained within
the cortex and excluded the polar body, while the ROI for embryos included the area encased
in the zona pellucida to maintain consistency between embryos. Mean total Mitotracker
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fluorescence was calculated from the fluorescence intensity of all samples within a group and
is represented in relative fluorescence units (RFU). A minimum of 3 females were used for
both oocyte and embryo collections, for all control and hormone treatment groups.

3.2.4

Active mitochondrial quantification
To analyze the active mitochondrial pools and the localization of active mitochondria,

at least 40 spontaneously ovulated and hormone-treated oocytes were stained with
Mitotracker® Red CMXRos (Molecular Probes, Invitrogen) at a final concentration of
0.250 µM in M2 media under mineral oil for 30 minutes at 37°C and 5% CO2 in air.
Subsequently, DNA was stained in M2 drops containing Hoechst 33342 (1:200 dilution) for
15 minutes at 37°C and 5% CO2 in air. For preimplantation embryos, a minimum of 20
control and hormone-treated 1-cell, 2-cell, 4-cell, 8-cell, morula and blastocyst-stage
embryos were stained using the same parameters as oocytes. Individual oocytes and embryos
were immediately transferred to 4 µL M2 drops under mineral oil in glass bottom dishes for
imaging.

Confocal images were obtained using identical acquisition parameters for all

Mitotracker red MII oocytes, 1-cell and 2-cell embryos (filter, 400 HV; Gain, 1; Offset, 2%)
and Mitotracker red 4-cell, 8-cell, morula- and blastocyst-stage embryos (filter, 370 HV;
Gain, 1; Offset, 2%). Mean total Mitotracker red fluorescence was calculated as described
above for Mitotracker green using Volocity. At least 3 females were used for both
spontaneous and superovulated oocyte and embryo collections.

3.2.5

Quantification of blastocyst cell number and blastocyst volume
Cell counting for blastocysts embryos was performed using Hoechst staining and was

done from the top to the bottom of each embryo Z-stack using images from the Olympus
FluoViewTM FV1000 system (Market-Velker et al., 2012). Blastocyst cavity volume was
calculated using two perpendicular measurements of blastocyst cavity length (μm) obtained
with Volocity software. Then lengths were then averaged and halved to determine an
average radius, and cavity volume was calculated using the formula for a sphere.

3.2.6

Quantification of superoxide levels
Superoxide accumulation in control and 10 IU blastocysts was determined by live cell

immunofluorescence staining with 5 µM MitoSOX Red (Molecular Probes, Invitrogen) for
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30 minutes at 37°C and 5% CO2 in air, followed by DNA detection via Hoechst 33342 (1:200
dilution) staining for 15 minutes at 37°C and 5% CO2 in air. Following imaging as described
above, mean total MitoSOX Red fluorescence was calculated. At least 3 females were used
for both control and hormone-treated oocyte and embryo collections.

3.2.7

Immunohistochemistry
For immunohistochemistry analyses, control and hormone-treated embryos were

flushed into warmed M2 medium, washed in 1X PBS and fixed in 4% PFA for 30 minutes.
Following fixation, embryos were permeabilized for 40 minutes in 0.5% Triton-X-100
(Sigma) in 1X PBS, blocked for 1 hour in 5% normal goat serum (NGS) (Jackson
ImmunoResearch), and incubated with 1:50 anti-Tom20 FL-145 (Santa Cruz Biotechnology),
1:100 CHDH (Proteintech), or 1:200 histone 3 lysine 9 dimethylation (H3K9me2) (Abcam)
overnight at 4°C. The next day, embryos were washed three times in antibody dilution buffer
(ADB, 0.005% Triton-X-100 and 1% NGS in 1X PBS), incubated with appropriate
secondary antibody in ADB (1:200) for 1 hour followed by Hoechst 33342 (1:200 dilution)
staining for 20 minutes. Embryos were then washed 3 times before imaging in 4 µL M2
drops under mineral oil in glass bottom dishes. Negative controls without primary antibody
incubation were processed with experimental groups.

3.2.8

Statistical analyses
Significant differences in total mitochondrial distribution for MII oocytes and active

mitochondrial distribution in MII oocytes, 1-cell and 2-cell embryos were analyzed using
one-way ANOVA followed by the nonparametric Kolmogorov-Smirnov (KS) test to analyze
differences between pairs. The nonparametric KS test was used to analyze distribution
differences between the control and treatment groups for total mitochondria in 1-cell and 2cell embryos and active mitochondria in 4-cell, 8-cell, morula and blastocyst embryos.
Statistics for fluorescence intensity analyses for total mitochondria in MII oocytes and active
mitochondria in MII oocytes, 1-cell and 2-cell embryos were performed using one-way
ANOVA followed by Student’s t-test, while Student’s t-test was used to identify significance
between control and hormone-treated 1-cell, 2-cell (total mitochondria, CHDH intensity) 4cell, 8-cell (active mitochondria), morula and blastocyst embryos (total and active
mitochondria, CHDH and H3K9me2 [blastocysts]). All mean fluorescence intensity bar
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graph values are presented as mean ± standard error of the mean (SEM). A p-value of
p<0.01 was considered to be statistically significant.

3.3 Results
3.3.1

Superovulation disrupted total and active mitochondrial pool
and active mitochondrial distribution in MII ovulated oocytes
Adequate mitochondrial numbers and mitochondrial activity are required for

successful meiotic maturation (Yu et al., 2010). To investigate the effects of superovulation
on the total mitochondrial pool in MII ovulated oocytes, live-cell immunofluorescence data
was first obtained for 50 spontaneous, 57 6.25 IU superovulated and 62 10 IU superovulated
oocytes using Mitotracker green and Hoechst 33342 staining. Mitotracker green stains all
mitochondria membranes irrespective of respiratory status and thus is a measure of the total
mitochondrial pool. Compared to control and the 6.25 IU groups, the total mitochondrial
pool was significantly decreased in the 10 IU high hormone treatment group (Figure 3-1A).
Since the high hormone dose disrupted the total mitochondrial pool in oocytes, this
may result in a concomitant decrease in the pool of active mitochondria. I therefore assessed
the active mitochondria pool in oocytes using Mitotracker red imaging in 48 spontaneously
ovulated, 68 6.25 IU superovulated and 67 10 IU superovulated oocytes. Mitotracker red is
a dye that specifically stains mitochondria that are actively respiring through oxidative
phosphorylation, since its accumulation is dependent on oxidation.

Compared to

spontaneous controls, a significant decrease in the respiring mitochondrial pool was present
at both 6.25 IU and 10 IU hormone dosages (Figure 3-1B).
As mitochondria are dynamic organelles and translocate to different regions of the
cytoplasm in oocytes and early embryos, I assessed the distribution of total mitochondria in
spontaneous and superovulated oocytes. Three distinct distribution patterns were observed,
perinuclear, homogenous, and clustered aggregates, with the latter either to one side of the
chromosomes or as clumps dispersed throughout the cytoplasm (Figure 3-1C). With respect
to total mitochondria, the majority of spontaneous, 6.25 IU, and 10 IU superovulated oocytes
had perinuclear mitochondrial localization (86%, 77%, and 77% oocytes, respectively), with
low percentages of oocytes exhibiting homogenous (2%, 5% and 8%, respectively) and
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clustered aggregate (12%, 18% and 15%, respectively) patterns (Figure 3-1C). These
distributions were not significantly different. Of note is that within the clustered distribution
category, oocytes possessed mitochondria that were clustered proximal to the DNA (75%
spontaneous; 36% 6.25 IU; 50% 10 IU), distal to the DNA (12.5% spontaneous; 43%
6.25 IU; 40% 10 IU), or in aggregates throughout the cytoplasm (12.5% spontaneous; 21%
6.25 IU; 10% 10 IU) (Figure 3-1D). These distributions were not significantly different,
although 6.25 IU and 10 IU oocytes trended toward decreased proximal clustering.
Perinuclear translocation of active mitochondria during oogenesis is essential for
oocyte competence (Calarco, 1995; Nagai et al., 2006; Van Blerkom, 1991; Yu et al., 2010).
Therefore, I analyzed whether actively respiring mitochondria were correctly localized to the
perinuclear region in spontaneous oocytes, and whether superovulation disrupted this
organization (Figure 3-1E).

Similar to total mitochondrial distribution, perinuclear,

homogenous, and clustered aggregate patterns were observed for active mitochondria.
However, unlike total mitochondria, distribution of active mitochondria was predominantly
perinuclear (92% oocytes; 4% homogenous; 4% clustered) in spontaneous oocytes, while
6.25 IU and 10 IU hormone-treated oocytes had significantly decreased perinuclear
localization (50%, 60%) and increased homogenous (26%, 22%) and clustered aggregate
(24%, 18%) distributions, respectively (Figure 3-1E).

Within the clustered distribution

category, oocytes had mitochondrial clusters proximal to the DNA (100% spontaneous; 62%
6.25 IU; 58% 10 IU), distal to DNA (0% spontaneous; 38% 6.25 IU; 30% 10 IU), and in
clustered aggregates throughout the cytoplasm (0% spontaneous; 0% 6.25 IU; 8% 10 IU)
(Figure 3-1F). These patterns were not significantly different, although 6.25 IU, and 10 IU
superovulated oocytes seemed to exhibit decreased proximal clustering compared to controls.
Overall, oocytes obtained after high-hormone treatment exhibited a significant
decrease in both the total mitochondrial and active mitochondrial pools. In contrast, the low
hormone dose group exhibited a decreased pool of active mitochondria only.

Total

mitochondria were correctly localized to the perinuclear region in spontaneous, 6.25 IU and
10 IU oocytes. However, active mitochondria were mislocalized as a result of both low and
high hormone treatment, displaying increased homogenous and clustered aggregate patterns
and decreased perinuclear accumulation.
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Figure 3-1: Superovulation disrupts mitochondria in MII ovulated oocytes
(A) The total mitochondrial pool, calculated from average total Mitotracker green
fluorescence intensity in oocytes, was significantly decreased in the 10 IU hormone treatment
group.

(B) The active mitochondrial pool, calculated using total Mitotracker red

fluorescence intensity in oocytes, was significantly decreased in both 6.25 IU and 10 IU
hormone treated groups. (C) Distribution of total mitochondria in spontaneously ovulated
(Spon), 6.25 IU and 10 IU superovulated oocytes was predominantly perinuclear, with a
small percentage of oocytes displaying homogenous and clustered aggregate patterns.
Quantification of distributions is represented as percentage of total oocytes analyzed. (D)
With respect to the clustered total mitochondrial distribution, spontaneously ovulated oocytes
primarily displayed mitochondrial clustering proximal to the DNA, while the 6.25 IU and
10 IU superovulated oocytes exhibited mitochondrial clustering proximal to the DNA, distal
to the DNA, or in clustered aggregates throughout the cytoplasm. (E) Distribution of active
mitochondria in spontaneously ovulated oocytes was a perinuclear ring. 6.25 IU and 10 IU
superovulated oocytes displayed perinuclear localization in addition to aberrant homogenous
and clustered aggregate patterns. Quantification of distributions is depicted as percentage of
total oocytes. (F) For clustered active mitochondrial distribution, spontaneously ovulated
oocytes displayed mitochondrial clustering proximal to the DNA, while the 6.25 IU and
10 IU superovulated oocytes exhibited mitochondrial clustering proximal to the DNA as well
as distal to the DNA and/or in clustered aggregates throughout the cytoplasm.
Representative images are shown. Quantification of mitochondrial fluorescence intensity
was calculated as the mean relative fluorescence units (RFU) in millions ± SEM for each
oocyte group. Numbers in parentheses indicate total number of oocytes analyzed per group.
Asterisks (*) indicate significant differences where p<0.01 determined by one-way ANOVA
followed by nonparametric Kolmogorov-Smirnov test. DAPI DNA staining, blue (A, B) or
magenta (C-F); Mitotracker green staining of total mitochondria, green (A); Mitotracker red
staining of active mitochondria, red (B); white scale bar, 20 µm. Pseudocolour imaging was
applied to analyze mitochondrial distribution (C-F). Pseudocolour scale is shown in panel C.
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3.3.2

Total mitochondrial pool was stable throughout preimplantation
development
To determine whether a decreased total mitochondrial pool persisted in early

cleavage-stage embryos following superovulation, control and 10 IU 1-cell and 2-cell
embryos were stained with Mitotracker green and subjected to live-cell immunofluorescence.
The 6.25 IU low hormone group was not analyzed, as no significant decrease was observed
in oocytes, and since mitochondria DNA does not replicate post-ovulation and mitochondrial
numbers are anticipated to decrease by approximately half with successive cell division
(Larsson et al., 1998; Pikó and Chase, 1973; Pikó and Taylor, 1987). At the 1-cell and 2-cell
stage, no significant difference in the total mitochondrial pool was detected in the control and
10 IU treatment groups (Figure 3-2A, B). I next analyzed the distribution of total
mitochondria within individual blastomeres of 1-cell and 2-cell embryos. Both the control
and 10 IU superovulated groups exhibited a homogenous distribution at the 1-cell stage
(Figure 3-2C) and perinuclear distribution at the 2-cell stage (Figure 3-2D). Since there was
no change in total mitochondrial numbers at the 1-cell and 2-cell stages, I proceeded to
analyze the total mitochondrial pool at the morula and blastocyst stages using Mitotracker
green. No significant difference in the total mitochondrial pool was observed between morula
(Figure 3-3A) and blastocysts (Figure 3-3B) in the control and 10 IU hormone-treated
groups. Overall, 10 IU hormone-treated 1-cell, 2-cell, morula and blastocyst-stage embryos
displayed similar total mitochondrial pools to their control counterparts. These results
indicate that the total mitochondrial pool during preimplantation development is relatively
stable following superovulation.

3.3.3

Total mitochondria distribution is unchanged throughout
preimplantation development
Symmetrical mitochondrial distribution between blastomeres in early preimplantation

embryos is important for competence (Van Blerkom et al., 2000). A previous study indicated
that human 1-cell to 8-cell preimplantation embryos with an uneven distribution of
mitochondria were developmentally compromised (Van Blerkom et al., 2000). To analyze
whether superovulation alters the symmetrical distribution of mitochondria surrounding
pronuclei in 1-cell embryos and between blastomeres in 2-cell embryos, embryos from
control and 10 IU hormone-treated females were classified as either having symmetrical
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(even) or asymmetrical (uneven) mitochondrial segregation. For 1-cell pronuclear embryos,
this was analyzed as the distribution of mitochondria surrounding the pronuclei.

The

majority of 1-cell and 2-cell embryos in the both control and hormone-treated groups
exhibited a symmetrical distribution of mitochondria surrounding pronuclei in 1-cell embryos
(Figure 3-E) or between blastomeres of 2-cell embryos (Figure 3-2F), respectively, with no
significant differences between groups (Figure 3-2E, F). Overall, mitochondrial localization
was predominantly symmetrical in both control and hormone-treated 1-cell and 2-cell
embryos.
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Figure 3-2: Total mitochondrial pool and distribution in 1-cell and 2-cell embryos
(A, B) Total mitochondrial pool quantification, calculated using Mitotracker green relative
fluorescence units (RFU) (millions ± SEM), in 1-cell (A) and 2-cell (B) stage control (Ctrl)
and 10 IU hormone-treated embryos. (C, D) Representative pseudocolour conversion slices
and quantification of the percent of total embryos showing a homogenous distribution of total
mitochondria at the 1-cell stage (C) and a perinuclear distribution of total mitochondria at the
2-cell stage (D). (E, F) Representative pseudocolour images and percentage of total embryos
with a symmetrical (even segregation) or asymmetrical (uneven segregation) distribution of
total mitochondria surrounding pronuclei at the 1-cell stage (E) and between blastomeres at
the 2-cell stage (F) are shown.

DAPI DNA staining, blue (A, B) or magenta (C-F);

Mitotracker green staining of total mitochondria, green (A, B); Mitotracker green staining,
pseudocolour (C-F). Pseudocolour scale is shown in panel C; numbers in brackets indicates
the total number of embryos analyzed per Spon and 10 IU treatment groups; white scale bar
is 20 µm.
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Figure 3-3: Total mitochondrial pool in morula- and blastocyst-stage embryos
Total mitochondrial pool quantification was measured as Mitotracker green relative
fluorescence units (RFU) (millions ± SEM) in control (Ctrl) and 10 IU hormone-treated
morula (A) and blastocysts (B). Representative Z-stack images are shown. DAPI DNA
staining, blue; Mitotracker green staining of total mitochondria, green. Numbers in
parentheses indicate total number of embryos analyzed per group; scale bar is 20 µm.
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3.3.4

Superovulation affected mitochondrial activity but not
mitochondrial organization at early cleavage stages
In addition to total mitochondria pools, I next investigated if the active mitochondrial

pool is perturbed in superovulated early cleavage embryos.

Compared to controls, the

decreased active mitochondrial pool in superovulated oocytes persisted in 1-cell (Figure 34A) and 2-cell (Figure 3-4B) embryos in the hormone groups. This effect was dosedependent. However, no significant difference was seen in the active mitochondrial pool
between 4-cell (Figure 3-4C) or 8-cell (Figure 3-4D) embryos in control and 10 IU groups.
Since perinuclear accumulation of active mitochondria was disrupted in
superovulated oocytes, I evaluated distribution of active mitochondria in cleavage embryos.
Similar to perinuclear active mitochondria in control oocytes (91.6%; Figure 1-1E), the
majority of 1-cell (100%; Figure 3-5A) and 2-cell (93.3%; Figure 3-5B) embryos in the
untreated group maintained perinuclear distribution. Beginning at the 4-cell stage, active
mitochondria move to a cortical arrangement in 4-cell (100%; Figure 3-5C) and 8-cell
(81.5%; Figure 3-5D) embryos. Embryos in superovulated groups displayed a statistically
similar perinuclear distribution to the controls at 1-cell (96.4% 6.25 IU, 82.9% 10 IU; Figure
3-5A) and 2-cell (93.3% 6.25 IU, 85.7% 10 IU; Figure 3-5B) stages, and a primarily cortical
distribution at the 4-cell (95.2% 10 IU, Figure 3-5C) and 8-cell (81.6% 10 IU, Figure 3-5D)
stages. Thus, active mitochondrial distribution defects in superovulated oocytes were no
longer evident in blastomeres of superovulated 1-cell, 2-cell, 4-cell and 8-cell embryos.
Symmetrical distribution of mitochondria exists in competent early cleavage embryos
(Van Blerkom et al., 2000). To determine if superovulation resulted in asymmetric
distribution of mitochondria surrounding pronuclei of the 1-cell embryo and between
blastomeres of cleavage stage embryos, embryos were classified as having symmetric or
asymmetric distribution. The majority of 1-cell (81.8% control, 100% 6.25 IU, 94.3% 10 IU;
Figure 3-6A), 2-cell (90% control, 93.3% 6.25 IU, 82.1% 10 IU; Figure 3-6B), and 4-cell
(95.2% control, 90.5% 10 IU; Figure 3-6C) embryos in the control and hormone groups
displayed a statistically similar symmetrical distribution of active mitochondria. Although
not statistically significant, compared to controls (92.6%, Figure 3-6D), the symmetrical
distribution in 10 IU 8-cell embryos (73.7%) was slightly decreased.
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Figure 3-4: Active mitochondrial pool in early cleavage stage embryos
Active mitochondrial pool quantification in 1-cell (A), 2-cell (B), 4-cell (C) and 8-cell (D)
early cleavage stage embryos. Representative Z-stack images are shown. Quantification of
active mitochondrial pool was calculated as the mean total Mitotracker red fluorescence units
(RFU in millions ± SEM). Numbers in parentheses indicate the total number of embryos
analyzed. DAPI DNA staining, blue; Mitotracker red staining of active mitochondria, red;
scale bar, 20 µm; Ctrl, control.
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Figure 3-5: Active mitochondrial distribution in early preimplantation embryos
Representative pseudocolour conversion slices of embryos showing active mitochondria
moving from a perinuclear distribution at the 1-cell (A) and 2-cell (B) stage to a cortical
distribution at the 4-cell (C) and 8-cell (D) stages. This occurred in both control (Ctrl) and
10 IU embryos.

Quantification of perinuclear (A, B) and cortical (C, D) staining is

represented as the percentage of total embryos analyzed. DAPI DNA staining, magenta;
Mitotracker red staining, pseudocolour (scale in panel A). Numbers in brackets indicate the
total number of embryos analyzed per group and the scale bar is 20 µm.
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Figure 3-6: Mitochondrial segregation between pronuclei and blastomeres in early
preimplantation embryos
Embryos at the 1-cell (A), 2-cell (B), 4-cell (C), and 8-cell (D) stage were classified as
having symmetrical (Sym, even segregation) or asymmetrical (Asym, uneven segregation)
distribution of active mitochondria between blastomeres.

Representative pseudocolour

image slices of symmetrical and asymmetrical distributions are shown above each graph.
Graphs display the percentage of control (Ctrl), 6.25 IU and 10 IU embryos displaying either
distribution. The pseudocolour scale is shown in panel B. DAPI DNA staining, magenta;
Mitotracker red staining of active mitochondria, pseudocolour; white bar, 20 µm.
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Overall, the active mitochondrial pool was significantly reduced in a dose-dependent
manner in superovulated 1-cell and 2-cell embryos, but this effect was not observed at 4-cell
and 8-cell stages. Furthermore, active mitochondria were correctly localized in control and
hormone-stimulated 1-cell to 8-cell embryos, specifically to the perinuclear region at 1-cell
and 2-cell stages, to the cortical region at 4-cell and 8-cell stages, and symmetrically around
pronuclei and between blastomeres from 1-cell to 8-cell stages. Thus, ovarian stimulation
led to reduced active mitochondrial pools up to the 2-cell stage, after which there were no
significant differences between control and hormone-stimulated early cleavage embryos.

3.3.5

Superovulation perturbs mitochondria in morula and blastocyststage embryos
A previous study on human preimplantation embryos demonstrated asymmetrical

mitochondrial distribution in developmentally competent late (12-16 cell) cleavage embryos
(Van Blerkom et al., 2000). To determine the effects of superovulation on mitochondrial
distribution between blastomeres in morula- and blastocyst-stage embryos, pseudocolour
imaging was applied to Mitotracker green and Mitotracker red staining to allow
characterization of mitochondrial intensity in individual blastomeres of an embryo.
Blastomeres were classified as having low (primarily blue pseudocolour), medium (mostly
green/yellow pseudocolour) or high (primarily red/white pseudocolour) amounts of
mitochondria (i.e. Mitotracker red, 10 IU morula #84; 12 low; 4 medium; 10 high; Figure 37A-J). Since a previous study identified increased levels of total mitochondria in
trophectoderm compared to inner cell mass cells at the blastocyst stage (Houghton, 2006), I
assessed inner and outer cells separately for total mitochondrial levels and active
mitochondria levels. For total mitochondria distribution, in both control and 10 IU groups,
inner blastomeres possessed low total mitochondria compared to outer blastomeres.
Furthermore, no significant difference was observed in the percent of inner blastomeres with
low levels of total mitochondria between control and 10 IU embryos. However, for outer
blastomeres, compared to controls, blastomeres of embryos in the 10 IU group exhibited an
increased percentage of blastomeres with low total mitochondria in both morula (control
18.3%; 10 IU 31.9%, Figure 3-7K) and blastocysts (control 33.7%; 10 IU 50.2%, Figure 37L). Additionally in blastocysts, outer cells in the 10 IU embryo group had significantly
decreased high total mitochondria (24.9% control, 8.8% 10 IU; Figure 3-7L).
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Figure 3-7: Total mitochondrial distribution in morula- and blastocyst-stage embryos
In morula- and blastocyst-stage preimplantation embryos, blastomeres were classified as
having low (L, primarily blue pseudocolour), medium (M, mostly green/yellow
pseudocolour) or high (H, primarily red/white pseudocolour) amounts of total mitochondria.
Individual slices (A-J, example Mitotracker red 10 IU morula #84) of each embryo were
analyzed, and each blastomere was followed throughout a subset of slices (see arrows for
examples) to determine its classification.

(K) Early morula- and (L) blastocyst-stage

embryos were divided into inner and outer cells for analysis. Representative morula (K) and
blastocyst (L) are shown, with percentage of total blastomeres showing each distribution
depicted in each graph. DAPI DNA staining, magenta; (A-J) Mitotracker red staining of
active mitochondria, pseudocolour; (K, L) Mitotracker green staining of total mitochondria,
pseudocolour; white bar, 20 µm; Ctrl, control. Pseudocolour scale bar is shown under panel J.
Asterisks indicate significant differences determined by Student’s T-test.
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My assessment of mitochondrial activity with Mitotracker Red revealed that morula
(Figure 3-8A) and blastocysts (Figure 3-8B) in the 10 IU group had a significant decrease in
the active mitochondria pool compared to controls. At the blastomere level, morula and
blastocysts in both control and 10 IU groups had an asymmetrical distribution of active
mitochondria between outer and inner blastomeres, with inner blastomeres primarily
displaying low mitochondrial activity.
For outer blastomeres, compared to the control group, embryos in the 10 IU group
displayed a significantly decreased percentage of blastomeres with high mitochondrial
activity in morula (control 50.9%; 10 IU 26.8%, Figure 3-8C) and blastocysts (control
53.3%; 10 IU 21.1%, Figure 3-8D).

This coincided with a decreased percentage of

blastomeres with low (morula control 19.5%; 10 IU 35.2%, Figure 3-8C; blastocysts control
14.5%; 10 IU 34.0% Figure 3-8D) and medium (morula control 29.6%; 10 IU 37.9%, Fig.
8C; blastocysts control 32.2%; 10 IU 44.8%, Figure 3-8D) amounts of active mitochondria in
embryos obtained after hormone treatment.
By comparison, inner blastomeres were indistinguishable between control and 10 IU
morula-stage embryos (Figure 3-8C). However, inner cells of blastocysts from the 10 IU
group displayed a decreased percentage of blastomeres with low amounts of active
mitochondria (control 96.6%, 10 IU 89.0%) and an increased percentage of blastomeres with
medium amounts of active mitochondria (control 3.4%, 10 IU 10.3%, Figure 3-8D).
On an individual embryo basis, few control morula (7%, Figure 3-9A) and blastocysts
(4% Figure 3-9B) had less than 15% of outer blastomeres with high mitochondrial activity.
By comparison, in the 10 IU group, approximately half of the morula (44%, Figure 3-9A)
and blastocysts (56% Figure 3-9B) had less than 15% of blastomeres with high amounts of
active mitochondria.
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Figure 3-8: Active mitochondria intensity and distribution in morula and blastocysts
Active mitochondrial pool quantification, calculated from total Mitotracker red fluorescence
intensity, in morula- (A) and blastocyst-stage (B) control (Ctrl) and 10 IU hormone-treated
embryos. Representative Z-stack images are shown along with mean relative fluorescence
units (RFU) in millions ± SEM for each group. Active mitochondrial distribution in inner
and outer blastomeres of morula (C) and blastocysts (D) depicted as percentage of
blastomeres with low (L, primarily blue pseudocolour), medium (M, mostly green/yellow
pseudocolour) or high (H, primarily red/white pseudocolour) amounts of active
mitochondria. Representative slices are shown. DAPI DNA staining, magenta; Mitotracker
red staining of active mitochondria, red (A, B) and pseudocolour (C, D); white bar, 20 µm;
Ctrl, control. Pseudocolour scale bar is shown in panel D. Asterisks indicate significant
differences.

147

148

Figure 3-9: Active mitochondrial distribution patterns in individual morula and
blastocysts
Distribution of active mitochondria in individual (A) control morula, (B) hormone-stimulated
morula, (C) control blastocysts and (D) hormone-stimulated blastocysts. Data is arranged
(left to right) in decreasing percentage of blastomeres with high (purple bars), then medium
(green bars), then low (orange bars) percentage amounts of active mitochondria. The dotted
black line represents where 15% of blastomeres within an embryo have high amounts of
active mitochondria.
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Since ATP is utilized by the Na+/K+-ATPase pump in trophectoderm cells, and this is
required for successful cavitation and blastocyst formation (Madan et al., 2007), I assessed
cell number (total, inner and outer) (Figure 3-10A) and blastocyst cavity volume (Figure 310B) in control and 10 IU blastocysts. Compared to controls, total cell numbers (Figure 310C), outer cell numbers and inner cell numbers (Figure 3-10D) were significantly increased
in the 10 IU blastocyst group compared to controls, while blastocyst cavity volume was not
significantly different (Figure 3-10E).
Overall, late preimplantation embryos exhibited an asymmetrical distribution of both
total and active mitochondria. In comparison to control embryos, morula and blastocysts
from the 10 IU hormone group exhibited an increase in the proportion of outer cells
exhibiting low amounts of mitochondria, both total and active.

In addition, high total

mitochondria in blastocysts and high active mitochondria in morula and blastocysts were
significantly decreased in outer cells of embryos in the 10 IU hormone group. The decrease
in active mitochondria in outer cells of blastocysts was not associated with decreased
blastocyst cell number or cavity volume.
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Figure 3-10: Cell number and blastocyst cavity volume
Merge of bright field and DAPI staining for (A) cell counts and (B) blastocyst cavity volume.
(C) Total cell number and (D) outer and inner cell numbers and (E) blastocyst cavity volume
in control and 10 IU blastocysts. Asterisks indicate significant differences determined by
Student’s t-test and numbers in parentheses indicate the number of embryos analyzed. DAPI
DNA staining, blue; white bar, 20 µm. Representative embryos are shown with embryo
number indicated on the top left of bright field images and cell number (A) and cavity
volume (B) indicated at the bottom right. Red line (1), horizontal cavity length; green line
(2), vertical cavity length.
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3.3.6

Superovulation does not alter TOM20 levels but increases
superoxide accumulation
To determine if mitochondrial function was affected following ovarian stimulation,

levels of the mitochondrial import protein translocase of outer membrane 20 (TOM20) and
oxidative stress was assessed. Nuclear-mitochondrial cross talk is vital for proper control of
gene expression and mitochondrial function (Woodson and Chory, 2008). Nuclear-encoded
proteins are imported into the mitochondria to control its function in response to cellular
demand (Jiang and Wang, 2012; Mootha et al., 2003). TOM20 specifically targets the outer
mitochondrial membrane and is responsible together with TOM22 to recognize and import
cytosolic N-terminal mitochondrial preproteins (Baker et al., 2007; Perry et al., 2008). Since
import of nuclear-encoded cytosolic proteins is crucial for mitochondrial function, TOM20
protein expression was analyzed by immunofluorescence in blastocysts from control and
10 IU superovulated females. No significant difference in TOM20 levels was observed
between blastocysts in the control and 10 IU hormone groups (Figure 3-11A). Furthermore,
there was no difference in the distribution of TOM20 between inner (control 80.0%, 10 IU
79.1%) and outer (control 73.2%, 10 IU 76.7%) blastomeres of these embryos, where the
majority displayed medium levels of TOM20 immunofluorescence (Figure 3-11B).
Mitochondrial dysfunction in aged oocytes has been attributed to increased oxidative
stress causing oxidative damage (Chappel, 2013; Venkatesh et al., 2010). To assess whether
superovulation leads to increased oxidative stress, I analyzed the accumulation of superoxide,
a reactive oxygen species (ROS) produced as a byproduct of mitochondrial respiration, using
MitoSOX live-cell immunofluorescence. Oxidation of MitoSOX by superoxide produces red
fluorescence. Compared to controls, blastocysts in the 10 IU group displayed significantly
increased superoxide intensity levels (Figure 3-11C).

To identify if accumulation of

superoxide is more prevalent in inner or outer cells, pseudocolour imaging was applied and
cells were quantified as having low, medium or high superoxide levels. Control blastocysts
exhibited low superoxide in both inner (100%) and outer (89.3%) cells (Figure 3-11D). In
contrast, while no significant difference in superoxide accumulation was observed between
inner cells of control blastocysts versus the 10 IU hormone group (97.5% low, Figure 311D), outer cells of the hormone group exhibited a significant increase in blastomeres with
medium superoxide levels (37.1%), and decrease in cells with low superoxide levels (58.1%).
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Figure 3-11: TOM20 and superoxide in control and 10 IU blastocysts
(A) TOM20 protein levels in control (Ctrl) and 10 IU blastocysts. Data were analyzed as
relative fluorescence units (RFUs) ± SEM. DAPI, blue; TOM20 protein, red. (B) Percentage
of outer and inner blastomeres with low (L), medium (M) or high (H) amounts of TOM20
immunofluorescence. (C) MitoSOX staining of superoxide levels in control (Ctrl) and 10 IU
blastocysts.

Data were analyzed as RFUs ± SEM. (D) Percentage of outer and inner

blastomeres with low (L), medium (M) or high (H) superoxide levels. Representative Zstacks (A, C) and slices (B, D) are shown. Number in parentheses indicate the total number
of embryos analyzed. DAPI DNA staining, blue; MitoSOX staining, red; pseudocolour L,
primarily blue, pseudocolour M, mostly green/yellow; pseudocolour H, primarily red/white.
The pseudocolour scale bar is shown in panel B and the white bars measure 20 µm.
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3.3.7

CHDH protein levels
Another function of mitochondria is to produce a proportion of the metabolites

required for epigenetic control of nuclear gene expression. For example, methylation groups,
provided by the methyl donor S-adenosylmethionine (SAM), in the blastocyst are derived
through two 1-carbon metabolic pathways (Ikeda et al., 2012); the folate cycle and the
betaine-homocysteine methyltransferase (BHMT) pathway (Zhang et al., 2015). The BHMT
pathway requires the enzyme choline dehydrogenase (CHDH).

Choline dehydrogenase

localizes to the inner mitochondrial membrane where it catalyzes the 2-step conversion of
choline to betaine. This specific pathway is active in mouse blastocysts (Anas et al., 2008;
Lee et al., 2012). Furthermore, Chdh deletion in mouse (Johnson et al., 2010) and a single
nucleotide polymorphism in the human CHDH that decreases CHDH protein levels (Johnson
et al., 2012) perturbs mitochondrial function in sperm and results in decreased sperm
motility, indicating a role for CHDH in mitochondrial function. Thus, CHDH dysregulation
has the potential to disrupt both mitochondrial function and DNA methylation. Since CHDH
is a maternal effect protein, levels were analyzed in fertilized 1-cell embryos by CHDH
protein immunofluorescence. There was a significant decrease in CHDH protein
immunofluorescence, as measured by total RFUs, in 1-cell embryos derived from 10 IU
hormone-treated females compared to controls (Figure 3-12A). I next assessed the levels of
CHDH and global H3K9me2, a repressive histone methylation mark, in control and 10 IU
blastocysts. In contrast to 1-cell embryos generated after ovarian stimulation, there was no
longer a significant difference in CHDH protein levels (Figure 3-12B). Furthermore, global
levels of the repressive histone 3 lysine 9 dimethylation (H3K9me2) mark (Figure 3-12C)
were unchanged between control and 10 IU blastocysts.

Additionally, there was no

difference in the distribution of CHDH between inner (control 28.0% high, 62.4% medium;
10 IU 26.0% high, 65.2% medium) and outer (control 71.8% high, 20.9%; 10 IU 71.2% high,
24.2% medium) blastomeres of these embryos, where the majority displayed high or medium
levels of CHDH immunofluorescence (Figure 3-12D). Having said this, a greater number of
blastocysts, and more stages of preimplantation development, need to assessed for CHDH
and H3K9me2 levels in control and hormone treated groups before this analysis is
completed.
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Figure 3-12: CHDH protein in 1-cells and blastocysts in the control and 10 IU groups
(A) CHDH protein levels in 1-cell embryos in the control (Ctrl) and 10 IU groups. (B)
CHDH protein levels in blastocysts in Ctrl and 10 IU groups. Data were analyzed as relative
fluorescence units (RFUs) ± SEM. DAPI, blue; CHDH protein, red. (C) Global H3K9me2
levels normalized to DAPI RFUs (quantified as total H3K9me2 RFU divided by total DAPI
RFU) in blastocysts in the Ctrl and 10 IU groups. DAPI, blue; H3K9me2, green. (D)
Percentage of outer and inner blastomeres with low (L), medium (M) or high (H) amounts of
CHDH immunofluorescence. Representative Z-stacks (A, C) and slices (B, D) are shown.
Number in parentheses indicates the number of embryos analyzed. The pseudocolour scale
bar is shown in panel D and white bars measure 20 µm.
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3.4 Discussion
My study is the first to report a detailed analysis of total and active mitochondrial
pools, location, and distribution in control and hormone-treated oocytes and embryos
throughout preimplantation development, specifically from the MII oocyte to the blastocyst
stage (Figure 3-13). I showed that high-hormone treatment led to a decrease in the total and
active mitochondria pool in oocytes and abnormal accumulation of active mitochondria away
from the perinuclear region. Subsequently, the total mitochondrial pool was no longer
affected by hormone administration in 1-cell, 2-cell, morula and blastocysts, although the
active mitochondria pool was significantly decreased in a dose-dependent manner in 1-cell
and 2-cell embryos. This decrease was no longer present in 4-cell and 8-cell embryos in the
10 IU group. With respect to mitochondrial distribution, 1-cell and 2-cell embryos from both
control and stimulated females displayed homogenous and perinuclear distribution patterns
of total mitochondria, respectively.

Furthermore, all embryos, regardless of exogenous

hormone administration, displayed perinuclear accumulation of active mitochondria at 1-cell
and 2-cell stages and cortical distribution of active mitochondria at 4-cell and 8-cell stages.
Finally, late preimplantation embryos exhibit an asymmetrical distribution of both total and
active mitochondria.

In comparison to control embryos, morula and blastocysts in the

hormone-treated group exhibited an increase in the proportion of outer cells with low
amounts of both total and active mitochondria. In addition, high total mitochondria in
blastocysts and high active mitochondria in morula and blastocysts were significantly
decreased in outer cells of embryos in the hormone-treated group. This was accompanied by
decreased active mitochondria in morula and blastocysts in the 10 IU hormone group, and
increased superoxide in outer cells of 10 IU embryos. Overall, these results indicate that
10 IU hormone stimulation ultimately leads to blastocysts exhibiting abnormal mitochondrial
dynamics in outer/TE cells.
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Figure 3-13: Summary of hormone-induced disruption of mitochondrial dynamics
The effects of hormone administration (10 IU) on the total mitochondrial pool (Total Mito,
Mitotracker green), the active mitochondrial pool (Active Mito, Mitotracker red), distribution
of total mitochondria (Total distribution, Mitotracker green), distribution of active
mitochondria (Active distribution, Mitotracker red), superoxide levels (MitoSOX staining),
TOM20 immunofluorescence (TOM20) and CHDH levels (CHDH) are summarized.
Upwards arrow, increased in 10 IU hormone embryos; downwards arrow, decreased in 10 IU
hormone-stimulated embryos; equal sign, no change between hormone and control groups;
NA, not analyzed; P, perinuclear; H, homogenous; Cl, clustered; Co, cortical; Outer, outer
cells of morula- and blastocyst-stage embryos
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It is well documented that oocytes with decreased mitochondria and/or mitochondrial
DNA molecules (Murakoshi et al., 2013; Pikó and Taylor, 1987; Reynier et al., 2001; Santos
et al., 2006) or a decreased ability to produce ATP (i.e. mitochondrial activity) (Assou et al.,
2006; Ge et al., 2012; May-Panloup et al., 2005; Selesniemi et al., 2011; St John et al., 2010;
Thouas et al., 2004; Yu et al., 2010) have reduced developmental competence. Furthermore,
domains of concentrated respiratory activity in oocytes, as previously observed in
differentiated cells (Collins et al., 2002; Diaz et al., 1999), permit local ATP supply and
demand for spatially localized processes during oogenesis (Van Blerkom et al., 2002; Yu et
al., 2010). Consistent with this, perinuclear accumulation of active mitochondria in mouse,
human and porcine is essential for the high-energy consuming processes that occur during
oogenesis, namely nuclear and meiotic maturation and polar body extrusion (Nagai et al.,
2006; Sun et al., 2001; Tokura et al., 1993; Van Blerkom, 1991; Van Blerkom and Runner,
1984; Van Blerkom et al., 2000; Yu et al., 2010). In this study, I observed a dose-dependent
effect of ovarian stimulation on mitochondria in resulting oocytes. In comparison to
spontaneously ovulated oocytes, oocytes ovulated after low hormone dose administration had
a decrease in the active mitochondrial pool, although the total mitochondrial pool was
unchanged. By comparison, high hormone-treated oocytes displayed a decrease in the total
mitochondrial pool and as well as a decrease in the active mitochondrial pool. This indicates
that a decrease in the total mitochondrial pool could lead to the diminished active
mitochondrial pool in the 10 IU hormone group.
Active mitochondrial accumulation at the perinuclear region is required for oocyte
maturation (Nagai et al., 2006; Sun et al., 2001; Tokura et al., 1993; Van Blerkom, 1991;
Van Blerkom and Runner, 1984; Van Blerkom et al., 2000; Yu et al., 2010). Although total
mitochondria in superovulated oocytes maintained a perinuclear organization, the active
mitochondria were mislocalized. Superovulated oocytes exhibited increased homogenous and
clustered distributions and decreased perinuclear organization in comparison to their
spontaneously ovulated counterparts.

Effects on the active mitochondria pool and

distribution also occurred at the lower hormone dose.
Overall, my results in oocytes indicate that superovulation leads to increased
production of oocytes with mitochondrial defects, namely a decreased total mitochondrial
pool, active mitochondrial pool, and active mitochondrial localization. These specific defects
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have previously been shown to impede successful completion of the second meiotic division
of oogenesis and subsequent development.

Future studies should confirm this data by

analyzing the effect of superovulation on total mitochondrial DNA numbers, total
mitochondrial numbers using transmission electron microscopy (TEM), and resulting ATP
production. As mitochondria in the mouse and human oocyte are translocated by microtubule
structures (Kan et al., 2011; Van Blerkom, 1991; Van Blerkom et al., 2000), it is possible that
superovulation disrupts the microtubule network required for successful perinuclear
translocation of active mitochondria. In fact, decreased mitochondrial generation of ATP has
been shown to cause disassembly of meiotic spindles (Zhang et al., 2006). Furthermore, in
mouse and human somatic cells, mitochondrial function and ROS levels/oxidative stress have
been implicated in regulating microtubule dynamics (Shi et al., 2010; Wilson and GonzálezBillault, 2015). Thus, it is possible that superovulation induced mitochondrial dysfunction
leads to failure to establish microtubule-dependent perinuclear accumulation of
mitochondria. Future research should investigate the effect of superovulation on cytoskeletal
structures, particularly the microtubule network.
The ability of superovulated oocytes with insufficient numbers of mitochondria to
complete meiosis and undergo successful fertilization is compromised in both human
(Reynier et al., 2001; Santos et al., 2006) and pig (Shourbagy et al., 2006). By extension
generation of ATP is important for oocyte maturation and fertilization (Dumollard et al.,
2004; Yu et al., 2010; Zhang et al., 2006). However, completion of meiosis and subsequent
fertilization can occur over a wide range of ATP contents, while it is continued
embryogenesis and implantation that is compromised in embryos from oocytes with low ATP
contents (Van Blerkom et al., 1995). Consistent with these studies, I have shown that
superovulation leads to the disruption of the total mitochondrial pool in oocytes, although
this was no longer evident in 1-cell and 2-cell embryos, which displayed a similar total
mitochondrial pool compared to spontaneous counterparts. However, 1-cell and 2-cell
preimplantation embryos continued to exhibit a decrease in the active mitochondrial pool
compared to spontaneous counterparts, and this was dose-dependent. This decrease in the
hormone-treated group was no longer evident in 4-cell and 8-cell embryos, suggesting that 2cell embryos with decreased mitochondrial activity may undergo a 2-cell block in
development; a phenomenon that was originally observed in cultured embryos and certain
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strains of mice (Biggers, 1998).

The 2-cell block depends on maternally inherited

cytoplasmic factors (Biggers, 1998; Goddard and Pratt, 1983; Muggleton-Harris and Brown,
1988; Zanoni et al., 2009) and is associated with lower ATP and mitochondrial membrane
potential (Komatsu et al., 2014; Wang et al., 2009). Two-cell embryos are particularly
vulnerable as the mouse embryonic genome is activated at this stage and this process requires
ATP (Bianchi and Sette, 2011; Bultman et al., 2006). Therefore, 2-cell embryos generated
after ovarian stimulation with reduced mitochondrial activity may be energetically incapable
of cleaving to the 4-cell stage.

Future studies should be directed towards analyzing

mitochondrial dynamics using time-lapse microscopy to determine whether oocytes with
decreased total mitochondria do not undergo successful fertilization, and whether 2-cell
embryos with decreased mitochondrial activity are unable to divide to the 4-cell stage.
Mouse and human 1-cell and 2-cell embryos display perinuclear accumulation of
mitochondria (Tokura et al., 1993; Van Blerkom, 2000; Van Blerkom et al., 2000; Van
Blerkom, 2009; Wilding et al., 2001; Zhao et al., 2009). Furthermore, developmentally
competent embryos exhibit an even distribution of mitochondria between blastomeres while
those that arrest and lyse have an uneven segregation of mitochondria. With regards to
mitochondrial distribution in early cleavage embryos, regardless of ovarian stimulation, total
mitochondria was homogenous in 1-cell embryos and perinuclear in 2-cell embryos, active
mitochondria accumulated at the perinuclear region in 1-cell and 2-cell embryos, while 4-cell
and 8-cell embryos exhibited cortical accumulation of active mitochondria.

Thus, it is

possible that superovulated oocytes that did not establish perinuclear translocation of active
mitochondria at the MII stage were unable to complete meiosis and be fertilized to create
perinuclear 1-cell embryos. In my study, the distribution of mitochondria around pronuclei
and between blastomeres was mostly symmetrical in both control and hormone stimulated
zygote to 8-cell embryos, indicating exogenous hormone administration does not lead to an
increased frequency of asymmetrically distributed mitochondria. Overall, by 4-cell and 8-cell
stages of preimplantation development, embryos generated spontaneously or by ovarian
stimulation were indistinguishable with respect to active mitochondrial intensity and
distribution.
Adequate amounts of mitochondrial activity throughout preimplantation are required
for successful development through to the blastocyst stage (Wakefield et al., 2011; Wilding
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et al., 2001). As embryos progress to the morula and blastocyst stages, blastomeres no longer
exhibit comparable mitochondrial distributions, with total and active mitochondria
preferentially localizing to the outer cells (Houghton, 2006; Van Blerkom et al., 2000). This
is further supported by ATP production, oxygen consumption, and amino acid turnover that
are significantly increased in blastocyst trophectoderm compared to inner cell mass cells
(Houghton, 2006). Additionally, activity of the Na+/K+-ATPase, located on the basolateral
surface of the trophectoderm cells accounts for 60% of the ATP used in human blastocysts
(Houghton et al., 2003). Ultimately, the blastocysts requires ATP-dependent Na+/K+-ATPase
to drive cavitation and blastocyst formation (Madan et al., 2007). In my study, I also
observed a similar unequal mitochondrial distribution in morula and blastocysts in both the
control and 10 IU hormone groups. Here, superovulation led to significant alteration in the
allocation of mitochondria in the outer blastomeres, with an increased percentage of
blastomeres displaying low amounts of total and active mitochondria, and a decreased
percentage of cells with high amounts of active mitochondria. This decrease did not coincide
with decreased number of cells in blastocysts obtained after hormone treatment, nor did it
result in decreased embryo cavity volume, which would be suggestive of defective blastocyst
cavitation. Instead, while blastocysts produced after hormone treatment had increased cell
numbers, they had similar embryo cavity volumes compared to controls. The increased cell
number could be due to a compensatory mechanism accounting for a lower mitochondrial
activity in 10 IU hormone-stimulated embryos. Future studies are required to investigate the
effect of low mitochondria in outer blastomeres of hormone-treated embryos on downstream
measurements such as successful blastocyst hatching, implantation and resulting pregnancy.
Hyperstimulation has previously been shown to result in increased superoxide
production in the mouse oocyte (Chao et al., 2005), and increased superoxide increases
mitochondrial DNA mutations, which can ultimately affect oxidative phosphorylation and
ATP generation (Jacobs et al., 2007; Keefe et al., 1995; Shamsi et al., 2013; Venkatesh et al.,
2010). In this study, superovulation led to a significant increase in superoxide accumulation
in blastocyst embryos, specifically in the outer blastomeres. Increased mitochondrial
superoxide accumulation could result in decreased mitochondrial activity in outer embryonic
cells. However, future studies will be required to determine the downstream consequences of
this superoxide accumulation. Having said this, superovulation did not seem to impact
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nuclear control over mitochondrial function, as measured by both intensity and localization
of the mitochondrial import protein TOM20, which was unchanged between control and
hormone groups.
In addition to providing the oocyte and preimplantation embryo with the energy
required for development, mitochondria also provide the cell with metabolites needed for
epigenetic control of gene expression (Martinez-Pastor et al., 2013; Wallace and Fan, 2010).
For example, methyl groups for the preimplantation embryo (generated from SAM) are
produced in part via the betaine pathway, where choline is catalyzed to betaine in a 2-step
process that involves CHDH (Anas et al., 2008; Ikeda et al., 2012; Lee et al., 2012). This
reaction occurs in the mitochondria. Therefore, I analyzed the effect of ovarian stimulation
on CHDH protein levels. My results indicate that the maternal supply of CHDH protein in
fertilized 1-cell embryos is significantly decreased after exogenous hormone treatment
compared to controls. Consequently, this could affect the methyl pool available during
preimplantation development. By the blastocyst stage, this decrease no longer appeared to be
present in the hormone-stimulated group, which showed similar levels of CHDH and the
repressive histone methylation mark, H3K9me2, in comparison to controls. Overall, future
studies are required to determine the effect of ovarian stimulation on CHDH protein levels
throughout preimplantation development, in addition to determining the consequences of
decreased CHDH methylation present in 1-cell embryos and subsequent cleavage stage
embryos with respect to both DNA and histone methylation.
Current practices to increase success in the ART clinic have begun to target the
mitochondria.

These include the controversial techniques of mitochondrial replacement

therapy and AUGMENT.

My study confirms the importance of mitochondria in

preimplantation development. Additionally, it points to the greater need to understand the
effects that all ARTs treatment modalities have on the mitochondria, as well as the basic
science behind new technologies targeting mitochondria in animal models and clinical trials.
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Chapter 4

4

Discussion

4.1 General overview
Infertility has risen to 16% of Canadian couples, tripling since 1984 (5.4%) (Bushnik
et al., 2012). Similar numbers exist in the United States, with infertility affecting more than
10% of adult women (6.1 million) and 9% (4.7 million) of adult males, representing 10 to
15% of couples (Chandra et al., 2013). Due to rising rates of infertility, many couples are
seeking medically assisted reproductive technologies (ARTs).

Thus, it is becoming

increasingly important for researchers to investigate the effects of these techniques on the
manipulated oocyte and preimplantation embryo.
The developmental competence and health of the preimplantation embryo is
dependent on successful completion of coordinated molecular processes that occur during
early gamete and embryo development. Two of these pathways include DNA methylation
reprogramming (Macdonald and Mann, 2014) and mitochondrial dynamics (Van Blerkom,
2011). Here, I investigated (a) the effects of ARTs on imprinted DNA methylation in human
preimplantation embryos, and (b) the effect of ovarian stimulation on mitochondrial
dynamics in mouse oocytes and preimplantation embryos. Although these pathways are
distinct, based on my data, I propose that ARTs predispose trophectoderm cells of
preimplantation embryos to aberrant imprinted methylation and mitochondrial defects.

4.1.1

Human ART embryos display a high frequency of imprinted
methylation errors
Genomic imprinting disorders occur at an increased prevalence in the population of

children conceived by ARTs (Okun and Sierra, 2014). Thus, numerous animal models have
investigated the impact of ARTs on imprint establishment in oocytes and maintenance in
preimplantation embryos [reviewed in (Denomme and Mann, 2012)]. One benefit of using
the mouse as a model is that it allows for controlled studies of the effects of individual ART
procedures without issues of confounding infertility. Major findings from mouse studies
indicate that imprinted methylation is disrupted by superovulation (Hajj et al., 2011; MarketVelker et al., 2010b), in vitro fertilization (IVF) (Fauque et al., 2010), in vitro embryo culture
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(Li et al., 2005; Mann et al., 2004; Market-Velker et al., 2010a; 2012) and cryopreservation
(Cheng et al., 2014).

Abnormal imprinted methylation occurs in 10-90% of ART

preimplantation embryos (Fauque et al., 2007; Hajj et al., 2011; Market-Velker et al., 2010b;
2012).
In contrast, due to the limited availability of and ethical issues associated with the use
of human gametes and preimplantation embryos, very few studies have analyzed imprinted
DNA methylation in the human, with the majority of studies utilizing human embryos not
suitable for embryo transfer (Chen et al., 2010; Geuns et al., 2003; 2007; Ibala-Romdhane et
al., 2011; Khoueiry et al., 2012; Shi et al., 2014). To uncover the discrepancy between
imprinted DNA methylation errors in mouse preimplantation embryos and human ART
children, I evaluated individual, good to high quality, day 3 and blastocyst stage human
preimplantation embryos for imprinted methylation at SNRPN, KCNQ1OT1 and H19. I
specifically analyzed these regions because they are associated with the three imprinting
disorders showing increased prevalence (1 in 5,000 children) in the ART population (Okun
and Sierra, 2014). The experimental design I used allowed for analysis of more than one gene
per embryo in addition to comparing short and extended embryo culture. The human
embryos used were subjected to the combined effect of multiple ARTs, namely ovarian
stimulation, IVF/ICSI, in vitro embryo culture, and cryopreservation. Importantly, these
embryos were suitable for transfer but instead were donated for research after patients no
longer needed embryos for their treatment. Overall, I observed a similar frequency of
imprinted methylation errors in the donated human embryos to that observed in mouse
(Fauque et al., 2007; Hajj et al., 2011; Market-Velker et al., 2010b; 2012) and other studies
of poor quality human preimplantation embryos (Chen et al., 2010; Geuns et al., 2003; 2007;
Ibala-Romdhane et al., 2011; Khoueiry et al., 2012; Shi et al., 2014). Imprinted methylation
in similar good to high-quality human preimplantation embryos has only been analyzed in
two previous studies with small embryo numbers (14 blastocysts (Khoueiry et al., 2012), 5
blastocysts (Ibala-Romdhane et al., 2011) compared to the 24 day 3 embryos and 29
blastocysts analyzed here). Therefore, my results are of clinical relevance as the embryos
analyzed are representative of cleavage-stage and blastocyst-stage embryos that could be
transferred to patients with the potential of future pregnancy. Overall, these results indicate
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that good quality, transferrable human ART preimplantation embryos possess a frequency of
imprinted methylation errors similar to that previously reported in the mouse.
Studies in the mouse permit controlled analysis of the effects of individual ARTs on
resulting imprinted DNA methylation, without the confounding effects of inherent infertility.
The results of these studies generally indicate that increasing the number of ART procedures
exacerbates imprinting errors (de Waal et al., 2015; Fauque et al., 2007; Market-Velker et al.,
2010a; Rivera et al., 2008). However, discrepancy in the field exists with regards to whether
it is the infertility treatment or inherent infertility itself that results in abnormal imprinted
methylation (Doornbos et al., 2007; Ludwig et al., 2005; Strawn et al., 2010). Notably, I
identified two embryos possessing abnormal imprinted methylation that were generated using
donor sperm due to male factor infertility. In these cases, inherent infertility is bypassed as
embryos were generated with oocytes and sperm from a fertile man and woman. Although
this is small subset of embryos, it provides support for ART-induced errors, presumably in
the absence of inherent infertility.
Taken together, I have identified similar imprinted DNA methylation abnormalities at
the SNRPN, KCNQ1OT1 and H19 ICRs in human embryos to that observed in the mouse.
Importantly, extending analyses to both day 3 cleavage and blastocyst stage embryos allowed
me to conclude that continued culture to the blastocyst stage does not seem to pose greater
risks for imprinting perturbations, although analyses during subsequent development would
be required to confirm this result.

4.1.2

Ovarian stimulation disrupts mitochondria in mouse oocytes
and preimplantation embryos
The vital role mitochondria have in establishing developmental competence of the

oocyte and preimplantation embryo, and consequently IVF success, has fueled the design of
new techniques aimed at improving or reconstituting the mitochondrial pool in oocytes and
embryos in IVF clinics worldwide (Meldrum et al., 2016; Reinhardt et al., 2013; Wolf et al.,
2015; Woods and Tilly, 2015). These techniques are experimental, and very few studies
have been performed to examine their safety. Additionally, the effects of standard ART
protocols on mitochondria have not been fully discerned. Here, I specifically demonstrated
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that the most commonly used, indispensable treatment modality, ovarian stimulation, led to
mitochondrial disruption in oocytes and preimplantation embryos.
To extend my analysis of the effects of ARTs on the oocyte and preimplantation
embryo, I analyzed the effects of ovarian stimulation on mitochondria in mouse oocytes and
throughout preimplantation development. Ovarian stimulation is implemented to increase
the number of follicles recruited for ovulation during assisted reproduction. The doses of
exogenous hormones that accompany ovarian stimulation are administered during oogenesis,
and coincide with the crucial time-points of drastic mitochondrial replication, biogenesis,
respiration, and mitochondrial localization changes. Consequently, this ART procedure has
the potential to disrupt mitochondria in the mature, ovulated MII oocyte. I specifically
identified that ovarian stimulation with exogenous hormones leads to a decrease in both total
and active mitochondrial pools, and an increase in the percentage of ovulated oocytes
displaying abnormal active mitochondrial localization.

These results are consistent with

previous studies, which showed that ovarian stimulation disrupted mitochondrial DNA copy
numbers and mitochondrial membrane potential in ovulated oocytes (Combelles and
Albertini, 2003; Ge et al., 2012; Gibson et al., 2005).
Analysis of embryos obtained after exogenous hormone treatment at later stages of
preimplantation development indicated that mitochondrial perturbations caused by ovarian
stimulation preferentially occurred in the outer trophectoderm cells. In both morula and
blastocyst-stage embryos, I reported a decrease in high amounts of active mitochondria in
outer cells and a concomitant increase in the percentage of outer blastomeres inheriting low
amounts of active mitochondria. I also saw increased superoxide in outer cells of hormonestimulated embryos compared to controls.

Increased oxidative damage could increase

mitochondrial DNA damage, consequently affecting respiration and ATP generation (Jacobs
et al., 2007; Keefe et al., 1995; Shamsi et al., 2013; Venkatesh et al., 2010). However, this
remains to be determined.
Finally, I investigated the effects of hormone treatment on choline dehydrogenase
(CHDH) levels.

CHDH links mitochondria to epigenetic regulation as it catalyzes the

conversion of choline into betaine aldehyde at the inner mitochondrial membrane. This
substrate is required for production of s-adenosylmethionine (SAM), the cells methyl donor,
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through the betaine pathway (Anas et al., 2008; Ikeda et al., 2012; Lee et al., 2012). I
identified a significant decrease in CHDH levels in hormone stimulated 1-cell embryos
compared to controls. However, this decrease no longer appeared to be present in hormonestimulated blastocysts compared to controls. Furthermore, there appeared to be no difference
in global levels of the repressive histone mark, histone 3 lysine 9 dimethylation (H3K9me2),
in blastocysts in the 10 IU group compared to controls. Thus, my results suggest that ovarian
stimulation may lead to the disruption of mitochondrial control of epigenetic regulation in
cleavage stage embryos, but this requires further investigation.
Overall, I have shown that ovarian stimulation alone, as an existing and indispensable
ART procedure, leads to the disruption of mitochondria in the outer/trophectoderm cells of
resultant morula- and blastocyst-stage embryos. As respiration in the outer/trophectoderm
cells is critical for blastocyst formation and hatching (Larsson et al., 1998; Madan et al.,
2007; Watson et al., 2004), future studies are required to investigate the downstream effects
of this disruption.

4.1.3

Contributions to the field of reproductive biology
Overall, my work presented in this thesis advances the field of reproductive biology

with the following novel findings: (a) ARTs disrupt imprinted methylation at the SNRPN,
KCNQ1OT1 and H19 imprinting control regions (ICRs) in day 3 and blastocyst-stage, good
to high quality, human embryos; (b) this occurs at a similar frequency to that observed in the
mouse; (c) extended culture from the day 3 to blastocyst stage did not pose a greater risk for
imprinting errors compared to short culture; (d) mitochondria were also disrupted by ARTs,
specifically ovarian stimulation, resulting in decreased active mitochondrial pools, and
mitochondrial localization defects as well as increased superoxide levels in the
outer/trophectoderm cells of morula- and blastocyst-stage embryos; and (e) ovarian
stimulation also leads to decreased CHDH protein levels in 1-cell embryos produced after
hormone treatment; however, this decrease no longer appeared to be present in blastocyststage embryos in the 10 IU group.

This research is relevant to the human clinic and

demonstrates the need to establish a mechanistic basis for the validation of optimal
techniques and procedures that will ensure the generation of healthy, viable embryos for
infertile couples.
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4.2 ARTs and the trophectoderm
The results of my thesis suggest that the trophectoderm is a selective target of ARTinduced defects. Specifically, in the first aim of this thesis, I demonstrated that human
embryos produced through the use of multiple ARTs in the human IVF clinic exhibit a high
frequency of abnormal imprinted DNA methylation. However, disparity still exists with
regards to the frequency of imprinting errors in human preimplantation embryos (6-89%
embryos) (Chen et al., 2010; Geuns et al., 2003; 2007; Ibala-Romdhane et al., 2011;
Khoueiry et al., 2012; Shi et al., 2014; White et al., 2015) compared to the frequencies of
imprinting errors reported in ART children (~1 in 5,000 children) (Okun and Sierra, 2014).
In the second aim of my thesis, I demonstrated that ovarian stimulation alone disrupted
mitochondrial dynamics in mouse oocytes and preimplantation embryos. This resulted in a
decreased amount of active mitochondria and increased superoxide production in
outer/trophectoderm cells of blastocysts obtained after hormone stimulation. Thus, ARTs
affected two important components of early embryogenesis: imprinted DNA methylation
maintenance and mitochondrial function. Hence, I hypothesize that the connection between
these results is that ARTs-induced disruptions selectively occur within the trophectoderm.
One explanation for the discrepancy between imprinting errors in human embryos
compared to resulting children could be that blastomeres with aberrant imprinted methylation
are preferentially relegated to the trophectoderm lineage. In support of this, many studies in
mouse have reported a selective loss of imprinted methylation and/or imprinted expression in
the placenta compared to the embryo in midgestation mouse embryos following
superovulation (Fortier et al., 2008; 2014) or preimplantation development in culture (de
Waal et al., 2014; Khosla et al., 2001; Mann et al., 2004; Rivera et al., 2008). A recent study
in mouse found that ART procedures reduced fetal and placental growth at midgestation,
reduced DNA methylation at H19, Kcnq1ot1 and Snrpn ICRs in the placenta, suppressed
placental expression of paternally expressed imprinted genes that enhance fetal growth, and
upregulated placental expression of maternally expressed imprinted genes that repress fetal
growth (Li et al., 2016).

In humans, placentas from a group of successful IVF/ICSI

pregnancies displayed abnormal H19/IGF2 expression compared to placentas from natural
conceptions (Sakian et al., 2015; Turan et al., 2010). If imprinted methylation errors in
human ART preimplantation embryos preferentially arise in the trophectoderm rather than
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embryonic cells, this would explain the reduced frequency of imprinting disorders in the
resulting child.
A greater frequency of imprinted methylation errors in trophectoderm and placenta
could lead to failed implantation or aberrant placental and fetal growth. The essential role of
imprinted genes in placental function and fetal growth has been established in the mouse
[reviewed in (Tunster et al., 2013)]. A correlation between imprinted gene expression in the
placenta and resulting fetal growth was recently demonstrated in human, where increased or
decreased placental expression of specific imprinted genes was correlated with large or small
for gestational age infants (Kappil et al., 2015). Thus, relegation of imprint abnormalities to
the trophectoderm could account for the increased frequencies of IUGR, low birth weight,
small for gestational age (Okun and Sierra, 2014) or large for gestational age (Hansen and
Bower, 2014; Ishihara et al., 2014; Korosec et al., 2014; 2016; Li et al., 2014; Pinborg et al.,
2014; Sazonova et al., 2012; Wennerholm et al., 2013) in ART children. Consistent with
this, abnormal imprinted gene methylation or expression has been detected in IUGR
(Gonzalez-Rodriguez et al., 2016; López-Abad et al., 2016; Madeleneau et al., 2015;
McMinn et al., 2006) and low birth weight/ small for gestational age (Bouwland-Both et al.,
2013; Kanber et al., 2009) placentas compared to controls. In my study, patients who
donated their frozen embryos had received a fresh embryo transfer from the same cycle of
which the donated frozen embryos were obtained. Resulting information was available
regarding live birth rate and pregnancy outcomes. Consistent with growth restriction and
overgrowth being associated with aberrant methylation or expression of imprinted genes,
45% of newborns from patients in my study were outside clinically normal birth weight, with
1 high (>4000g), 5 low (<2500g), 1 very low (<1500g) and 1 extremely low (<1000g). This
may suggest that the high frequency of imprinted DNA methylation errors in remaining day 3
cleavage and blastocyst embryos could lead to a range of effects regarding placental
development and growth. While risk of multiples increases the risk of low birth weight, it
should be noted that one of the very low birth weight infants and one of the high birth weight
infants were singletons, resulting in 2 out of 9 (22%) singletons under/above clinically
normal birth weight. This increased risk of low birth weight (Helmerhorst et al., 2004;
Jackson et al., 2004; Okun and Sierra, 2014; Reddy et al., 2007; Savage et al., 2011; Schieve
et al., 2002; Sunderam et al., 2014; 2015; Wisborg et al., 2010) and large for gestational age
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(Hansen and Bower, 2014; Ishihara et al., 2014; Korosec et al., 2014; 2016; Li et al., 2014;
Pinborg et al., 2014; Sazonova et al., 2012; Wennerholm et al., 2013) in singletons of ART
pregnancies has been previously reported.
In addition to imprinted genes playing a role in placental function, mitochondrial
studies also indicate a specific role for mitochondria in the trophectoderm. Trophectoderm
cells of blastocysts exhibit increased mitochondrial content, ATP production, oxygen
consumption, and amino acid turnover compared to cells in the inner cell mass (Assou et al.,
2006; Houghton, 2006; Houghton et al., 2003; Thundathil et al., 2005).

Increased

mitochondrial activity in the trophectoderm lineage is required to activate the Na+/K+
ATPase, which accounts for 60% of the ATP used in human blastocysts (Houghton et al.,
2003) and is required for cavity formation (Madan et al., 2007). I also observed in untreated,
control embryos preferential total and active mitochondrial localization to trophectoderm
cells in morula and blastocysts, indicating that this is a consistent process that normally
occurs during preimplantation development. Ovarian stimulation led to a disruption in the
mitochondria content of outer/trophectoderm cells, specifically resulting in decreased active
mitochondrial pools and increased superoxide levels in outer/trophectoderm cells of morula
and blastocysts. This indicates that the disruption was initiated when blastomeres adopted
inner and outer cell identity, as outer morula cells will be specified to the trophectoderm
lineage (Artus and Chazaud, 2014).
Consistent with these observations, ART-induced mitochondrial defects have been
demonstrated preferentially in the placental cell lineage (Thouas et al., 2006; Wakefield et
al., 2011). Specifically, embryos cultured in media containing low concentrations of a
mitochondrial inhibitor had reduced placental but not fetal growth (Wakefield et al., 2011),
while mitochondrial dysfunction in mouse oocytes lead to a decrease in trophectoderm cell
number (Thouas et al., 2006).

Although the consequences of perturbed mitochondrial

function in trophectoderm cells is unknown, like imprinted DNA methylation errors,
mitochondrial disruption in the placenta has been implicated in growth restriction of the
developing fetus. Data from human IUGR placentas demonstrate a significant decrease in
the expression of genes involved in mitochondrial function and oxidative phosphorylation,
specifically affecting 3 out of 5 complexes of the respiratory chain (Madeleneau et al., 2015).
Lower mitochondrial DNA content and higher placental superoxide dismutase activity, likely
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to counteract oxidative damage, has also been observed in small for gestational age
pregnancies (Díaz et al., 2014). Finally in the mouse, mutation of a subunit of complex II of
the respiratory chain induced ROS production and resulted in excessive apoptosis leading to
low birth weight and growth retardation (Ishii et al., 2011). Overall, ART induced disruption
of imprinted DNA methylation and mitochondria could be preferentially occurring in the
outer/trophectoderm cells of the blastocyst embryo, and I propose this would lead to failed
implantation or aberrant placental function and consequently, abnormal fetal growth.

4.2.1

Potential link between ART-induced disruption of mitochondria
and imprinted DNA methylation
The role of mitochondria in epigenetic regulation is a recently emerging area of

interest. The relationship between mitochondria and chromatin arises through the metabolic
products of energy consumption, as numerous intermediate epigenetic metabolites are
produced by mitochondrial utilization of carbon sources to generate ATP (Castegna et al.,
2015; Martinez-Pastor et al., 2013; Wallace, 2010; Wallace and Fan, 2010) (Figure 4-1).
First, histone acetylation and corresponding active chromatin depends on the availability of
the acetyl-coA substrate. In mammals, the majority of acetyl-coA is derived from the
precursor citrate, which is produced solely by the mitochondria as a byproduct of the
tricarboxylic acid (TCA) cycle and converted into acetyl-coA by the nuclear-encoded
enzyme ATP-citrate lyase (ACL) (Martinez-Pastor et al., 2013; Wellen et al., 2009) (Figure
4-1A). The ACL-catalyzed generation of acetyl-coA from citrate is required for histone
acetylation (Wellen et al., 2009). In contrast to histone acetylation, histone deacetylation and
corresponding repressive chromatin exhibits a metabolic influence through histone
deacetylase (HDAC) activity and nicotinamide adenine dinucleotide (NAD+), another
product of mitochondrial metabolism (Carafa et al., 2016; Martinez-Pastor et al., 2013)
(Figure 4-1B). DNA and histone methylation are also regulated by mitochondrial-produced
metabolites (Martinez-Pastor et al., 2013). During preimplantation development, two 1carbon metabolic pathways, the betaine pathway (Figure 1-4C) and the folate cycle (Figure
4-1D), are required to produce methionine and ultimately S-adenosylmethionine (SAM)
(Ikeda et al., 2012). S-adenosylmethionine (SAM), the universal methyl donor for histone
and DNA methylation, is produced from methionine by S-adenosylmethionine transferase
(MAT) (Lu, 2000). This reaction requires ATP, the product of mitochondrial respiration (Lu,
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2000; Martinez-Pastor et al., 2013; Teperino et al., 2010) (Figure 4-1E). The reverse reaction,
or removal of methyl groups from histone proteins, is catalyzed by histone demethylases
(HDMs), which require two metabolites [flavin adenine dinucleotide (FAD+) (Anand and
Marmorstein, 2007) and α-ketoglutarate (Tsukada et al., 2006)], that are produced during the
TCA cycle (Martinez-Pastor et al., 2013; Teperino et al., 2010) (Figure 4-1F). Finally, the
end product of cellular respiration, ATP, is required as a substrate for histone
phosphorylation in addition to powering ATP-dependent chromatin remodeling complexes
(Runge et al., 2016). Thus, it is likely that fluctuations in mitochondrial respiration impact
epigenetic dynamics. As the oocyte provides the preimplantation embryo with its only source
of mitochondria during preimplantation development, and mitochondria provide the
preimplantation embryo with its source of epigenetic metabolites, it is possible epigenetic
control of imprint maintenance during preimplantation development is dependent on
mitochondrial respiration. Overall, I would anticipate that decreased mitochondrial
respiration, and consequently decreased ATP, would force blastomeres to allocate their
metabolites to processes vital for immediate survival (i.e. DNA replication, transcription, cell
division, and cavitation in blastocyst-stage embryos). This would have the net effect of
reducing the metabolite pool required for proper epigenetic control of gene expression, for
example, imprinted DNA methylation.
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Figure 4-1: Mitochondria and epigenetics
The relationship between mitochondria and nuclear epigenetic regulation is mediated through
intermediate metabolites produced during mitochondrial respiration.

(A, pink arrows)

Citrate, produced through the tricarboxylic acid cycle (TCA), is converted to acetyl-coA by
ATP citrate lyase (ACL). Histone acetyltransferases (HATs) catalyze the addition of acetyl
groups (green square) to histones for formation of active chromatin. (B, red arrow) Histone
deacetylation requires histone deacetylases (HDACs) and nicotinamide adenine dinucleotide
(NAD+), a metabolite from the TCA cycle, to remove acetyl groups. In preimplantation
embryos, two 1-carbon metabolism pathways are involved in generation of methionine and
ultimately S-adenosylmethionine (SAM), the universal methyl donor. (C, blue arrows) In the
first pathway, choline is converted into betaine aldehyde by the inner mitochondrial
membrane enzyme choline dehydrogenase (CHDH, green circle).

Betaine aldehyde is

subsequently converted into betaine in the mitochondrial matrix by betaine aldehyde
dehydrogenase (BADH). Betaine-homocysteine S-methyltransferase (BHMT) then converts
betaine and homocysteine to dimethylglycine (DMG) and methionine, respectively. (D,
orange arrows) In the folate pathway, folic acid is reduced to tetrahydrofolate (THF), which
is

converted

to

methylene

hydroxymethyltransferase (SHMT).

tetrahydrofolate

(methylene

THF)

Methylene tetrahydrofolate reductase

by

serine

(MTHFR)

catalyzes methylene THF conversion to methyl THF, and methionine synthase converts
methyl THF and homocysteine to THF and methionine, respectively. (E, purple arrows)
Finally, methionine from both pathways is converted into S-adenosylmethionine (SAM) by
S-adenosylmethionine transferase (MAT) and ATP. SAM is the methyl donor for DNA
methylation (white circle; unmethylated CpGs; black circles, methylated CpGs) and histone
(i.e. H3K9me2) methylation (red square).

(F, yellow arrow) Demethylation by histone

demethylases (HDMs) involves substrates flavin adenine dinucleotide (FAD+, utilized in the
TCA cycle) and α-ketoglutarate, an intermediate in the TCA cycle.
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A few studies have directly analyzed the effect of mitochondrial disruption on
epigenetic control of nuclear gene expression. Depletion of mitochondrial DNA resulted in
significant DNA methylation changes at a number of genes (Smiraglia et al., 2008), in
addition to decreasing the presence of multiple acetylation marks of histone H3, H2B and H4
(Martínez-Reyes et al., 2016). A further relationship between mitochondria and epigenetics
was demonstrated in Dnmt1o-deficient placentas (Himes et al., 2015). These placentas were
characterized by swollen mitochondria with abnormal cristae, and exhibited metabolomic
profiles indicative of mitochondrial dysfunction (Himes et al., 2015). I hypothesized that
ovarian stimulation-induced disruption of mitochondria consequently leads to aberrant
epigenetic regulation. Specifically, I demonstrated that CHDH, a mitochondrial membrane
protein involved in production of SAM during preimplantation development (Ikeda et al.,
2012; Zhang et al., 2015), was significantly decreased in the 1-cell 10 IU hormone stimulated
group. By the blastocyst stage, there was no apparent difference in CHDH levels or the
repressive histone 3 lysine 9 dimethylation (H3K9me2) mark in 10 IU blastocysts compared
to controls.

Future studies are needed to investigate downstream effects of CHDH

disruption in 1-cell and subsequent cleavage stage embryos, in addition to determining the
effects of ARTs on other mitochondrial metabolites involved in epigenetic regulation.

4.3 Translating results to the human ART clinic
The results that I obtained in this thesis are relevant to the human ART clinic. Of
particular relevance are the findings I obtained regarding imprinted methylation after
extended culture to the blastocyst stage. Specifically, I was the first to analyze imprinted
methylation at two different stages of preimplantation development: the day 3 cleavage and
the blastocyst stage. Recently, there has been movement towards elective single embryo
transfer (eSET) in ART to decrease the rate of multiple births (Maheshwari et al., 2011; Styer
et al., 2016). Furthermore, the advent of one free cycle of ART funding specifically in
Ontario requires that a single embryo be transferred in patients ≤35 years of age (Motluk,
2016).

Consequently, many fertility clinics will culture embryos from good prognosis

patients to the blastocyst stage to help identify the best embryo for transfer based on rate of
development and morphological grading (Blake et al., 2007; Gardner et al., 2000; Gleicher et
al., 2015; Glujovsky et al., 2012; Ubaldi et al., 2015). The data I obtained in this study
support additional culture to the blastocyst stage. Specifically, the presence of methylation
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errors in both day 3 (76%) and blastocyst (50%) stage embryos indicated that methylation
errors already exist in ~6 to 8-cell cleavage embryos, and extending culture to the blastocyst
stage of development does not appear to pose an increased risk for imprinted methylation
errors.
Human fertility clinics implement supraphysiological exogenous hormone doses in
addition to using multiple ART procedures to generate preimplantation embryos for transfer
to mothers. The overall live birth rate after ART is 25% per egg retrieval and 29% per
embryo transfer in Canada (Human Assisted Reproduction 2014) and 39.4% per embryo
transfer in the United States (Sunderam et al., 2015)]. Furthermore, the incidence of low
birth weight (29.1% ART, 8% non-ART) and preterm birth (33.6% ART, 11.4% non-ART)
is higher in the ART population than among all infants in the total birth population of the
United States (Sunderam et al., 2015).

As the embryos analyzed in this study were

transferrable but frozen for future cycles, the results here are applicable to the human clinic.
The high frequency of imprinted DNA methylation abnormalities that I reported might
provide one explanation for the birth rates between 25%-39% and increased incidences of
fetal growth abnormalities in the ART population. Mild stimulation and minimizing the
number of ARTs used in human IVF could be beneficial, as additional studies in the mouse
have also demonstrated dose-dependent effects of hormone-stimulation on imprinted DNA
methylation (Market-Velker et al., 2010b) as well as confounding effects of multiple ARTs
on imprinted DNA methylation errors (de Waal et al., 2015; Fauque et al., 2007; MarketVelker et al., 2010a; Rivera et al., 2008). The same is true for mitochondrial dynamics
throughout human IVF. My research along with others demonstrates that ARTs disrupt
mitochondrial numbers, activity, membrane potential and distribution in the oocyte and
preimplantation embryo (Acton et al., 2004; Amoushahi et al., 2013; Combelles and
Albertini, 2003; Ge et al., 2012; Gibson et al., 2005; Lee et al., 2006; Lei et al., 2014;
Manipalviratn et al., 2011; Wilding et al., 2001; Zander-Fox et al., 2013; Zhao et al., 2011a;
2011b; 2009). Minimizing the hormone dose and number of ART techniques may minimize
effects to mitochondria during IVF. Furthermore, with the recent advent of novel procedures
in human ART designed to alter mitochondrial sources by nuclear transfer into donor oocytes
(Reinhardt et al., 2013; Wolf et al., 2015) or injecting mitochondria from ovarian cortex cells
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into the oocyte during ICSI (Woods and Tilly, 2015), it is important to continue studies on
mitochondria with regards to both pre-existing and novel ART methods.

4.4 Future directions
4.4.1

ARTs and imprinted DNA methylation in human preimplantation
embryos
During preimplantation development in the mouse, recruitment of protein complexes

to ICRs is required to ensure maintenance of DNA methylation when the remainder of the
genome undergoes genome-wide DNA demethylation (Denomme and Mann, 2013). These
maternal effect protector proteins include DPPA3 (Nakamura et al., 2007; 2012), DNMT1o
and DNMT1s (Cirio et al., 2008a; 2008b; Hirasawa et al., 2008), and ZFP57 (Li et al., 2008;
Quenneville et al., 2011; Zuo et al., 2012). As I reported similar disruptions to imprinted
DNA methylation in the human preimplantation embryo to those reported in mouse, the next
steps would be to determine the mechanism behind this disruption. Specifically, I would
assess the maternal factors that regulate imprinted methylation maintenance in donated
human preimplantation embryos. First, I would analyze whether DPPA3/DPPA3 mRNA and
protein are present in donated human zygotes. As DPPA3 transcript has been detected in
human oocytes (Goto et al., 2002; Kobayashi et al., 2012; Yan et al., 2013), I expect that the
role of this protein in protecting imprinted domains from active DNA demethylation from the
1-cell to 2-cell stage is conserved. Co-localization of DPPA3 and H3K9me2 (Nakamura et
al., 2007; 2012) in human zygotes would be conducted by immunofluorescence to identify
whether DPPA3 and H3K9me2 preferentially localize to the maternal pronucleus to protect
imprinted domains from active DNA demethylation, and whether a subset of human embryos
display mislocalization. Mislocalization of DPPA3 and H3K9me2 in human zygotes would
suggest that the imprinted methylation errors I observed in day 3 human preimplantation
embryos originates at the first cleavage division. Next, I would assess the DNMT1o/s mRNA
and DNMT1o/s protein levels at all stages of preimplantation development in donated human
embryos. The presence of these mRNAs and proteins has been confirmed in human oocytes
and preimplantation embryos (Huntriss et al., 2004; Okae et al., 2014; Petrussa et al., 2014).
Therefore, I would specifically analyze nuclear localization of DNMT1o/s in early cleavagestage embryos and separately, in inner/outer cell nuclei of later-stage preimplantation
embryos. Finally, I would analyze the ZFP57 expression and ZFP57 protein levels in
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donated human preimplantation embryos.

Although ZFP57 mRNA was not present in

human oocytes (Okae et al., 2014), levels were detected in human morula (Yan et al., 2013).
Additionally, the fact that mouse and human ZFP57 proteins are interchangeable in
maintaining imprinted DNA methylation in mouse indicates conservation of this protein
(Takikawa et al., 2013). In mouse, ZFP57 is required for imprint maintenance at the 8-cell
stage of preimplantation development (Denomme and Mann, 2013; Li et al., 2008;
Quenneville et al., 2011). Therefore I would concentrate analyses of ZFP57 to later stages of
preimplantation development.

Again, I would assess nuclear localization of ZFP57

beginning at the 8-cell stage and separately in inner and outer nuclei of morula and
blastocysts.

Overall, I would anticipate a disruption in DPPA3 and/or DNMT1o/s

localization during early cleavage development to account for the aberrant imprinted DNA
methylation I identified in day 3 embryos.

Furthermore, I would also expect to see

preferential loss of DNMT1o/s and/or ZFP57 in the outer nuclei of donated human morula
and blastocysts.

4.4.2

ARTs and mitochondria
My second aim was to analyze the effect of an indispensable ART treatment, ovarian

stimulation, on mitochondrial pools, localization, and function during preimplantation
development. I identified that ovarian stimulation led to decreased active mitochondrial pools
and increased superoxide levels in the outer cells of morula and blastocyst-stage embryos.
Mitochondrial activity in control and hormone-stimulated embryos was assessed at all stages
of preimplantation development. However, embryos were recovered at distinct stages and not
followed throughout the course of cleavage development. Consequently, this analysis would
benefit from time-lapse imaging of embryos and mitochondria throughout the course of
preimplantation development, for multiple reasons. Using this technique, mitochondrial
dynamics could be linked to specific embryo characteristics such as failed fertilization and
embryonic cleavage. From my results, I hypothesized that hormone-stimulated oocytes with
decreased total mitochondria pool cannot be fertilized to generate zygotes. This hypothesis
could be tested using time-lapse imaging. Specifically, MitoTracker green-stained oocytes
would be subjected to live-cell imaging, after which sperm would be injected using ICSI and
successful fertilization of individual oocytes could be examined with time-lapse imaging.
Next, I hypothesized that hormone-treated 2-cell embryos with decreased active
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mitochondrial pool undergo a 2-cell block in development. Using time-lapse microscopy, I
would test this hypothesis by assessing the ability of hormone-stimulated 2-cell embryos with
decreased mitochondrial activity to cleave to the 4-cell stage. This finding would indicate
that sufficient energy is required for 2-cell embryos to activate the embryonic genome and
bypass a 2-cell block in development. The use of time-lapse during subsequent cleavage
development will help to identify the segregation patterns of mitochondria in later-stage
preimplantation embryos.

Specifically as 8-cell and morula-stage embryos divide,

orientation of the plane of cleavage will determine whether a blastomere will give rise to an
inner (inner cell mass) and outer (trophectoderm) cell (asymmetric cleavage), or two outer
(trophectoderm) cells (symmetric cleavage) (Artus and Chazaud, 2014). I would therefore
use time-lapse imaging to analyze the segregation of mitochondria with respect to the
orientation of division. In the hormone-treated groups, which exhibit a decrease in the
percentage of outer blastomeres inheriting high mitochondria, I would expect to see an
abnormal segregation of mitochondria during symmetric cleavage generating two outer cells.
Specifically, I anticipate that distribution of mitochondria in this scenario will be reminiscent
of asymmetric cleavage, where one cell inherits less mitochondria than the other.
Investigation of the downstream consequences of abnormal mitochondrial dynamics
in trophectoderm cells of blastocysts should also be assessed. Specifically, I would assess
whether blastocysts with abnormal mitochondria in trophectoderm cells are able to undergo
blastocyst hatching and implantation. To analyze whether hormone-stimulated embryos with
aberrant mitochondria in the trophectoderm exhibit decreased hatching rates, control and
10 IU blastocysts would be subjected to live-cell Mitotracker red imaging and subsequently
cultured until hatching is complete or embryos degenerate. To analyze post-implantation
development of blastocysts, control and hormone-stimulated embryos would be subjected to
live-cell Mitotracker red imaging then transferred to pseudopregnant females. Specifically,
recipient females would randomly receive embryos with abnormal mitochondria in one
uterine horn and control embryos in the other. Implantation rates will be calculated as the
number of implantation sites compared to the number of embryos transferred, and this will be
compared for uterine horns containing embryos with abnormal mitochondria versus control
embryos along with fetal and placental analysis.
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Recent experimental infertility treatments have been aimed at replacing existing
oocyte mitochondria in an attempt to bypass inheritance of mitochondrial disease or enhance
IVF success (Chappel, 2013; Reinhardt et al., 2013; Wolf et al., 2015; Woods and Tilly,
2015). These techniques are already implemented in human IVF with little supporting
research performed to assess their safety. The need for investigation of these techniques has
been acknowledged by few research groups, and a recent study examining replacement of
mitochondria through nuclear transfer between a donor and recipient oocyte found that
mitochondrial heteroplasmy leads to reversion to the disease phenotype (Yamada et al.,
2016). This further emphasizes the need to carefully analyze these treatments. Since I have
shown that ovarian stimulation alone leads to mitochondrial disruption, it is essential that
these new techniques be scrutinized. To study the effects of mitochondrial replacement
therapy, AUGMENT and CoQ10 administration on mitochondrial dynamics, I would first
use time-lapse imaging to assess the activity and distribution of mitochondria throughout
preimplantation development after each treatment. This would be completed using a mouse
model. Specifically, oocytes generated using each treatment will be fertilized and cultured to
the blastocyst stage while being subjected to time-lapse Mitotracker red imaging. Treatment
groups would be compared to spontaneously obtained zygotes cultured to the blastocyst stage
and subjected to Mitotracker time-lapse imaging. Additionally with respect to AUGMENT, I
would assess mitochondrial morphology in injected oocytes and throughout preimplantation
development using transmission electron microscopy to assess whether mitochondria are
structurally underdeveloped and elongate to mature forms first in trophectoderm cells of
blastocysts (Motta et al., 2000; Pikó and Chase, 1973; Van Blerkom et al., 1973). If I find
that this is not the case, it will mean that mitochondria injected during AUGMENT are not
morphologically equivalent to mitochondria in a mature oocyte.

4.4.3

Establishing a connection between the effects ARTs on
mitochondria and imprinted DNA methylation
Together, the results presented in my thesis suggest that ARTs might affect processes

specifically in the trophectoderm. This is supported by the discrepancy between the high
frequency of imprinted methylation errors in human preimplantation embryos and low
penetrance of imprinting disorders in resultant ART children; mitochondrial abnormalities in
the trophectoderm of hormone-stimulated blastocysts; and the seeming role of imprinted
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gene regulation and mitochondria respiration in placental insufficiency. Overall, I propose
that decreased mitochondrial activity in trophectoderm cells of blastocysts derived from
hormone-treated females causes abnormal imprinted DNA methylation. I hypothesize that
this would be due to decreased availability of metabolites/epigenetic molecules produced as
products of mitochondrial respiration. In support of this, I identified decreased CHDH
protein levels in 1-cell embryos in the hormone-stimulated group. This decrease no longer
appeared to be present in blastocysts in the hormone-stimulated group and did not correspond
with diminished global H3K9me2 levels in blastocysts. Therefore, to further test the effect of
ovarian stimulation on mitochondrial control of epigenetic regulation, I would analyze
CHDH protein levels throughout all stages of preimplantation development to determine
whether embryonic genome activation at the 2-cell stage compensates for the decreased
maternally-derived CHDH in 1-cell embryos. Additionally, rather than analyzing the effect
of ovarian stimulation on global methylation levels as I did using H3K9me2
immunofluorescence analyses, I would analyze the effect of ovarian stimulation-induced
mitochondrial disruption on gene-specific DNA methylation. Specifically, blastocysts in the
control and 10 IU treated group would be subjected to live-cell Mitotracker red imaging and
then trophectoderm and inner cell mass would be isolated separately to single
trophectoderm/epiblast cells, which would be subjected to the bisulfite mutagenesis and
sequencing assay. Imprinted methylation would be tested at the Snrpn, Kcnq1ot1 and H19
imprinted domains for both maternal and paternal alleles in hormone-stimulated embryos
with normal mitochondria, hormone-stimulated embryos with abnormal mitochondria, and
control untreated embryos.

Abnormal imprinted methylation in trophectoderm but not

epiblast samples would indicate that imprinted methylation errors predominantly occur in the
trophectoderm lineage. Furthermore, if this occurs in the group of embryos with abnormal
mitochondria, a correlation between decreased mitochondrial activity and imprinted
methylation errors in the trophectoderm can be made.
If the above results indicate a linkage between mitochondria and imprinted DNA
methylation in the trophectoderm, I would assess postimplantation development of normal
and affected embryos. Embryos with normal and aberrant mitochondria will be transferred to
separate uterine horns of recipient females.

Downstream postimplantation development

would be then be assessed separately for fetal and placental parameters as previously
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described (Wakefield et al., 2011). Additionally, imprinted DNA methylation and expression
would be assessed.

Overall, I would anticipate that embryos obtained after hormone

stimulation with decreased mitochondrial activity in trophectoderm cells display decreased
fetal and placental weights and abnormal imprinted regulation compared to controls. This
would mean that ART-induced effects occurring in the trophectoderm disrupt both
mitochondria and imprinted DNA methylation, ultimately resulting in abnormal growth of
the embryo through placental insufficiencies.

4.5 Conclusions
The use of assisted reproductive technologies has rapidly increased since the first
human success story in 1978 (Steptoe and Edwards, 1978). The treatment modalities used by
infertile couples to conceive their own biological child are continually growing in number. It
is therefore imperative that research be conducted to assess any negative consequences of
these techniques on the oocyte, preimplantation embryo, and resulting children. Work in this
thesis has specifically provided insight on the effects of ARTs on two critical components of
successful development: imprinted DNA methylation maintenance and mitochondrial
dynamics. Specifically, I have shown that imprinted DNA methylation is disrupted in human
preimplantation embryos, and ovarian stimulation alone leads to perturbations in
mitochondrial dynamics in mouse oocytes and embryos. These two affected pathways may
converge, and future studies are required to delineate whether these effects are (1) specific to
the trophectoderm cell lineage, and (2) whether ART-induced mitochondrial dysfunction
alters epigenetic signatures such as imprinted DNA methylation.
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